ACADIA Pharmaceuticals Inc.
Pendahuluan
Halaman ini memberikan analisis komprehensif tentang sejarah perdagangan orang dalam yang diketahui dari Baker Bros. Advisors (GP) LLC. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Adalah ilegal bagi orang dalam untuk melakukan perdagangan di perusahaan mereka berdasarkan informasi spesifik yang tidak dipublikasikan. Ini tidak berarti bahwa mereka dilarang melakukan perdagangan apa pun di perusahaan mereka sendiri. Namun, mereka harus melaporkan semua perdagangan kepada SEC melalui Formulir 4. Terlepas dari pembatasan ini, penelitian akademis menunjukkan bahwa orang dalam - secara umum - cenderung mengungguli pasar di perusahaan mereka sendiri.
Rata-rata Profitabilitas Perdagangan
Profitabilitas perdagangan rata-rata adalah pengembalian rata-rata dari semua pembelian pasar terbuka yang dilakukan oleh orang dalam dalam tiga tahun terakhir. Untuk menghitung ini, kami memeriksa setiap pembelian pasar terbuka yang tidak direncanakan yang dilakukan oleh orang dalam, tidak termasuk semua perdagangan yang ditandai sebagai bagian dari rencana perdagangan 10b5-1. Kami kemudian menghitung kinerja rata-rata dari perdagangan tersebut selama 3, 6, dan 12 bulan, dengan merata-ratakan setiap durasi tersebut untuk menghasilkan metrik kinerja akhir untuk setiap perdagangan. Terakhir, kami merata-ratakan semua metrik kinerja untuk menghitung metrik kinerja untuk orang dalam. Daftar ini hanya mencakup orang dalam yang telah melakukan setidaknya tiga perdagangan dalam dua tahun terakhir.
Jika profitabilitas perdagangan orang dalam ini adalah "N/A", maka orang dalam tersebut belum melakukan pembelian di pasar terbuka dalam tiga tahun terakhir, atau perdagangan yang mereka lakukan terlalu baru untuk menghitung metrik kinerja yang andal.
Frekuensi Pembaruan: Setiap Hari
Lihat daftar pedagang dalam perusahaan yang paling menguntungkan.
Perusahaan dengan Posisi Orang Dalam yang Dilaporkan
Pengajuan SEC menunjukkan bahwa Baker Bros. Advisors (GP) LLC telah melaporkan kepemilikan atau perdagangan di perusahaan-perusahaan berikut:
Cara Membaca Grafik
Grafik berikut menunjukkan kinerja saham sekuritas setelah setiap perdagangan pasar terbuka yang tidak direncanakan yang dilakukan oleh Baker Bros. Advisors (GP) LLC. Perdagangan yang tidak direncanakan adalah perdagangan yang tidak dilakukan sebagai bagian dari rencana perdagangan 10b5-1. Kinerja saham digambarkan sebagai perubahan persentase kumulatif dalam harga saham. Misalnya, jika perdagangan orang dalam dilakukan pada 1 Januari 2019, grafik akan menunjukkan perubahan persentase harian sekuritas hingga saat ini. Jika harga saham naik dari $10 menjadi $15 selama periode ini, perubahan persentase kumulatif dalam harga saham akan menjadi 50%. Perubahan harga dari $10 menjadi $20 akan menjadi 100%, dan perubahan harga dari $10 menjadi $5 akan menjadi -50%.
Pada akhirnya, kita mencoba menentukan seberapa erat korelasi perdagangan orang dalam dengan pengembalian berlebih (positif atau negatif) pada harga saham untuk melihat apakah orang dalam tersebut mengatur waktu perdagangannya untuk mendapatkan keuntungan dari informasi orang dalam. Pertimbangkan situasi di mana orang dalam melakukan hal ini. Dalam situasi ini, kita akan mengharapkan (a) pengembalian positif setelah pembelian, atau (b) pengembalian negatif setelah penjualan. Dalam kasus (a), grafik PEMBELIAN akan menunjukkan serangkaian kurva yang miring ke atas, menunjukkan pengembalian positif setelah setiap transaksi pembelian. Dalam kasus (b), grafik PENJUALAN akan menunjukkan serangkaian kurva yang miring ke bawah, menunjukkan pengembalian negatif setelah setiap transaksi penjualan.
Namun, ini saja tidak cukup untuk menarik kesimpulan. Jika, misalnya, harga saham perusahaan berada dalam tren kenaikan non-siklikal selama bertahun-tahun, maka kita akan mengharapkan semua plot pasca-pembelian memiliki kemiringan ke atas. Demikian pula, penurunan non-siklikal selama bertahun-tahun akan menghasilkan plot pasca-perdagangan dengan kemiringan ke bawah. Tak satu pun dari grafik ini akan menunjukkan aktivitas perdagangan orang dalam.
Indikator terkuat adalah situasi di mana harga saham sangat siklikal, dan terdapat sinyal positif pada grafik PEMBELIAN dan plot negatif pada grafik PENJUALAN. Situasi ini akan sangat menunjukkan adanya orang dalam yang mengatur waktu perdagangan untuk keuntungan finansial mereka.
Pembelian Orang Dalam ACAD / ACADIA Pharmaceuticals Inc. - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Penjualan Orang Dalam ACAD / ACADIA Pharmaceuticals Inc. - Analisis Kerugian Jangka Pendek
Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Ticker | Orang Dalam | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari-hari menuju Menit |
Harga di Menit |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini. |
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Pembelian Orang Dalam BCRX / BioCryst Pharmaceuticals, Inc. - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Penjualan Orang Dalam BCRX / BioCryst Pharmaceuticals, Inc. - Analisis Kerugian Jangka Pendek
Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Pembelian Orang Dalam BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock) - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Penjualan Orang Dalam BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock) - Analisis Kerugian Jangka Pendek
Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Ticker | Orang Dalam | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari-hari menuju Menit |
Harga di Menit |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini. |
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Pembelian Orang Dalam CELC / Celcuity Inc. - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Ticker | Orang Dalam | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari-hari menuju Maksimal |
Harga di Maksimal |
Maksimal Keuntungan ($) |
Maksimum Pengembalian (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini. |
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Penjualan Orang Dalam CELC / Celcuity Inc. - Analisis Kerugian Jangka Pendek
Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Ticker | Orang Dalam | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari-hari menuju Menit |
Harga di Menit |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini. |
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Pembelian Orang Dalam HOOK / HOOKIPA Pharma Inc. - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Penjualan Orang Dalam HOOK / HOOKIPA Pharma Inc. - Analisis Kerugian Jangka Pendek
Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Ticker | Orang Dalam | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari-hari menuju Menit |
Harga di Menit |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini. |
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Pembelian Orang Dalam IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock) - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Penjualan Orang Dalam IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock) - Analisis Kerugian Jangka Pendek
Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Ticker | Orang Dalam | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari-hari menuju Menit |
Harga di Menit |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini. |
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Pembelian Orang Dalam KALA / KALA BIO, Inc. - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Penjualan Orang Dalam KALA / KALA BIO, Inc. - Analisis Kerugian Jangka Pendek
Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Ticker | Orang Dalam | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari-hari menuju Menit |
Harga di Menit |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini. |
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Pembelian Orang Dalam KNSA / Kiniksa Pharmaceuticals, Ltd. - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Penjualan Orang Dalam KNSA / Kiniksa Pharmaceuticals, Ltd. - Analisis Kerugian Jangka Pendek
Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Ticker | Orang Dalam | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari-hari menuju Menit |
Harga di Menit |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini. |
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Pembelian Orang Dalam KOD / Kodiak Sciences Inc. - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Penjualan Orang Dalam KOD / Kodiak Sciences Inc. - Analisis Kerugian Jangka Pendek
Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Ticker | Orang Dalam | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari-hari menuju Menit |
Harga di Menit |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini. |
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Pembelian Orang Dalam KYMR / Kymera Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Penjualan Orang Dalam KYMR / Kymera Therapeutics, Inc. - Analisis Kerugian Jangka Pendek
Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Ticker | Orang Dalam | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari-hari menuju Menit |
Harga di Menit |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini. |
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Pembelian Orang Dalam MDGL / Madrigal Pharmaceuticals, Inc. - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Penjualan Orang Dalam MDGL / Madrigal Pharmaceuticals, Inc. - Analisis Kerugian Jangka Pendek
Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Ticker | Orang Dalam | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari-hari menuju Menit |
Harga di Menit |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini. |
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Pembelian Orang Dalam NTLA / Intellia Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Penjualan Orang Dalam NTLA / Intellia Therapeutics, Inc. - Analisis Kerugian Jangka Pendek
Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Ticker | Orang Dalam | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari-hari menuju Menit |
Harga di Menit |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini. |
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Pembelian Orang Dalam PRLD / Prelude Therapeutics Incorporated - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Penjualan Orang Dalam PRLD / Prelude Therapeutics Incorporated - Analisis Kerugian Jangka Pendek
Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Ticker | Orang Dalam | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari-hari menuju Menit |
Harga di Menit |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini. |
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Pembelian Orang Dalam REPL / Replimune Group, Inc. - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Ticker | Orang Dalam | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari-hari menuju Maksimal |
Harga di Maksimal |
Maksimal Keuntungan ($) |
Maksimum Pengembalian (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini. |
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Penjualan Orang Dalam REPL / Replimune Group, Inc. - Analisis Kerugian Jangka Pendek
Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Ticker | Orang Dalam | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari-hari menuju Menit |
Harga di Menit |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini. |
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Pembelian Orang Dalam RYTM / Rhythm Pharmaceuticals, Inc. - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Penjualan Orang Dalam RYTM / Rhythm Pharmaceuticals, Inc. - Analisis Kerugian Jangka Pendek
Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Ticker | Orang Dalam | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari-hari menuju Menit |
Harga di Menit |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini. |
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Pembelian Orang Dalam SERA / Sera Prognostics, Inc. - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Ticker | Orang Dalam | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari-hari menuju Maksimal |
Harga di Maksimal |
Maksimal Keuntungan ($) |
Maksimum Pengembalian (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini. |
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Penjualan Orang Dalam SERA / Sera Prognostics, Inc. - Analisis Kerugian Jangka Pendek
Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Ticker | Orang Dalam | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari-hari menuju Menit |
Harga di Menit |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini. |
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Pembelian Orang Dalam SYRE / Spyre Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Ticker | Orang Dalam | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari-hari menuju Maksimal |
Harga di Maksimal |
Maksimal Keuntungan ($) |
Maksimum Pengembalian (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini. |
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Penjualan Orang Dalam SYRE / Spyre Therapeutics, Inc. - Analisis Kerugian Jangka Pendek
Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Ticker | Orang Dalam | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari-hari menuju Menit |
Harga di Menit |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini. |
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Pembelian Orang Dalam TCRX / TScan Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Penjualan Orang Dalam TCRX / TScan Therapeutics, Inc. - Analisis Kerugian Jangka Pendek
Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Ticker | Orang Dalam | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari-hari menuju Menit |
Harga di Menit |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini. |
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Pembelian Orang Dalam TLIS / Talis Biomedical Corporation - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Penjualan Orang Dalam TLIS / Talis Biomedical Corporation - Analisis Kerugian Jangka Pendek
Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Ticker | Orang Dalam | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari-hari menuju Menit |
Harga di Menit |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini. |
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Pembelian Orang Dalam TRDA / Entrada Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Penjualan Orang Dalam TRDA / Entrada Therapeutics, Inc. - Analisis Kerugian Jangka Pendek
Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Ticker | Orang Dalam | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari-hari menuju Menit |
Harga di Menit |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini. |
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Pembelian Orang Dalam VTVT / vTv Therapeutics Inc. - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Ticker | Orang Dalam | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari-hari menuju Maksimal |
Harga di Maksimal |
Maksimal Keuntungan ($) |
Maksimum Pengembalian (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini. |
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Penjualan Orang Dalam VTVT / vTv Therapeutics Inc. - Analisis Kerugian Jangka Pendek
Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Ticker | Orang Dalam | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari-hari menuju Menit |
Harga di Menit |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini. |
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Pembelian Orang Dalam XOMAO / XOMA Royalty Corporation - Preferred Stock - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Penjualan Orang Dalam XOMAO / XOMA Royalty Corporation - Preferred Stock - Analisis Kerugian Jangka Pendek
Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Pembelian Orang Dalam ZYME / Zymeworks Inc. - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Ticker | Orang Dalam | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari-hari menuju Maksimal |
Harga di Maksimal |
Maksimal Keuntungan ($) |
Maksimum Pengembalian (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini. |
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Penjualan Orang Dalam ZYME / Zymeworks Inc. - Analisis Kerugian Jangka Pendek
Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Ticker | Orang Dalam | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari-hari menuju Menit |
Harga di Menit |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini. |
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Sejarah Perdagangan Orang Dalam
Tabel ini menunjukkan daftar lengkap transaksi orang dalam yang dilakukan oleh Baker Bros. Advisors (GP) LLC sebagaimana diungkapkan kepada Komisi Bursa Efek (Securities Exchange Commission/SEC).
| Tanggal File | Tanggal Transaksi | Formulir | Ticker | Keamanan | Kode | Saham | Sisa Saham | Persen Ubah |
Bagikan Harga |
Tran Nilai |
Sisa Nilai |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-05 |
|
4 | VTVT |
vTv Therapeutics Inc.
Common Stock |
A - Award | 46,692 | 135,946 | 52.31 | ||||
| 2025-09-05 |
|
4 | VTVT |
vTv Therapeutics Inc.
Common Stock |
A - Award | 4,308 | 12,368 | 53.45 | ||||
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10,128 | 1,859,091 | 0.55 | 372.16 | 3,769,209 | 691,874,287 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 933 | 194,625 | 0.48 | 372.16 | 347,223 | 72,431,115 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5,494 | 1,848,963 | 0.30 | 371.00 | 2,038,301 | 685,974,518 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 506 | 193,692 | 0.26 | 371.00 | 187,729 | 71,860,700 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,747 | 1,843,469 | 0.15 | 369.34 | 1,014,563 | 680,857,623 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 253 | 193,186 | 0.13 | 369.34 | 93,442 | 71,350,351 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,419 | 1,840,722 | 0.08 | 368.84 | 523,384 | 678,931,902 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 131 | 192,933 | 0.07 | 368.84 | 48,318 | 71,161,408 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,798 | 1,839,303 | 0.26 | 367.77 | 1,764,565 | 676,442,304 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 442 | 192,802 | 0.23 | 367.77 | 162,555 | 70,906,984 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,289 | 1,834,505 | 0.12 | 366.30 | 838,459 | 671,977,714 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 211 | 192,360 | 0.11 | 366.30 | 77,289 | 70,461,314 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,772 | 1,832,216 | 0.15 | 363.75 | 1,008,308 | 666,463,806 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 255 | 192,149 | 0.13 | 363.75 | 92,756 | 69,893,699 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5,587 | 1,829,444 | 0.31 | 362.39 | 2,024,662 | 662,968,735 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 515 | 191,894 | 0.27 | 362.39 | 186,630 | 69,540,102 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5,443 | 1,823,857 | 0.30 | 361.37 | 1,966,957 | 659,093,770 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 502 | 191,379 | 0.26 | 361.37 | 181,410 | 69,159,318 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 8,514 | 1,818,414 | 0.47 | 359.39 | 3,059,873 | 653,525,445 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 784 | 190,877 | 0.41 | 359.39 | 281,764 | 68,599,877 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,472 | 1,809,900 | 0.14 | 358.21 | 885,495 | 648,324,279 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 228 | 190,093 | 0.12 | 358.21 | 81,672 | 68,093,214 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 8,328 | 1,807,428 | 0.46 | 357.02 | 2,973,289 | 645,293,728 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 767 | 189,865 | 0.41 | 357.02 | 273,837 | 67,786,210 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 916 | 1,799,100 | 0.05 | 355.00 | 325,180 | 638,680,500 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 84 | 189,098 | 0.04 | 355.00 | 29,820 | 67,129,790 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,923 | 1,798,184 | 0.11 | 353.88 | 680,503 | 636,333,262 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 177 | 189,014 | 0.09 | 353.88 | 62,636 | 66,887,424 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 9,362 | 1,947,968 | 0.48 | 392.24 | 3,672,178 | 764,076,617 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 862 | 202,813 | 0.43 | 392.24 | 338,113 | 79,551,959 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,506 | 1,938,606 | 0.13 | 389.89 | 977,059 | 755,838,828 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 231 | 201,951 | 0.11 | 389.89 | 90,064 | 78,738,231 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 366 | 1,936,100 | 0.02 | 389.00 | 142,374 | 753,142,900 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 34 | 201,720 | 0.02 | 389.00 | 13,226 | 78,469,080 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,441 | 1,935,734 | 0.23 | 387.07 | 1,718,969 | 749,260,688 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 409 | 201,686 | 0.20 | 387.07 | 158,311 | 78,066,197 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 13,545 | 1,931,293 | 0.71 | 385.06 | 5,215,601 | 743,658,468 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,248 | 201,277 | 0.62 | 385.06 | 480,552 | 77,503,178 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,049 | 1,917,748 | 0.21 | 383.79 | 1,553,954 | 736,007,135 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 373 | 200,029 | 0.19 | 383.79 | 143,153 | 76,768,570 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,838 | 1,913,699 | 0.15 | 382.82 | 1,086,447 | 732,604,739 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 262 | 199,656 | 0.13 | 382.82 | 100,299 | 76,432,569 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,136 | 1,910,861 | 0.06 | 382.29 | 434,280 | 730,501,332 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 105 | 199,394 | 0.05 | 382.29 | 40,140 | 76,226,153 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 9,477 | 1,909,725 | 0.50 | 381.12 | 3,611,889 | 727,837,448 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 873 | 199,289 | 0.44 | 381.12 | 332,719 | 75,953,343 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,919 | 1,900,248 | 0.10 | 380.78 | 730,717 | 723,576,433 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 176 | 198,416 | 0.09 | 380.78 | 67,017 | 75,552,844 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5,209 | 1,898,329 | 0.28 | 380.44 | 1,981,694 | 722,193,641 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 480 | 198,240 | 0.24 | 380.44 | 182,610 | 75,417,732 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7,325 | 1,893,120 | 0.39 | 374.43 | 2,742,728 | 708,848,115 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 675 | 197,760 | 0.34 | 374.43 | 252,743 | 74,048,028 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 26,704 | 1,885,795 | 1.44 | 372.87 | 9,957,102 | 703,155,062 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,460 | 197,085 | 1.26 | 372.87 | 917,258 | 73,486,946 | |
| 2025-08-18 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
U - Other | -3,763,362 | 0 | -100.00 | ||||
| 2025-08-18 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
U - Other | -357,048 | 0 | -100.00 | ||||
| 2025-08-01 | 3 | CELC |
Celcuity Inc.
Common Stock |
689,944 | ||||||||
| 2025-08-01 | 3 | CELC |
Celcuity Inc.
Common Stock |
7,055,748 | ||||||||
| 2025-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 492 | 28,187,581 | 0.00 | ||||
| 2025-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 492 | 28,187,581 | 0.00 | ||||
| 2025-07-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 953 | 3,763,362 | 0.03 | ||||
| 2025-07-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 953 | 3,763,362 | 0.03 | ||||
| 2025-06-30 |
|
4 | KYMR |
Kymera Therapeutics, Inc.
Common Stock |
P - Purchase | 600,309 | 6,117,295 | 10.88 | 44.00 | 26,413,596 | 269,160,980 | |
| 2025-06-30 |
|
4 | KYMR |
Kymera Therapeutics, Inc.
Common Stock |
P - Purchase | 55,191 | 534,134 | 11.52 | 44.00 | 2,428,404 | 23,501,896 | |
| 2025-06-24 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1,430 | 1,796,261 | 0.08 | ||||
| 2025-06-24 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1,430 | 1,796,261 | 0.08 | ||||
| 2025-06-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2,518 | 28,187,089 | 0.01 | ||||
| 2025-06-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2,518 | 28,187,089 | 0.01 | ||||
| 2025-06-05 | 3 | DNLI |
Denali Therapeutics Inc.
Common Stock |
326,302 | ||||||||
| 2025-06-05 | 3 | DNLI |
Denali Therapeutics Inc.
Common Stock |
3,405,393 | ||||||||
| 2025-06-05 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 10,565 | 3,415,958 | 0.31 | ||||
| 2025-06-05 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 10,565 | 3,415,958 | 0.31 | ||||
| 2025-06-05 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 8,397 | 2,738,816 | 0.31 | ||||
| 2025-06-05 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 8,397 | 2,738,816 | 0.31 | ||||
| 2025-06-02 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 16,214 | 39,365,965 | 0.04 | ||||
| 2025-06-02 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 16,214 | 39,365,965 | 0.04 | ||||
| 2025-05-22 |
|
4 | ONC |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 21,970 | 148,069 | 17.42 | ||||
| 2025-05-22 |
|
4 | ONC |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 21,970 | 148,065 | 17.42 | ||||
| 2025-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 487 | 28,184,571 | 0.00 | ||||
| 2025-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 487 | 2,813,892 | 0.02 | ||||
| 2025-04-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 953 | 3,762,409 | 0.03 | ||||
| 2025-04-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 953 | 356,095 | 0.27 | ||||
| 2025-03-19 |
|
4 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
P - Purchase | 92,349 | 2,144,060 | 4.50 | 29.56 | 2,729,864 | 63,379,057 | |
| 2025-03-19 |
|
4 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
P - Purchase | 8,589 | 178,596 | 5.05 | 29.56 | 253,893 | 5,279,351 | |
| 2025-03-19 |
|
4 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
P - Purchase | 646,290 | 2,051,711 | 45.99 | 29.74 | 19,221,699 | 61,021,168 | |
| 2025-03-19 |
|
4 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
P - Purchase | 60,110 | 170,007 | 54.70 | 29.74 | 1,787,768 | 5,056,280 | |
| 2025-03-07 | 3 | REPL |
Replimune Group, Inc.
Common Stock |
929,241 | ||||||||
| 2025-03-07 | 3 | REPL |
Replimune Group, Inc.
Common Stock |
10,116,095 | ||||||||
| 2025-02-28 |
|
4 | ONC |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -671,976 | 8,068,411 | -7.69 | 260.00 | -174,713,760 | 2,097,786,860 | |
| 2025-02-28 |
|
4 | ONC |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -60,851 | 730,642 | -7.69 | 260.00 | -15,821,260 | 189,966,920 | |
| 2025-02-14 | 3 | SERA |
SERA PROGNOSTICS, INC.
Common Stock |
432,434 | ||||||||
| 2025-02-14 | 3 | SERA |
SERA PROGNOSTICS, INC.
Common Stock |
5,065,736 | ||||||||
| 2025-01-06 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
A - Award | 4,400 | 9,999,674 | 0.04 | ||||
| 2025-01-06 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
A - Award | 4,400 | 918,483 | 0.48 | ||||
| 2025-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 446 | 28,184,084 | 0.00 | ||||
| 2025-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 446 | 28,184,084 | 0.00 | ||||
| 2025-01-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1,994 | 3,761,456 | 0.05 | ||||
| 2025-01-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1,994 | 355,142 | 0.56 | ||||
| 2024-12-31 |
|
4 | KALA |
KALA BIO, Inc.
Common Stock |
P - Purchase | 279,939 | 1,083,398 | 34.84 | 6.44 | 1,802,807 | 6,977,083 | |
| 2024-12-31 |
|
4 | KALA |
KALA BIO, Inc.
Common Stock |
P - Purchase | 30,620 | 118,496 | 34.84 | 6.44 | 197,193 | 763,114 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 457,631 | 9,995,274 | 4.80 | 15.34 | 7,020,883 | 153,345,495 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 42,369 | 914,083 | 4.86 | 15.34 | 650,017 | 14,023,679 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 566,814 | 9,537,643 | 6.32 | 13.80 | 7,824,300 | 131,657,624 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 52,656 | 871,714 | 6.43 | 13.80 | 726,863 | 12,033,140 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 244,587 | 8,970,829 | 2.80 | 13.72 | 3,356,761 | 123,117,451 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 22,722 | 819,058 | 2.85 | 13.72 | 311,841 | 11,240,916 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 59,995 | 8,726,242 | 0.69 | 13.63 | 817,660 | 118,928,207 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 5,573 | 796,336 | 0.70 | 13.63 | 75,953 | 10,853,104 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 30,241 | 8,666,247 | 0.35 | 13.50 | 408,190 | 116,976,135 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 2,809 | 790,763 | 0.36 | 13.50 | 37,916 | 10,673,640 | |
| 2024-12-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -916,964 | 8,740,387 | -9.49 | 186.50 | -171,013,786 | 1,630,082,176 | |
| 2024-12-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -83,036 | 791,493 | -9.49 | 186.50 | -15,486,214 | 147,613,444 | |
| 2024-12-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -33,943 | 9,657,351 | -0.35 | 208.01 | -7,060,609 | 2,008,861,314 | |
| 2024-12-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -3,074 | 874,529 | -0.35 | 208.01 | -639,434 | 181,914,013 | |
| 2024-10-08 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 4,730 | 2,730,419 | 0.17 | ||||
| 2024-10-08 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 4,730 | 2,730,419 | 0.17 | ||||
| 2024-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 496 | 28,183,638 | 0.00 | ||||
| 2024-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 496 | 2,812,959 | 0.02 | ||||
| 2024-10-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1,994 | 3,759,462 | 0.05 | ||||
| 2024-10-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1,994 | 353,148 | 0.57 | ||||
| 2024-08-22 |
|
4 | KYMR |
Kymera Therapeutics, Inc.
Common Stock |
P - Purchase | 1 | 5,516,986 | 0.00 | 46.41 | 46 | 256,043,320 | |
| 2024-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 537 | 28,183,142 | 0.00 | ||||
| 2024-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 537 | 28,183,142 | 0.00 | ||||
| 2024-07-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1,994 | 3,757,468 | 0.05 | ||||
| 2024-07-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1,994 | 3,757,468 | 0.05 | ||||
| 2024-06-28 | 3 | KALA |
KALA BIO, Inc.
Common Stock |
87,876 | ||||||||
| 2024-06-28 | 3 | KALA |
KALA BIO, Inc.
Common Stock |
803,459 | ||||||||
| 2024-06-27 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1,428 | 1,794,831 | 0.08 | ||||
| 2024-06-27 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1,428 | 1,794,831 | 0.08 | ||||
| 2024-06-20 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
C - Conversion | 2,186,686 | 8,636,006 | 33.91 | ||||
| 2024-06-20 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
C - Conversion | 196,098 | 787,954 | 33.13 | ||||
| 2024-06-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
D - Sale to Issuer | -5,283,206 | 28,182,605 | -15.79 | 60.00 | -316,992,360 | 1,690,956,300 | |
| 2024-06-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
D - Sale to Issuer | -175,977 | 2,811,926 | -5.89 | 60.00 | -10,558,620 | 168,715,560 | |
| 2024-06-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2,830 | 33,465,811 | 0.01 | ||||
| 2024-06-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2,830 | 33,465,811 | 0.01 | ||||
| 2024-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 32,682 | 126,099 | 34.99 | ||||
| 2024-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 32,682 | 126,099 | 34.99 | ||||
| 2024-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 6,346 | 2,725,689 | 0.23 | ||||
| 2024-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 6,346 | 2,725,689 | 0.23 | ||||
| 2024-05-31 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 18,774 | 39,349,751 | 0.05 | ||||
| 2024-05-31 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 18,774 | 39,349,751 | 0.05 | ||||
| 2024-05-29 | 3 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
109,897 | ||||||||
| 2024-05-29 | 3 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
1,405,421 | ||||||||
| 2024-05-09 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 15,000 | 33,462,981 | 0.04 | 49.01 | 735,150 | 1,640,020,699 | |
| 2024-05-09 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 15,000 | 2,985,073 | 0.51 | 49.01 | 735,150 | 146,298,428 | |
| 2024-04-22 |
|
4 | BCYC |
BICYCLE THERAPEUTICS plc
American Depositary Shares |
A - Award | 12,000 | 6,449,320 | 0.19 | ||||
| 2024-04-22 |
|
4 | BCYC |
BICYCLE THERAPEUTICS plc
American Depositary Shares |
A - Award | 12,000 | 6,449,320 | 0.19 | ||||
| 2024-04-18 | 3 | BCYC |
BICYCLE THERAPEUTICS plc
American Depositary Shares |
579,856 | ||||||||
| 2024-04-18 | 3 | BCYC |
BICYCLE THERAPEUTICS plc
American Depositary Shares |
6,437,320 | ||||||||
| 2024-04-01 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1,994 | 3,755,474 | 0.05 | ||||
| 2024-04-01 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1,994 | 3,755,474 | 0.05 | ||||
| 2024-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 543 | 33,447,981 | 0.00 | ||||
| 2024-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 543 | 2,970,073 | 0.02 | ||||
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 89,407 | 3,753,480 | 2.44 | 9.62 | 860,042 | 36,106,226 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 8,066 | 347,166 | 2.38 | 9.62 | 77,590 | 3,339,529 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 8,439 | 3,664,073 | 0.23 | 9.27 | 78,207 | 33,956,064 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 761 | 339,100 | 0.22 | 9.27 | 7,052 | 3,142,541 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 17,101 | 3,655,634 | 0.47 | 9.22 | 157,683 | 33,707,504 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 1,543 | 338,339 | 0.46 | 9.22 | 14,228 | 3,119,722 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 247,656 | 3,638,533 | 7.30 | 8.26 | 2,046,159 | 30,061,923 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 22,344 | 336,796 | 7.11 | 8.26 | 184,608 | 2,782,642 | |
| 2024-03-07 | 3 | VTVT |
vTv Therapeutics Inc.
Common Stock |
12,836 | ||||||||
| 2024-03-07 | 3 | VTVT |
vTv Therapeutics Inc.
Common Stock |
142,135 | ||||||||
| 2024-03-07 |
|
4 | VTVT |
vTv Therapeutics Inc.
Common Stock |
D - Sale to Issuer | -52,881 | 89,254 | -37.20 | ||||
| 2024-03-07 |
|
4 | VTVT |
vTv Therapeutics Inc.
Common Stock |
D - Sale to Issuer | -4,776 | 8,060 | -37.21 | ||||
| 2024-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 556 | 33,447,438 | 0.00 | ||||
| 2024-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 556 | 33,447,438 | 0.00 | ||||
| 2024-01-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 3,390,877 | 0.02 | ||||
| 2024-01-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 3,390,877 | 0.02 | ||||
| 2023-12-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | -42,977,301 | 0 | -100.00 | 229.00 | -9,841,801,929 | ||
| 2023-12-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | -1,731,202 | 0 | -100.00 | 229.00 | -396,445,258 | ||
| 2023-12-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | -23,277 | 0 | -100.00 | 229.00 | -5,330,433 | ||
| 2023-12-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | -23,280 | 0 | -100.00 | 229.00 | -5,331,120 | ||
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 214,025 | 3,390,323 | 6.74 | 6.60 | 1,412,565 | 22,376,132 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 17,066 | 313,898 | 5.75 | 6.60 | 112,636 | 2,071,727 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 52,528 | 3,176,298 | 1.68 | 6.37 | 334,399 | 20,220,631 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 4,188 | 296,832 | 1.43 | 6.37 | 26,661 | 1,889,662 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 185 | 3,123,770 | 0.01 | 6.36 | 1,176 | 19,851,558 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 15 | 292,644 | 0.01 | 6.36 | 95 | 1,859,753 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 145,749 | 3,123,585 | 4.89 | 6.50 | 947,602 | 20,308,300 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 11,621 | 292,629 | 4.14 | 6.50 | 75,555 | 1,902,557 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 71,219 | 2,977,836 | 2.45 | 5.99 | 426,751 | 17,843,491 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 5,679 | 281,008 | 2.06 | 5.99 | 34,029 | 1,683,828 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 9,649 | 2,906,617 | 0.33 | 5.76 | 55,567 | 16,738,626 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 769 | 275,329 | 0.28 | 5.76 | 4,429 | 1,585,565 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3,857 | 1,699,129 | 0.23 | 221.24 | 853,330 | 375,918,358 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 308 | 178,461 | 0.17 | 221.24 | 68,142 | 39,483,033 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,408 | 1,695,272 | 0.26 | 220.65 | 972,645 | 374,069,565 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 352 | 178,153 | 0.20 | 220.65 | 77,670 | 39,310,279 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15,005 | 1,690,864 | 0.90 | 219.24 | 3,289,711 | 370,706,714 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,195 | 177,801 | 0.68 | 219.24 | 261,993 | 38,981,269 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,873 | 1,675,859 | 0.17 | 217.91 | 626,049 | 365,182,748 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 229 | 176,606 | 0.13 | 217.91 | 49,901 | 38,483,825 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 185 | 1,672,986 | 0.01 | 217.90 | 40,312 | 364,543,649 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15 | 176,377 | 0.01 | 217.90 | 3,268 | 38,432,548 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,769 | 1,672,801 | 0.11 | 216.67 | 383,286 | 362,442,949 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 141 | 176,362 | 0.08 | 216.67 | 30,550 | 38,212,055 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 668 | 1,671,032 | 0.04 | 214.72 | 143,434 | 358,807,834 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 53 | 176,221 | 0.03 | 214.72 | 11,380 | 37,838,578 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 515 | 1,670,364 | 0.03 | 213.80 | 110,107 | 357,122,821 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 41 | 176,168 | 0.02 | 213.80 | 8,766 | 37,664,613 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 185 | 1,669,849 | 0.01 | 213.62 | 39,521 | 356,721,493 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15 | 176,127 | 0.01 | 213.62 | 3,204 | 37,625,130 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 648 | 1,669,664 | 0.04 | 212.04 | 137,403 | 354,037,892 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 52 | 176,112 | 0.03 | 212.04 | 11,026 | 37,343,035 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 93 | 1,669,016 | 0.01 | 209.76 | 19,508 | 350,101,141 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7 | 176,060 | 0.00 | 209.76 | 1,468 | 36,931,226 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 370 | 1,668,923 | 0.02 | 208.69 | 77,216 | 348,289,710 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 30 | 176,053 | 0.02 | 208.69 | 6,261 | 36,740,729 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 648 | 1,668,553 | 0.04 | 206.93 | 134,092 | 345,277,176 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 52 | 176,023 | 0.03 | 206.93 | 10,760 | 36,424,809 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 708 | 1,667,905 | 0.04 | 205.60 | 145,565 | 342,921,268 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 56 | 175,971 | 0.03 | 205.60 | 11,514 | 36,179,638 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 93 | 1,667,197 | 0.01 | 205.32 | 19,095 | 342,308,888 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7 | 175,915 | 0.00 | 205.32 | 1,437 | 36,118,868 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3,960 | 1,793,403 | 0.22 | 229.86 | 910,264 | 412,240,043 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 316 | 185,979 | 0.17 | 229.86 | 72,637 | 42,750,007 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,204 | 1,789,443 | 0.12 | 228.79 | 504,252 | 409,405,411 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 176 | 185,663 | 0.09 | 228.79 | 40,267 | 42,477,708 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 11,602 | 1,787,239 | 0.65 | 227.86 | 2,643,597 | 407,234,917 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 925 | 185,487 | 0.50 | 227.86 | 210,768 | 42,264,511 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,343 | 1,775,637 | 0.08 | 226.97 | 304,822 | 403,018,106 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 107 | 184,562 | 0.06 | 226.97 | 24,286 | 41,890,222 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5,594 | 1,774,294 | 0.32 | 224.91 | 1,258,156 | 399,059,480 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 446 | 184,455 | 0.24 | 224.91 | 100,311 | 41,486,088 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 363 | 1,768,700 | 0.02 | 223.94 | 81,289 | 396,078,079 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 29 | 184,009 | 0.02 | 223.94 | 6,494 | 41,206,497 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 9,262 | 1,768,337 | 0.53 | 222.68 | 2,062,425 | 393,766,210 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 738 | 183,980 | 0.40 | 222.68 | 164,335 | 40,967,930 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,532 | 1,759,075 | 0.26 | 221.78 | 1,005,101 | 390,125,367 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 361 | 183,242 | 0.20 | 221.78 | 80,062 | 40,639,173 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,518 | 1,754,543 | 0.26 | 219.87 | 993,351 | 385,762,948 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 360 | 182,881 | 0.20 | 219.87 | 79,151 | 40,209,168 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 29,738 | 1,750,025 | 1.73 | 218.46 | 6,496,513 | 382,307,486 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,373 | 182,521 | 1.32 | 218.46 | 518,402 | 39,873,227 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10,894 | 1,720,287 | 0.64 | 217.52 | 2,369,611 | 374,188,571 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 869 | 180,148 | 0.48 | 217.52 | 189,021 | 39,184,928 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10,264 | 1,709,393 | 0.60 | 216.70 | 2,224,203 | 370,424,437 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 818 | 179,279 | 0.46 | 216.70 | 177,260 | 38,849,652 | |
| 2023-11-24 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
X - Other | 1,941,607 | 2,168,818 | 854.54 | 0.00 | 194 | 217 | |
| 2023-11-24 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
X - Other | 174,742 | 196,654 | 797.47 | 0.00 | 17 | 20 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7,917 | 1,667,104 | 0.48 | 190.14 | 1,505,308 | 316,976,653 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 655 | 175,908 | 0.37 | 190.14 | 124,539 | 33,446,461 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15,620 | 1,659,187 | 0.95 | 188.70 | 2,947,539 | 313,093,399 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,291 | 175,253 | 0.74 | 188.70 | 243,615 | 33,070,749 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 13,505 | 1,643,567 | 0.83 | 188.46 | 2,545,218 | 309,754,690 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,117 | 173,962 | 0.65 | 188.46 | 210,515 | 32,785,731 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 13,011 | 1,630,062 | 0.80 | 188.32 | 2,450,273 | 306,978,492 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,076 | 172,845 | 0.63 | 188.32 | 202,636 | 32,550,724 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,712 | 1,617,051 | 0.29 | 187.27 | 882,420 | 302,826,273 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 388 | 171,769 | 0.23 | 187.27 | 72,661 | 32,167,301 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,124 | 1,612,339 | 0.13 | 187.24 | 397,706 | 301,900,642 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 176 | 171,381 | 0.10 | 187.24 | 32,955 | 32,090,047 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,385 | 1,610,215 | 0.09 | 186.59 | 258,431 | 300,454,847 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 115 | 171,205 | 0.07 | 186.59 | 21,458 | 31,945,655 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 647 | 1,608,830 | 0.04 | 186.32 | 120,547 | 299,752,540 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 53 | 171,090 | 0.03 | 186.32 | 9,875 | 31,876,993 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 369 | 1,608,183 | 0.02 | 183.16 | 67,586 | 294,554,798 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 31 | 171,037 | 0.02 | 183.16 | 5,678 | 31,327,137 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 146 | 1,607,814 | 0.01 | 185.94 | 27,148 | 298,963,688 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 12 | 171,006 | 0.01 | 185.94 | 2,231 | 31,797,574 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3,022 | 1,607,668 | 0.19 | 189.70 | 573,267 | 304,971,083 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 250 | 170,994 | 0.15 | 189.70 | 47,424 | 32,437,186 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,147 | 1,604,646 | 0.07 | 188.84 | 216,595 | 303,014,772 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 95 | 170,744 | 0.06 | 188.84 | 17,939 | 32,242,597 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,895 | 1,603,499 | 0.31 | 187.34 | 917,054 | 300,407,520 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 405 | 170,649 | 0.24 | 187.34 | 75,875 | 31,970,237 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,206 | 1,598,604 | 0.08 | 185.86 | 224,153 | 297,124,532 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 100 | 170,244 | 0.06 | 185.86 | 18,586 | 31,642,401 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7,010 | 1,597,398 | 0.44 | 183.40 | 1,285,633 | 292,962,633 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 579 | 170,144 | 0.34 | 183.40 | 106,189 | 31,204,393 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,847 | 1,590,388 | 0.12 | 181.93 | 336,025 | 289,339,289 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 153 | 169,565 | 0.09 | 181.93 | 27,835 | 30,848,960 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10,715 | 1,588,541 | 0.68 | 175.82 | 1,883,889 | 279,293,943 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 903 | 169,412 | 0.54 | 175.82 | 158,764 | 29,785,662 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,923 | 1,577,826 | 0.31 | 175.72 | 865,062 | 277,253,218 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 415 | 168,509 | 0.25 | 175.72 | 72,923 | 29,610,149 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 18,125 | 1,572,903 | 1.17 | 174.87 | 3,169,606 | 275,061,098 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,528 | 168,094 | 0.92 | 174.87 | 267,209 | 29,395,405 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 978 | 1,554,778 | 0.06 | 174.67 | 170,827 | 271,572,762 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 82 | 166,566 | 0.05 | 174.67 | 14,323 | 29,094,050 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,660 | 1,553,800 | 0.11 | 173.75 | 288,422 | 269,969,798 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 140 | 166,484 | 0.08 | 173.75 | 24,325 | 28,926,279 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,151 | 1,552,140 | 0.27 | 173.20 | 718,960 | 268,833,131 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 350 | 166,344 | 0.21 | 173.20 | 60,621 | 28,811,047 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 461 | 1,547,989 | 0.03 | 171.79 | 79,195 | 265,929,030 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 39 | 165,994 | 0.02 | 171.79 | 6,700 | 28,516,109 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,107 | 1,547,528 | 0.07 | 168.78 | 186,842 | 261,195,645 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 93 | 165,955 | 0.06 | 168.78 | 15,697 | 28,010,300 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 646 | 1,546,421 | 0.04 | 167.63 | 108,289 | 259,226,552 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 54 | 165,862 | 0.03 | 167.63 | 9,052 | 27,803,447 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 13,548 | 1,500,227 | 0.91 | 154.78 | 2,096,961 | 232,205,285 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,142 | 161,969 | 0.71 | 154.78 | 176,759 | 25,069,578 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 8,098 | 1,486,679 | 0.55 | 153.97 | 1,246,878 | 228,909,318 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 683 | 160,827 | 0.43 | 153.97 | 105,164 | 24,763,112 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,877 | 1,478,581 | 0.19 | 153.25 | 440,907 | 226,595,939 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 242 | 160,144 | 0.15 | 153.25 | 37,087 | 24,542,436 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 646 | 1,475,704 | 0.04 | 152.21 | 98,330 | 224,621,185 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 54 | 159,902 | 0.03 | 152.21 | 8,219 | 24,339,147 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 6,022 | 1,475,058 | 0.41 | 152.48 | 918,235 | 224,916,844 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 507 | 159,848 | 0.32 | 152.48 | 77,307 | 24,373,623 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3,542 | 1,469,036 | 0.24 | 154.60 | 547,582 | 227,108,412 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 299 | 159,341 | 0.19 | 154.60 | 46,224 | 24,633,625 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 26,426 | 1,465,494 | 1.84 | 146.21 | 3,863,756 | 214,270,464 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,228 | 159,042 | 1.42 | 146.21 | 325,757 | 23,253,594 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,994 | 1,439,068 | 0.21 | 145.98 | 437,057 | 210,071,549 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 252 | 156,814 | 0.16 | 145.98 | 36,786 | 22,891,316 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 6,369 | 1,436,074 | 0.45 | 145.46 | 926,430 | 208,890,175 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 537 | 156,562 | 0.34 | 145.46 | 78,112 | 22,773,383 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,291 | 1,429,705 | 0.09 | 142.86 | 184,429 | 204,244,082 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 109 | 156,025 | 0.07 | 142.86 | 15,571 | 22,289,341 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10,790 | 1,428,414 | 0.76 | 141.44 | 1,526,192 | 202,042,018 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 910 | 155,916 | 0.59 | 141.44 | 128,715 | 22,053,539 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5,072 | 1,417,624 | 0.36 | 140.90 | 714,657 | 199,746,624 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 427 | 155,006 | 0.28 | 140.90 | 60,165 | 21,840,717 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,631 | 1,412,552 | 0.33 | 137.69 | 637,622 | 194,487,928 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 390 | 154,579 | 0.25 | 137.69 | 53,697 | 21,283,287 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3,693 | 1,407,921 | 0.26 | 136.91 | 505,605 | 192,756,915 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 311 | 154,189 | 0.20 | 136.91 | 42,579 | 21,109,846 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3,144 | 1,404,228 | 0.22 | 136.18 | 428,151 | 191,228,471 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 265 | 153,878 | 0.17 | 136.18 | 36,088 | 20,955,183 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 14,018 | 1,545,775 | 0.92 | 161.97 | 2,270,439 | 250,362,994 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,181 | 165,808 | 0.72 | 161.97 | 191,282 | 26,855,259 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 31,530 | 1,531,757 | 2.10 | 156.42 | 4,932,061 | 239,604,170 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,658 | 164,627 | 1.64 | 156.42 | 415,776 | 25,751,680 | |
| 2023-11-14 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -1,008,660 | 9,691,294 | -9.43 | 180.50 | -182,063,130 | 1,749,278,567 | |
| 2023-11-14 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -91,340 | 877,603 | -9.43 | 180.50 | -16,486,870 | 158,407,342 | |
| 2023-10-23 |
|
4 | BCEL |
Atreca, Inc.
Class A common stock |
S - Sale | -251,902 | 2,971,128 | -7.82 | 0.40 | -101,391 | 1,195,879 | |
| 2023-10-23 |
|
4 | BCEL |
Atreca, Inc.
Class A common stock |
S - Sale | -22,837 | 286,893 | -7.37 | 0.40 | -9,192 | 115,474 | |
| 2023-10-10 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
X - Other | 535,601 | 1,658,190 | 47.71 | ||||
| 2023-10-10 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
X - Other | 57,049 | 155,874 | 57.73 | ||||
| 2023-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 510 | 33,446,882 | 0.00 | ||||
| 2023-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 510 | 2,968,974 | 0.02 | ||||
| 2023-10-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2,896,968 | 0.02 | ||||
| 2023-10-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 274,560 | 0.20 | ||||
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 61,134 | 5,612,949 | 1.10 | 0.69 | 42,354 | 3,888,651 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 5,041 | 494,133 | 1.03 | 0.69 | 3,492 | 342,335 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 93,091 | 5,551,815 | 1.71 | 0.69 | 64,456 | 3,844,077 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 7,676 | 489,092 | 1.59 | 0.69 | 5,315 | 338,647 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 4,434 | 5,458,724 | 0.08 | 0.68 | 3,028 | 3,727,217 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 366 | 481,416 | 0.08 | 0.68 | 250 | 328,711 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 207,676 | 5,454,290 | 3.96 | 0.68 | 141,324 | 3,711,644 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 17,124 | 481,050 | 3.69 | 0.68 | 11,653 | 327,355 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 4,342 | 5,246,614 | 0.08 | 0.66 | 2,887 | 3,488,998 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 358 | 463,926 | 0.08 | 0.66 | 238 | 308,511 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 1,740,581 | 5,242,272 | 49.71 | 0.63 | 1,097,958 | 3,306,825 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 143,519 | 463,568 | 44.84 | 0.63 | 90,532 | 292,419 | |
| 2023-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 512 | 33,446,372 | 0.00 | ||||
| 2023-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 512 | 33,446,372 | 0.00 | ||||
| 2023-07-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2,896,414 | 0.02 | ||||
| 2023-07-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2,896,414 | 0.02 | ||||
| 2023-06-20 | 3 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
148,821 | ||||||||
| 2023-06-20 | 3 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
1,396,292 | ||||||||
| 2023-06-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4,792 | 1,401,084 | 0.34 | ||||
| 2023-06-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4,792 | 1,401,084 | 0.34 | ||||
| 2023-06-20 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 25,844 | 93,417 | 38.25 | ||||
| 2023-06-20 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 25,844 | 93,417 | 38.25 | ||||
| 2023-06-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2,505 | 33,445,860 | 0.01 | ||||
| 2023-06-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2,505 | 33,445,860 | 0.01 | ||||
| 2023-06-08 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 8,746 | 2,719,343 | 0.32 | ||||
| 2023-06-08 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 8,746 | 2,719,343 | 0.32 | ||||
| 2023-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 13,304 | 39,330,977 | 0.03 | ||||
| 2023-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 13,304 | 39,330,977 | 0.03 | ||||
| 2023-06-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 2,044 | 42,977,301 | 0.00 | ||||
| 2023-06-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 2,044 | 42,977,301 | 0.00 | ||||
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 259,109 | 39,317,673 | 0.66 | 25.65 | 6,646,146 | 1,008,498,312 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24,113 | 3,610,443 | 0.67 | 25.65 | 618,498 | 92,607,863 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 28,878 | 39,058,564 | 0.07 | 25.51 | 736,788 | 996,532,390 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2,688 | 3,586,330 | 0.08 | 25.51 | 68,581 | 91,500,906 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 218,171 | 39,029,686 | 0.56 | 25.27 | 5,513,683 | 986,369,933 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 20,304 | 3,583,642 | 0.57 | 25.27 | 513,129 | 90,566,876 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 74,582 | 38,811,515 | 0.19 | 25.54 | 1,904,824 | 991,246,093 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 6,941 | 3,563,338 | 0.20 | 25.54 | 177,273 | 91,007,653 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 116,672 | 38,736,933 | 0.30 | 25.33 | 2,955,325 | 981,214,260 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 10,858 | 3,556,397 | 0.31 | 25.33 | 275,035 | 90,084,247 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 12,500 | 38,620,261 | 0.03 | 17.01 | 212,625 | 656,930,640 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 12,500 | 38,620,261 | 0.03 | 17.01 | 212,625 | 656,930,640 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 40,632 | 38,607,761 | 0.11 | 24.80 | 1,007,674 | 957,472,473 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,781 | 3,533,039 | 0.11 | 24.80 | 93,769 | 87,619,367 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 82,148 | 38,567,129 | 0.21 | 24.46 | 2,009,373 | 943,367,402 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7,645 | 3,529,258 | 0.22 | 24.46 | 187,000 | 86,327,062 | |
| 2023-05-05 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
21,912 | ||||||||
| 2023-05-05 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
227,211 | ||||||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | -209,175 | 23,277 | -89.99 | ||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | -209,175 | 23,277 | -89.99 | ||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
J - Other | 209,175 | 232,452 | 898.63 | ||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
J - Other | 209,175 | 232,452 | 898.63 | ||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
J - Other | -2,368,357 | 1,729,158 | -57.80 | ||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 8,750 | 42,975,257 | 0.02 | 36.70 | 321,125 | 1,577,191,932 | |
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 8,750 | 42,975,257 | 0.02 | 36.70 | 321,125 | 1,577,191,932 | |
| 2023-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 429 | 33,443,355 | 0.00 | ||||
| 2023-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 429 | 33,443,355 | 0.00 | ||||
| 2023-04-04 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2,895,860 | 0.02 | ||||
| 2023-04-04 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2,895,860 | 0.02 | ||||
| 2023-03-15 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 33,442,926 | 0.06 | 22.74 | 454,800 | 760,492,137 | |
| 2023-03-15 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 33,442,926 | 0.06 | 22.74 | 454,800 | 760,492,137 | |
| 2023-01-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 15,000 | 38,484,981 | 0.04 | 5.22 | 78,300 | 200,891,601 | |
| 2023-01-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 15,000 | 38,484,981 | 0.04 | 5.22 | 78,300 | 200,891,601 | |
| 2023-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 397 | 33,422,926 | 0.00 | ||||
| 2023-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 397 | 33,422,926 | 0.00 | ||||
| 2022-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 457 | 33,422,529 | 0.00 | ||||
| 2022-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 457 | 33,422,529 | 0.00 | ||||
| 2022-07-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 433 | 33,422,072 | 0.00 | ||||
| 2022-07-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 433 | 33,422,072 | 0.00 | ||||
| 2022-06-30 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 10,000 | 2,710,597 | 0.37 | ||||
| 2022-06-30 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 10,000 | 2,710,597 | 0.37 | ||||
| 2022-06-24 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 33,384 | 67,573 | 97.65 | ||||
| 2022-06-24 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 33,384 | 67,569 | 97.66 | ||||
| 2022-06-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2,144 | 33,421,639 | 0.01 | ||||
| 2022-06-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2,144 | 33,421,639 | 0.01 | ||||
| 2022-06-13 |
|
4 | DBVT |
DBV Technologies S.A.
Ordinary Shares |
A - Award | 10,622,568 | 14,575,984 | 268.69 | ||||
| 2022-06-13 |
|
4 | DBVT |
DBV Technologies S.A.
Ordinary Shares |
A - Award | 1,252,432 | 1,585,054 | 376.53 | ||||
| 2022-06-09 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 17,104 | 38,469,981 | 0.04 | ||||
| 2022-06-09 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 17,104 | 38,469,981 | 0.04 | ||||
| 2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 26,450 | 4,501,658 | 0.59 | 6.42 | 169,849 | 28,907,397 | |
| 2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 3,118 | 364,161 | 0.86 | 6.42 | 20,022 | 2,338,460 | |
| 2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 7,815 | 4,475,208 | 0.17 | 6.35 | 49,654 | 28,434,129 | |
| 2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 921 | 361,043 | 0.26 | 6.35 | 5,852 | 2,293,959 | |
| 2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2,364 | 4,467,393 | 0.05 | 5.82 | 13,759 | 26,001,121 | |
| 2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 279 | 360,122 | 0.08 | 5.82 | 1,624 | 2,095,982 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 170,549 | 15,967,504 | 1.08 | 7.78 | 1,327,008 | 124,239,955 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 20,108 | 1,342,986 | 1.52 | 7.78 | 156,456 | 10,449,505 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 101,315 | 15,796,955 | 0.65 | 7.75 | 785,070 | 122,407,445 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11,945 | 1,322,878 | 0.91 | 7.75 | 92,559 | 10,250,717 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 78,271 | 15,695,640 | 0.50 | 7.95 | 622,466 | 124,822,716 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9,224 | 1,310,933 | 0.71 | 7.95 | 73,356 | 10,425,457 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 13,155 | 15,617,369 | 0.08 | 7.93 | 104,363 | 123,897,273 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,550 | 1,301,709 | 0.12 | 7.93 | 12,297 | 10,326,848 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 138,122 | 15,604,214 | 0.89 | 7.68 | 1,060,680 | 119,829,441 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 16,278 | 1,300,159 | 1.27 | 7.68 | 125,004 | 9,984,311 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10,585 | 15,466,092 | 0.07 | 7.51 | 79,540 | 116,218,402 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,247 | 1,283,881 | 0.10 | 7.51 | 9,370 | 9,647,595 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 88,046 | 15,455,507 | 0.57 | 6.92 | 609,278 | 106,952,108 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10,386 | 1,282,634 | 0.82 | 6.92 | 71,871 | 8,875,827 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 51,082 | 15,367,461 | 0.33 | 6.78 | 346,367 | 104,200,606 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6,026 | 1,272,248 | 0.48 | 6.78 | 40,860 | 8,626,605 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 358 | 15,316,379 | 0.00 | 6.64 | 2,375 | 101,624,175 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 42 | 1,266,222 | 0.00 | 6.64 | 279 | 8,401,383 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 984 | 15,316,021 | 0.01 | 6.76 | 6,647 | 103,459,722 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 116 | 1,266,180 | 0.01 | 6.76 | 784 | 8,553,046 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 53,401 | 15,315,037 | 0.35 | 6.75 | 360,521 | 103,394,878 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6,299 | 1,266,064 | 0.50 | 6.75 | 42,526 | 8,547,451 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 29,090 | 15,261,636 | 0.19 | 6.71 | 195,089 | 102,350,636 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3,432 | 1,259,765 | 0.27 | 6.71 | 23,016 | 8,448,488 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 42,250 | 15,232,546 | 0.28 | 6.60 | 279,002 | 100,589,641 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4,984 | 1,256,333 | 0.40 | 6.60 | 32,912 | 8,296,321 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 48,222 | 15,190,296 | 0.32 | 6.53 | 315,058 | 99,245,799 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5,688 | 1,251,349 | 0.46 | 6.53 | 37,163 | 8,175,689 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 19,789 | 4,465,029 | 0.45 | 5.74 | 113,619 | 25,635,964 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2,334 | 359,843 | 0.65 | 5.74 | 13,401 | 2,066,039 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 1,521 | 4,445,240 | 0.03 | 5.93 | 9,020 | 26,360,273 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 179 | 357,509 | 0.05 | 5.93 | 1,061 | 2,120,028 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 7,010 | 4,443,719 | 0.16 | 5.99 | 41,972 | 26,606,323 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 827 | 357,330 | 0.23 | 5.99 | 4,952 | 2,139,478 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 7,772 | 4,436,709 | 0.18 | 5.84 | 45,405 | 25,919,698 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 946 | 356,503 | 0.27 | 5.84 | 5,527 | 2,082,726 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 7,248 | 4,428,937 | 0.16 | 5.84 | 42,335 | 25,868,978 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 883 | 355,557 | 0.25 | 5.84 | 5,158 | 2,076,773 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7,489 | 15,142,074 | 0.05 | 5.97 | 44,701 | 90,381,525 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 912 | 1,245,661 | 0.07 | 5.97 | 5,444 | 7,435,226 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 182,827 | 15,134,585 | 1.22 | 5.97 | 1,091,221 | 90,332,284 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22,266 | 1,244,749 | 1.82 | 5.97 | 132,897 | 7,429,409 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9,157 | 14,951,758 | 0.06 | 5.95 | 54,518 | 89,018,282 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,115 | 1,222,483 | 0.09 | 5.95 | 6,638 | 7,278,297 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 90,674 | 14,942,601 | 0.61 | 5.99 | 542,929 | 89,471,812 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11,043 | 1,221,368 | 0.91 | 5.99 | 66,122 | 7,313,185 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8,118 | 14,851,927 | 0.05 | 5.99 | 48,599 | 88,912,546 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 989 | 1,210,325 | 0.08 | 5.99 | 5,921 | 7,245,732 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 15,154 | 14,843,809 | 0.10 | 5.75 | 87,098 | 85,314,792 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,846 | 1,209,336 | 0.15 | 5.75 | 10,610 | 6,950,659 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 93,690 | 14,828,655 | 0.64 | 5.71 | 534,979 | 84,673,103 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11,410 | 1,207,490 | 0.95 | 5.71 | 65,152 | 6,894,889 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 30,003 | 4,421,689 | 0.68 | 6.00 | 180,018 | 26,530,134 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 3,654 | 354,674 | 1.04 | 6.00 | 21,924 | 2,128,044 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 692 | 4,391,686 | 0.02 | 5.92 | 4,095 | 25,989,998 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 84 | 351,020 | 0.02 | 5.92 | 497 | 2,077,336 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 16,501 | 4,390,994 | 0.38 | 6.13 | 101,153 | 26,917,232 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2,010 | 350,936 | 0.58 | 6.13 | 12,322 | 2,151,273 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 16,937 | 4,374,493 | 0.39 | 5.83 | 98,673 | 25,485,359 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2,063 | 348,926 | 0.59 | 5.83 | 12,019 | 2,032,808 | |
| 2022-05-17 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 3,676 | 3,676 | |||||
| 2022-05-17 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 1,503 | 42,966,507 | 0.00 | ||||
| 2022-05-17 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 1,503 | 42,966,507 | 0.00 | ||||
| 2022-05-16 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 25,000 | 25,000 | |||||
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 22,983 | 2,528,583 | 0.92 | 1.99 | 45,628 | 5,019,996 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 2,882 | 256,209 | 1.14 | 1.99 | 5,722 | 508,652 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 758,094 | 2,505,600 | 43.38 | 1.95 | 1,478,283 | 4,885,920 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 95,060 | 253,327 | 60.06 | 1.95 | 185,367 | 493,988 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 101,831 | 1,747,506 | 6.19 | 1.93 | 196,962 | 3,380,026 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 12,769 | 158,267 | 8.78 | 1.93 | 24,698 | 306,120 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 325,373 | 1,645,675 | 24.64 | 1.70 | 553,134 | 2,797,648 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 40,800 | 145,498 | 38.97 | 1.70 | 69,360 | 247,347 | |
| 2022-04-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Voting Common Stock |
P - Purchase | 2,592,497 | 4,674,392 | 124.53 | 23.00 | 59,627,431 | 107,511,016 | |
| 2022-04-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Voting Common Stock |
P - Purchase | 233,590 | 421,532 | 124.29 | 23.00 | 5,372,570 | 9,695,236 | |
| 2022-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 440 | 33,419,495 | 0.00 | ||||
| 2022-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 440 | 33,419,495 | 0.00 | ||||
| 2022-03-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 29,497 | 29,497 | |||||
| 2022-03-10 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -17,500 | 0 | -100.00 | ||||
| 2022-03-10 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -17,500 | 0 | -100.00 | ||||
| 2022-03-10 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 17,500 | 42,965,004 | 0.04 | 20.06 | 351,050 | 861,877,980 | |
| 2022-03-10 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 17,500 | 42,965,004 | 0.04 | 20.06 | 351,050 | 861,877,980 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 175,795 | 33,419,055 | 0.53 | 73.31 | 12,887,303 | 2,449,907,477 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 14,490 | 2,941,147 | 0.50 | 73.31 | 1,062,243 | 215,611,663 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1,017 | 33,243,260 | 0.00 | 71.95 | 73,177 | 2,391,975,557 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 84 | 2,926,657 | 0.00 | 71.95 | 6,044 | 210,583,800 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 25,107 | 33,242,243 | 0.08 | 71.90 | 1,805,126 | 2,390,027,518 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2,070 | 2,926,573 | 0.07 | 71.90 | 148,827 | 210,412,697 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 65,147 | 33,217,136 | 0.20 | 71.72 | 4,672,408 | 2,382,366,211 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 5,370 | 2,924,503 | 0.18 | 71.72 | 385,142 | 209,748,280 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 92,385 | 33,151,989 | 0.28 | 70.68 | 6,529,310 | 2,343,016,823 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7,615 | 2,919,133 | 0.26 | 70.68 | 538,190 | 206,309,725 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 33,059,604 | 0.06 | 22.05 | 441,000 | 728,964,268 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 33,059,604 | 0.06 | 22.05 | 441,000 | 728,964,268 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 92,234 | 33,039,604 | 0.28 | 68.07 | 6,278,507 | 2,249,055,404 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7,566 | 2,891,518 | 0.26 | 68.07 | 515,029 | 196,829,968 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 22,178 | 32,947,370 | 0.07 | 68.43 | 1,517,656 | 2,254,611,592 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1,827 | 2,883,952 | 0.06 | 68.43 | 125,023 | 197,350,854 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 100,731 | 32,925,192 | 0.31 | 68.37 | 6,886,696 | 2,251,003,187 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 8,296 | 2,882,125 | 0.29 | 68.37 | 567,174 | 197,042,816 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 285,672 | 32,824,461 | 0.88 | 67.74 | 19,352,821 | 2,223,689,828 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7,300 | 32,538,789 | 0.02 | 67.40 | 491,984 | 2,192,951,685 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 271,997 | 14,734,965 | 1.88 | 54.57 | 14,843,883 | 804,141,559 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22,403 | 1,196,080 | 1.91 | 54.57 | 1,222,615 | 65,274,511 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5,174 | 14,462,968 | 0.04 | 53.82 | 278,457 | 778,376,690 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 426 | 1,173,677 | 0.04 | 53.82 | 22,927 | 63,165,653 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 64,119 | 14,457,794 | 0.45 | 54.26 | 3,479,200 | 784,503,035 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5,281 | 1,173,251 | 0.45 | 54.26 | 286,556 | 63,662,476 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 23,804 | 14,393,675 | 0.17 | 53.73 | 1,279,048 | 773,408,142 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,961 | 1,167,970 | 0.17 | 53.73 | 105,369 | 62,757,948 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5,359 | 14,369,871 | 0.04 | 54.16 | 290,217 | 778,200,364 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 441 | 1,166,009 | 0.04 | 54.16 | 23,882 | 63,145,217 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 182,326 | 32,531,489 | 0.56 | 66.04 | 12,040,390 | 2,148,304,711 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 320,526 | 32,349,163 | 1.00 | 66.02 | 21,159,973 | 2,135,575,284 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 10,985 | 32,028,637 | 0.03 | 66.95 | 735,433 | 2,144,278,813 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 265,522 | 32,017,652 | 0.84 | 66.81 | 17,740,295 | 2,139,192,181 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 772,751 | 31,752,130 | 2.49 | 67.54 | 52,192,839 | 2,144,589,664 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 6,100 | 30,979,379 | 0.02 | 67.20 | 409,899 | 2,081,705,841 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 40,164 | 30,973,279 | 0.13 | 66.57 | 2,673,577 | 2,061,782,777 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 27,841 | 14,364,512 | 0.19 | 57.22 | 1,593,076 | 821,944,559 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,307 | 1,165,568 | 0.20 | 57.22 | 132,008 | 66,694,384 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11,526 | 14,336,671 | 0.08 | 51.61 | 594,898 | 739,967,202 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 953 | 1,163,261 | 0.08 | 51.61 | 49,188 | 60,040,088 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 17,119 | 14,325,145 | 0.12 | 50.56 | 865,460 | 724,214,868 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,414 | 1,162,308 | 0.12 | 50.56 | 71,485 | 58,761,062 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22,395 | 14,308,026 | 0.16 | 49.70 | 1,113,056 | 711,124,631 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,851 | 1,160,894 | 0.16 | 49.70 | 91,997 | 57,697,709 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 54,024 | 14,285,631 | 0.38 | 51.67 | 2,791,490 | 738,157,125 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4,465 | 1,159,043 | 0.39 | 51.67 | 230,712 | 59,889,259 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 117,291 | 14,231,607 | 0.83 | 51.59 | 6,050,820 | 734,181,565 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 86,479 | 14,114,316 | 0.62 | 52.04 | 4,500,497 | 734,530,176 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5,500 | 14,027,837 | 0.04 | 58.90 | 323,934 | 826,198,919 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 57,547 | 14,022,337 | 0.41 | 58.87 | 3,387,844 | 825,507,599 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9,350 | 13,964,790 | 0.07 | 58.76 | 549,368 | 820,513,805 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 132,367 | 13,955,440 | 0.96 | 58.13 | 7,693,938 | 811,171,114 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 25,900 | 13,823,073 | 0.19 | 57.59 | 1,491,519 | 796,037,599 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 116,083 | 13,797,173 | 0.85 | 56.86 | 6,601,060 | 784,576,243 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,200 | 13,681,090 | 0.01 | 56.60 | 67,914 | 774,281,289 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 19,750 | 13,679,890 | 0.14 | 56.39 | 1,113,649 | 771,372,061 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 31,207 | 13,660,140 | 0.23 | 57.53 | 1,795,292 | 785,847,364 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 102,207 | 13,628,933 | 0.76 | 56.57 | 5,782,279 | 771,045,981 | |
| 2022-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 419 | 30,933,115 | 0.00 | ||||
| 2022-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 419 | 30,933,115 | 0.00 | ||||
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 193,997 | 30,932,696 | 0.63 | 72.91 | 14,144,224 | 2,255,287,399 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 881,875 | 30,738,699 | 2.95 | 72.77 | 64,177,924 | 2,236,990,377 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 29,703 | 29,856,824 | 0.10 | 72.00 | 2,138,616 | 2,149,691,328 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 139,612 | 29,827,121 | 0.47 | 71.96 | 10,045,795 | 2,146,213,474 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 288,368 | 29,687,509 | 0.98 | 71.91 | 20,736,197 | 2,134,793,147 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 5,382 | 29,399,141 | 0.02 | 71.03 | 382,302 | 2,088,323,882 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 9,893 | 29,393,759 | 0.03 | 70.24 | 694,840 | 2,064,485,360 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 36,476 | 29,383,866 | 0.12 | 69.63 | 2,539,700 | 2,045,898,684 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 9,352 | 29,347,390 | 0.03 | 68.52 | 640,841 | 2,011,015,226 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 861 | 29,338,038 | 0.00 | 67.90 | 58,460 | 1,991,999,972 | |
| 2021-12-16 | 3 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
346,863 | ||||||||
| 2021-12-16 | 3 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
4,357,556 | ||||||||
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -51,399 | 42,947,504 | -0.12 | 161.39 | -8,295,146 | 6,931,181,712 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -4,738 | 4,069,762 | -0.12 | 161.39 | -764,653 | 656,807,901 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -8,332 | 42,998,903 | -0.02 | 161.34 | -1,344,327 | 6,937,658,005 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -768 | 4,074,500 | -0.02 | 161.34 | -123,913 | 657,400,202 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -25,833 | 43,007,235 | -0.06 | 160.80 | -4,154,029 | 6,915,701,011 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -2,381 | 4,075,268 | -0.06 | 160.80 | -382,872 | 655,316,135 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -1,007 | 43,033,068 | 0.00 | 165.68 | -166,844 | 7,129,895,142 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -93 | 4,077,649 | 0.00 | 165.68 | -15,409 | 675,601,605 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -9,618 | 43,034,075 | -0.02 | 164.82 | -1,585,266 | 7,092,996,737 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -886 | 4,077,742 | -0.02 | 164.82 | -146,033 | 672,104,854 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -1,337 | 43,043,693 | 0.00 | 163.39 | -218,449 | 7,032,809,999 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -123 | 4,078,628 | 0.00 | 163.39 | -20,097 | 666,397,648 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -20,154 | 43,045,030 | -0.05 | 160.96 | -3,243,986 | 6,928,523,724 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -1,858 | 4,078,751 | -0.05 | 160.96 | -299,063 | 656,515,353 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -29,432 | 43,065,184 | -0.07 | 160.53 | -4,724,631 | 6,913,124,792 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -2,713 | 4,080,609 | -0.07 | 160.53 | -435,510 | 655,047,921 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -5,860 | 43,094,616 | -0.01 | 160.08 | -938,044 | 6,898,400,822 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -540 | 4,083,322 | -0.01 | 160.08 | -86,441 | 653,640,627 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -208,597 | 43,100,476 | -0.48 | 160.00 | -33,375,520 | 6,896,076,160 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -19,226 | 4,083,862 | -0.47 | 160.00 | -3,076,160 | 653,417,920 | |
| 2021-11-19 |
|
4 | TLIS |
Talis Biomedical Corp
Common Stock |
P - Purchase | 50,000 | 7,053,176 | 0.71 | 4.36 | 218,250 | 30,787,113 | |
| 2021-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 393 | 29,337,177 | 0.00 | ||||
| 2021-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 393 | 29,337,177 | 0.00 | ||||
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 86,932 | 13,526,726 | 0.65 | 95.83 | 8,330,572 | 1,296,247,215 | |
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock Warrant (right to buy) |
M - Exercise | -138,815 | 0 | -100.00 | ||||
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock Warrant (right to buy) |
M - Exercise | -11,184 | 0 | -100.00 | ||||
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
F - Taxes | -14 | 13,439,794 | 0.00 | 102.00 | -1,428 | 1,370,858,988 | |
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
M - Exercise | 138,815 | 13,439,808 | 1.04 | 0.01 | 1,388 | 134,398 | |
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
F - Taxes | -2 | 1,154,578 | 0.00 | 102.00 | -204 | 117,766,956 | |
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
M - Exercise | 11,184 | 1,154,580 | 0.98 | 0.01 | 112 | 11,546 | |
| 2021-09-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,153 | 13,300,993 | 0.01 | 94.59 | 109,064 | 1,258,164,870 | |
| 2021-09-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 400 | 13,299,840 | 0.00 | 94.48 | 37,791 | 1,256,535,634 | |
| 2021-09-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 30,285 | 13,299,440 | 0.23 | 94.38 | 2,858,425 | 1,255,257,005 | |
| 2021-09-09 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 52,201 | 13,269,155 | 0.39 | 93.35 | 4,872,948 | 1,238,671,639 | |
| 2021-09-09 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5,300 | 13,216,954 | 0.04 | 92.88 | 492,279 | 1,227,629,017 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 73,635 | 13,211,654 | 0.56 | 87.61 | 6,451,464 | 1,157,527,175 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,396 | 13,138,019 | 0.02 | 87.48 | 209,607 | 1,149,341,492 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4,649 | 13,135,623 | 0.04 | 87.07 | 404,793 | 1,143,731,830 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,968 | 13,130,974 | 0.02 | 86.94 | 258,033 | 1,141,587,183 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 400 | 13,128,006 | 0.00 | 89.66 | 35,863 | 1,177,008,444 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,100 | 13,127,606 | 0.01 | 88.16 | 96,982 | 1,157,395,383 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8,186 | 13,126,506 | 0.06 | 87.91 | 719,659 | 1,153,995,773 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 12,898 | 13,118,320 | 0.10 | 87.79 | 1,132,303 | 1,151,644,194 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7,764 | 13,105,422 | 0.06 | 85.95 | 667,333 | 1,126,439,853 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 400 | 13,097,658 | 0.00 | 84.80 | 33,921 | 1,110,714,143 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 400 | 13,097,258 | 0.00 | 88.82 | 35,526 | 1,163,232,969 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 16,269 | 13,096,858 | 0.12 | 88.76 | 1,444,017 | 1,162,461,400 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 21,595 | 13,080,589 | 0.17 | 88.59 | 1,913,036 | 1,158,770,138 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6,086 | 13,058,994 | 0.05 | 88.01 | 535,634 | 1,149,333,815 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4,600 | 13,052,908 | 0.04 | 86.44 | 397,646 | 1,128,354,716 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 300 | 13,048,308 | 0.00 | 85.58 | 25,674 | 1,116,674,199 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4,500 | 13,048,008 | 0.03 | 88.00 | 395,990 | 1,148,195,998 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 44,700 | 13,043,508 | 0.34 | 86.07 | 3,847,481 | 1,122,699,081 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 600 | 12,998,808 | 0.00 | 85.72 | 51,434 | 1,114,295,518 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3,723 | 12,998,208 | 0.03 | 84.39 | 314,185 | 1,096,922,673 | |
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Non-Voting Common Stock |
C - Conversion | 3,960,811 | 3,960,811 | |||||
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Series C Convertible Preferred Stock |
C - Conversion | -3,960,811 | 0 | -100.00 | ||||
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Non-Voting Common Stock |
C - Conversion | 315,777 | 315,777 | |||||
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Series C Convertible Preferred Stock |
C - Conversion | -315,777 | 0 | -100.00 | ||||
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 1,320,302 | 1,320,302 | 15.00 | 19,804,530 | 19,804,530 | ||
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 104,698 | 104,698 | 15.00 | 1,570,470 | 1,570,470 | ||
| 2021-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 345 | 29,336,784 | 0.00 | ||||
| 2021-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 345 | 29,336,784 | 0.00 | ||||
| 2021-07-01 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Non-Qualified Share Option (right to buy) |
A - Award | 66,474 | 66,474 | |||||
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Non-Qualified Stock Options (right to buy) |
A - Award | 7,368 | 7,368 | |||||
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 121,612 | 12,994,485 | 0.94 | 92.75 | 11,279,014 | 1,205,185,206 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7,009 | 12,872,873 | 0.05 | 91.64 | 642,276 | 1,179,617,303 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22,353 | 12,865,864 | 0.17 | 90.20 | 2,016,332 | 1,160,553,683 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4,603 | 12,843,511 | 0.04 | 89.74 | 413,070 | 1,152,566,402 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 30,221 | 12,838,908 | 0.24 | 90.70 | 2,741,157 | 1,164,536,460 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,200 | 12,808,687 | 0.01 | 90.40 | 108,474 | 1,157,841,261 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11,731 | 12,807,487 | 0.09 | 90.39 | 1,060,378 | 1,157,682,838 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3,847 | 12,795,756 | 0.03 | 89.90 | 345,828 | 1,150,282,163 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7,079 | 12,791,909 | 0.06 | 89.87 | 636,196 | 1,149,620,375 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10,459 | 12,784,830 | 0.08 | 91.87 | 960,845 | 1,174,514,205 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22,445 | 12,774,371 | 0.18 | 91.80 | 2,060,393 | 1,172,654,044 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10,170 | 12,751,926 | 0.08 | 90.76 | 923,046 | 1,157,386,482 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5,200 | 12,741,756 | 0.04 | 90.27 | 469,420 | 1,150,237,814 | |
| 2021-06-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Options (right to buy) |
A - Award | 23,274 | 23,274 | |||||
| 2021-06-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 12,782 | 38,452,877 | 0.03 | ||||
| 2021-06-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 12,782 | 38,452,877 | 0.03 | ||||
| 2021-06-22 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Qualified Stock Options (right to buy) |
A - Award | 23,344 | 23,344 | |||||
| 2021-06-21 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
A - Award | 34,996 | 34,996 | |||||
| 2021-06-21 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 15,600 | 34,189 | 83.92 | ||||
| 2021-06-21 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 15,600 | 34,189 | 83.92 | ||||
| 2021-06-10 |
|
4 | AGLE |
Aeglea BioTherapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 40,000 | 40,000 | |||||
| 2021-05-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 8,010 | 8,010 | |||||
| 2021-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1,923 | 29,336,439 | 0.01 | ||||
| 2021-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1,923 | 29,336,439 | 0.01 | ||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 3,462 | 3,462 | |||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -17,500 | 0 | -100.00 | ||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -17,500 | 0 | -100.00 | ||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 1,402 | 43,309,073 | 0.00 | ||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 1,402 | 43,309,073 | 0.00 | ||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 17,500 | 43,307,671 | 0.04 | 19.02 | 332,850 | 823,711,902 | |
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 17,500 | 43,307,671 | 0.04 | 19.02 | 332,850 | 823,711,902 | |
| 2021-05-18 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2021-05-18 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2021-05-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 29,334,516 | 0.07 | 18.97 | 379,400 | 556,475,769 | |
| 2021-05-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 2,870,749 | 0.70 | 18.97 | 379,400 | 54,458,109 | |
| 2021-05-13 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 25,000 | 25,000 | |||||
| 2021-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 364 | 29,314,516 | 0.00 | ||||
| 2021-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 364 | 29,314,516 | 0.00 | ||||
| 2021-02-25 |
|
4 | AGLE |
Aeglea BioTherapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 47,200 | 47,200 | |||||
| 2021-02-25 | 3 | AGLE |
Aeglea BioTherapeutics, Inc.
Common Stock |
315,516 | ||||||||
| 2021-02-25 | 3 | AGLE |
Aeglea BioTherapeutics, Inc.
Common Stock |
3,094,590 | ||||||||
| 2021-02-23 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 6,423 | 6,423 | |||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 6,427,576 | 27,511,741 | 30.49 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 536,438 | 2,345,481 | 29.65 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 7,286,794 | 21,084,165 | 52.81 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 536,414 | 1,809,043 | 42.15 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 1,941 | 5,420 | 55.79 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 6,654,603 | 13,797,371 | 93.17 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 598,860 | 1,272,629 | 88.88 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 7,142,768 | 7,142,768 | |||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 673,769 | 673,769 | |||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 3,479 | 3,479 | |||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series F-2 Convertible Preferred Stock |
M - Exercise | -9,191,433 | 0 | -100.00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series F-2 Convertible Preferred Stock |
M - Exercise | -767,106 | 0 | -100.00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series E-2 Convertible Preferred Stock |
M - Exercise | -10,420,117 | 0 | -100.00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series E-2 Convertible Preferred Stock |
M - Exercise | -767,072 | 0 | -100.00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series E-1 Convertible Preferred Stock |
M - Exercise | -2,776 | 0 | -100.00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series D-2 Convertible Preferred Stock |
M - Exercise | -9,516,082 | 0 | -100.00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series D-2 Convertible Preferred Stock |
M - Exercise | -856,370 | 0 | -100.00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series C-1 Convertible Preferred Stock |
M - Exercise | -10,214,159 | 0 | -100.00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series C-1 Convertible Preferred Stock |
M - Exercise | -963,490 | 0 | -100.00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series C-1 Convertible Preferred Stock |
M - Exercise | -4,975 | 0 | -100.00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Common Stock |
P - Purchase | 5,792,538 | 7,003,176 | 478.47 | 16.00 | 92,680,608 | 112,050,816 | |
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Common Stock |
P - Purchase | 457,462 | 571,659 | 400.59 | 16.00 | 7,319,392 | 9,146,544 | |
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series F-2 Convertible Preferred Stock |
A - Award | 9,191,433 | 9,191,433 | 8.55 | 78,586,752 | 78,586,752 | ||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series F-2 Convertible Preferred Stock |
A - Award | 767,106 | 767,106 | 8.55 | 6,558,756 | 6,558,756 | ||
| 2021-02-16 |
|
5 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | -158,456 | 23,277 | -87.19 | ||||
| 2021-02-16 |
|
5 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | -158,460 | 23,280 | -87.19 | ||||
| 2021-02-11 | 3 | TLIS |
Talis Biomedical Corp
Common Stock |
590 | ||||||||
| 2021-02-11 | 3 | TLIS |
Talis Biomedical Corp
Common Stock |
114,197 | ||||||||
| 2021-02-11 | 3 | TLIS |
Talis Biomedical Corp
Common Stock |
1,210,638 | ||||||||
| 2021-01-29 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5,188 | 41,500 | -11.11 | ||||
| 2021-01-29 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5,188 | 41,500 | -11.11 | ||||
| 2021-01-29 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
M - Exercise | 5,188 | 9,252,951 | 0.06 | 12.85 | 66,666 | 118,900,420 | |
| 2021-01-29 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
M - Exercise | 5,188 | 9,252,951 | 0.06 | 12.85 | 66,666 | 118,900,420 | |
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5,833 | 2,527 | -69.77 | ||||
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5,833 | 2,527 | -69.77 | ||||
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5,377 | 6,723 | -44.44 | ||||
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5,377 | 6,723 | -44.44 | ||||
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
M - Exercise | 5,833 | 2,895,306 | 0.20 | 40.27 | 234,895 | 116,593,973 | |
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
M - Exercise | 5,833 | 2,895,306 | 0.20 | 40.27 | 234,895 | 116,593,973 | |
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
M - Exercise | 5,377 | 2,889,473 | 0.19 | 16.00 | 86,032 | 46,231,568 | |
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
M - Exercise | 5,377 | 2,889,473 | 0.19 | 16.00 | 86,032 | 46,231,568 | |
| 2021-01-13 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
P - Purchase | 154,222 | 5,212,371 | 3.05 | 60.00 | 9,253,320 | 312,742,260 | |
| 2021-01-13 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
P - Purchase | 12,444 | 509,480 | 2.50 | 60.00 | 746,640 | 30,568,800 | |
| 2021-01-11 | 3 | DBVT |
DBV Technologies S.A.
Ordinary Shares |
332,622 | ||||||||
| 2021-01-11 | 3 | DBVT |
DBV Technologies S.A.
Ordinary Shares |
3,953,416 | ||||||||
| 2021-01-11 | 3 | DBVT |
DBV Technologies S.A.
American Depositary Shares |
1,200,369 | ||||||||
| 2021-01-11 | 3 | DBVT |
DBV Technologies S.A.
American Depositary Shares |
13,413,895 | ||||||||
| 2021-01-06 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -111,094 | 10,699,954 | -1.03 | 220.50 | -24,496,227 | 2,359,339,857 | |
| 2021-01-06 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -10,060 | 968,943 | -1.03 | 220.50 | -2,218,230 | 213,651,932 | |
| 2021-01-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2,884,096 | 0.01 | ||||
| 2021-01-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2,884,096 | 0.01 | ||||
| 2021-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 343 | 29,314,152 | 0.00 | ||||
| 2021-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 343 | 29,314,152 | 0.00 | ||||
| 2020-12-23 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Pre-Funded Warrants |
P - Purchase | 518,555 | 10,283,888 | 5.31 | ||||
| 2020-12-23 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Pre-Funded Warrants |
P - Purchase | 38,974 | 1,199,122 | 3.36 | ||||
| 2020-12-23 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 394,360 | 3,501,691 | 12.69 | 15.25 | 6,013,990 | 53,400,788 | |
| 2020-12-23 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 29,640 | 320,049 | 10.21 | 15.25 | 452,010 | 4,880,747 | |
| 2020-12-11 |
|
4 | IGMS |
IGM Biosciences, Inc.
Pre-funded Warrants |
P - Purchase | 616,846 | 616,846 | 89.99 | 55,509,972 | 55,509,972 | ||
| 2020-12-11 |
|
4 | IGMS |
IGM Biosciences, Inc.
Pre-funded Warrants |
P - Purchase | 49,820 | 49,820 | 89.99 | 4,483,302 | 4,483,302 | ||
| 2020-12-04 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -1,386,033 | 10,811,048 | -11.36 | 220.50 | -305,620,276 | 2,383,836,084 | |
| 2020-12-04 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -125,513 | 979,003 | -11.36 | 220.50 | -27,675,616 | 215,870,162 | |
| 2020-12-04 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
G - Gift | -13,516 | 10,418 | -56.47 | ||||
| 2020-12-04 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
G - Gift | -13,516 | 10,418 | -56.47 | ||||
| 2020-11-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,411,619 | 12,736,556 | 12.46 | 108.00 | 152,454,852 | 1,375,548,048 | |
| 2020-11-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 116,158 | 1,143,396 | 11.31 | 108.00 | 12,545,064 | 123,486,768 | |
| 2020-10-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2,883,873 | 0.01 | ||||
| 2020-10-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2,883,873 | 0.01 | ||||
| 2020-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 317 | 29,313,809 | 0.00 | ||||
| 2020-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 317 | 29,313,809 | 0.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 382,884 | 5,058,149 | 8.19 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Convertible Preferred Stock |
C - Conversion | -382,884 | 0 | -100.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 30,349 | 497,036 | 6.50 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Convertible Preferred Stock |
C - Conversion | -30,349 | 0 | -100.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Convertible Preferred Stock |
C - Conversion | -574,327 | 0 | -100.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Convertible Preferred Stock |
C - Conversion | -45,524 | 0 | -100.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 2,698,424 | 4,675,265 | 136.50 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Convertible Preferred Stock |
C - Conversion | -2,698,424 | 0 | -100.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 247,034 | 466,687 | 112.47 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Convertible Preferred Stock |
C - Conversion | -247,034 | 0 | -100.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Convertible Preferred Stock |
C - Conversion | -4,047,634 | 0 | -100.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Convertible Preferred Stock |
C - Conversion | -370,552 | 0 | -100.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 1,976,841 | 1,976,841 | |||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series A Convertible Preferred Stock |
C - Conversion | -1,976,841 | 0 | -100.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 219,653 | 219,653 | |||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series A Convertible Preferred Stock |
C - Conversion | -219,653 | 0 | -100.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series A Convertible Preferred Stock |
C - Conversion | -2,965,263 | 0 | -100.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series A Convertible Preferred Stock |
C - Conversion | -329,478 | 0 | -100.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
P - Purchase | 1,474,319 | 9,247,763 | 18.97 | 19.00 | 28,012,061 | 175,707,497 | |
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
P - Purchase | 104,628 | 870,873 | 13.65 | 19.00 | 1,987,932 | 16,546,587 | |
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 574,327 | 7,773,444 | 7.98 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 45,524 | 766,245 | 6.32 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 4,047,634 | 7,199,117 | 128.44 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 370,552 | 720,721 | 105.82 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 2,965,263 | 3,151,483 | 1,592.34 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 329,478 | 350,169 | 1,592.37 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Qualified Stock Option (right to buy) |
A - Award | 46,688 | 46,688 | |||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Preferred Stock |
P - Purchase | 957,211 | 957,211 | 14.52 | 13,898,321 | 13,898,321 | ||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Preferred Stock |
P - Purchase | 75,873 | 75,873 | 14.52 | 1,101,646 | 1,101,646 | ||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Preferred Stock |
P - Purchase | 3,373,029 | 3,373,029 | 3.93 | 13,264,099 | 13,264,099 | ||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Preferred Stock |
P - Purchase | 308,793 | 308,793 | 3.93 | 1,214,298 | 1,214,298 | ||
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7,843 | 11,324,937 | 0.07 | 58.09 | 455,565 | 657,814,628 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 557 | 1,027,238 | 0.05 | 58.09 | 32,354 | 59,667,633 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 19,235 | 11,317,094 | 0.17 | 56.92 | 1,094,854 | 644,167,859 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,365 | 1,026,681 | 0.13 | 56.92 | 77,696 | 58,438,580 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4,705 | 11,297,859 | 0.04 | 56.76 | 267,055 | 641,265,347 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 334 | 1,025,316 | 0.03 | 56.76 | 18,958 | 58,196,834 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 13,153 | 11,293,154 | 0.12 | 55.35 | 728,057 | 625,108,824 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 933 | 1,024,982 | 0.09 | 55.35 | 51,644 | 56,735,726 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 29,327 | 11,280,001 | 0.26 | 52.11 | 1,528,374 | 587,856,124 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,081 | 1,024,049 | 0.20 | 52.11 | 108,451 | 53,368,211 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4,306 | 11,250,674 | 0.04 | 51.41 | 221,368 | 578,388,150 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 306 | 1,021,968 | 0.03 | 51.41 | 15,731 | 52,538,557 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 74,381 | 11,246,368 | 0.67 | 52.44 | 3,900,235 | 589,713,428 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5,278 | 1,021,662 | 0.52 | 52.44 | 276,757 | 53,571,766 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10,467 | 11,171,987 | 0.09 | 52.40 | 548,468 | 585,408,767 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 743 | 1,016,384 | 0.07 | 52.40 | 38,933 | 53,258,217 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,120 | 11,161,520 | 0.01 | 51.97 | 58,206 | 580,064,194 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 80 | 1,015,641 | 0.01 | 51.97 | 4,158 | 52,782,863 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22,361 | 11,160,400 | 0.20 | 51.98 | 1,162,235 | 580,072,950 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,587 | 1,015,561 | 0.16 | 51.98 | 82,486 | 52,784,799 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 36,647 | 11,138,039 | 0.33 | 50.15 | 1,837,909 | 558,591,591 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,601 | 1,013,974 | 0.26 | 50.15 | 130,445 | 50,852,520 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10,983 | 11,101,392 | 0.10 | 49.72 | 546,102 | 551,988,964 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 779 | 1,011,373 | 0.08 | 49.72 | 38,734 | 50,287,994 | |
| 2020-09-24 | 3 | PRLD |
Prelude Therapeutics Inc
Common Stock |
20,691 | ||||||||
| 2020-09-24 | 3 | PRLD |
Prelude Therapeutics Inc
Common Stock |
186,220 | ||||||||
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 15,172 | 11,090,409 | 0.14 | 47.47 | 720,200 | 526,450,625 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,220 | 1,010,594 | 0.12 | 47.47 | 57,912 | 47,971,887 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 76,473 | 11,075,237 | 0.70 | 47.39 | 3,623,857 | 524,826,686 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6,151 | 1,009,374 | 0.61 | 47.39 | 291,480 | 47,831,609 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 15,807 | 10,998,764 | 0.14 | 47.04 | 743,482 | 517,326,865 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,272 | 1,003,223 | 0.13 | 47.04 | 59,829 | 47,186,594 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 185 | 10,982,957 | 0.00 | 45.88 | 8,487 | 503,843,152 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 15 | 1,001,951 | 0.00 | 45.88 | 688 | 45,964,502 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9,101 | 10,982,772 | 0.08 | 47.50 | 432,281 | 521,661,901 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 712 | 1,001,936 | 0.07 | 47.50 | 33,819 | 47,590,157 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 26,238 | 10,973,671 | 0.24 | 47.26 | 1,239,984 | 518,605,815 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,054 | 1,001,224 | 0.21 | 47.26 | 97,070 | 47,316,945 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 29,319 | 10,947,433 | 0.27 | 46.62 | 1,366,767 | 510,337,579 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,295 | 999,170 | 0.23 | 46.62 | 106,986 | 46,578,408 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 12,132 | 10,918,114 | 0.11 | 45.30 | 549,535 | 494,550,167 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 950 | 996,875 | 0.10 | 45.30 | 43,031 | 45,154,749 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 32,088 | 10,905,982 | 0.30 | 49.00 | 1,572,312 | 534,393,118 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,512 | 995,925 | 0.25 | 49.00 | 123,088 | 48,800,325 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 77,456 | 10,873,894 | 0.72 | 47.60 | 3,686,658 | 517,562,558 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6,062 | 993,413 | 0.61 | 47.60 | 288,532 | 47,283,280 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,987 | 10,796,438 | 0.03 | 47.45 | 141,725 | 512,260,753 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 234 | 987,351 | 0.02 | 47.45 | 11,103 | 46,847,040 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,359 | 10,793,451 | 0.02 | 46.97 | 110,798 | 506,947,886 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 185 | 987,117 | 0.02 | 46.97 | 8,689 | 46,363,010 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 83,832 | 10,791,092 | 0.78 | 49.08 | 4,114,734 | 529,660,248 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6,645 | 986,932 | 0.68 | 49.08 | 326,157 | 48,441,682 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,286 | 10,707,260 | 0.02 | 48.74 | 111,430 | 521,922,177 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 181 | 980,287 | 0.02 | 48.74 | 8,823 | 47,783,796 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 42,714 | 10,704,974 | 0.40 | 47.74 | 2,039,256 | 511,077,939 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3,386 | 980,106 | 0.35 | 47.74 | 161,655 | 46,792,319 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 754 | 10,662,260 | 0.01 | 47.82 | 36,058 | 509,896,995 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 60 | 976,720 | 0.01 | 47.82 | 2,869 | 46,709,290 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 41,155 | 10,661,506 | 0.39 | 47.72 | 1,963,970 | 508,780,926 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3,262 | 976,660 | 0.34 | 47.72 | 155,667 | 46,607,485 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10,640 | 10,620,351 | 0.10 | 46.50 | 494,716 | 493,802,778 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 843 | 973,398 | 0.09 | 46.50 | 39,196 | 45,259,016 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3,576 | 10,609,711 | 0.03 | 46.30 | 165,575 | 491,248,717 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 283 | 972,555 | 0.03 | 46.30 | 13,103 | 45,031,047 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3,585 | 10,606,135 | 0.03 | 46.99 | 168,447 | 498,345,162 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 284 | 972,272 | 0.03 | 46.99 | 13,344 | 45,683,658 | |
| 2020-07-28 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 1,335,362 | 11,638,314 | 12.96 | 21.00 | 28,042,602 | 244,404,594 | |
| 2020-07-28 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 93,210 | 1,143,650 | 8.87 | 21.00 | 1,957,410 | 24,016,650 | |
| 2020-07-20 |
|
4 | BCEL |
Atreca, Inc.
Class B Common Stock |
P - Purchase | 728,370 | 6,173,327 | 13.38 | 16.00 | 11,653,920 | 98,773,232 | |
| 2020-07-20 |
|
4 | BCEL |
Atreca, Inc.
Class B Common Stock |
P - Purchase | 52,880 | 542,114 | 10.81 | 16.00 | 846,080 | 8,673,824 | |
| 2020-07-20 |
|
4 | BCEL |
Atreca, Inc.
Class B Common Stock |
P - Purchase | 728,370 | 6,173,327 | 13.38 | 16.00 | 11,653,920 | 98,773,232 | |
| 2020-07-20 |
|
4 | BCEL |
Atreca, Inc.
Class B Common Stock |
P - Purchase | 52,880 | 542,114 | 10.81 | 16.00 | 846,080 | 8,673,824 | |
| 2020-07-17 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 13,589,904 | 18,840,379 | 258.83 | 14.23 | 193,395,206 | 268,113,665 | |
| 2020-07-17 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 994,276 | 1,021,851 | 3,605.72 | 14.23 | 14,149,343 | 14,541,757 | |
| 2020-07-06 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2,883,650 | 0.01 | ||||
| 2020-07-06 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2,883,650 | 0.01 | ||||
| 2020-07-02 |
|
4 | KOD |
Kodiak Sciences Inc.
Non-Qualified Stock Options (right to buy) |
A - Award | 7,106 | 7,106 | |||||
| 2020-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 294 | 29,313,492 | 0.00 | ||||
| 2020-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 294 | 29,313,492 | 0.00 | ||||
| 2020-07-02 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Non-Qualified Share Option (right to buy) |
A - Award | 37,520 | 37,520 | |||||
| 2020-06-25 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Options (right to buy) |
A - Award | 11,158 | 11,158 | |||||
| 2020-06-25 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 6,118 | 38,440,095 | 0.02 | ||||
| 2020-06-25 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 6,118 | 38,440,095 | 0.02 | ||||
| 2020-06-19 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
A - Award | 90,766 | 90,766 | |||||
| 2020-06-10 |
|
4 | KOD |
Kodiak Sciences Inc.
Non-Qualified Stock Options (right to buy) |
A - Award | 4,135 | 4,135 | |||||
| 2020-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1 | 29,313,198 | 0.00 | 102.55 | 103 | 3,006,068,455 | |
| 2020-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1 | 29,313,198 | 0.00 | 102.55 | 103 | 3,006,068,455 | |
| 2020-05-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 10,514 | 10,514 | |||||
| 2020-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1,282 | 29,313,197 | 0.00 | ||||
| 2020-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1,282 | 29,313,197 | 0.00 | ||||
| 2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 3,171 | 3,171 | |||||
| 2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 1,335 | 43,290,171 | 0.00 | ||||
| 2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 1,335 | 43,290,171 | 0.00 | ||||
| 2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -1,602,312 | 43,288,836 | -3.57 | 160.00 | -256,369,920 | 6,926,213,760 | |
| 2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -147,688 | 4,082,851 | -3.49 | 160.00 | -23,630,080 | 653,256,160 | |
| 2020-05-18 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 1,465,603 | 10,302,952 | 16.58 | 18.25 | 26,747,255 | 188,028,874 | |
| 2020-05-18 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 134,397 | 1,050,440 | 14.67 | 18.25 | 2,452,745 | 19,170,530 | |
| 2020-05-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1,189 | 7,846,213 | 0.02 | ||||
| 2020-05-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1,189 | 7,846,213 | 0.02 | ||||
| 2020-05-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3,468 | 7,845,024 | 0.04 | ||||
| 2020-05-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3,468 | 7,845,024 | 0.04 | ||||
| 2020-05-12 |
|
4 | ZYME |
Zymeworks Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 9,000 | 9,000 | |||||
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -457,803 | 44,891,148 | -1.01 | 158.50 | -72,561,776 | 7,115,246,958 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -42,197 | 4,230,539 | -0.99 | 158.50 | -6,688,224 | 670,540,432 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -4,343 | 45,348,951 | -0.01 | 166.15 | -721,610 | 7,534,941,349 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -400 | 4,272,736 | -0.01 | 166.15 | -66,462 | 709,935,168 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -48,880 | 45,353,294 | -0.11 | 164.96 | -8,063,118 | 7,481,361,460 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -4,505 | 4,273,136 | -0.11 | 164.96 | -743,133 | 704,885,404 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -84,663 | 45,402,174 | -0.19 | 164.19 | -13,901,157 | 7,454,764,558 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -7,805 | 4,277,641 | -0.18 | 164.19 | -1,281,534 | 702,362,986 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -16,159 | 45,486,837 | -0.04 | 163.41 | -2,640,610 | 7,433,195,079 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -1,489 | 4,285,446 | -0.03 | 163.41 | -243,324 | 700,302,730 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -41,072 | 45,502,996 | -0.09 | 166.62 | -6,843,564 | 7,581,873,004 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -3,786 | 4,286,935 | -0.09 | 166.62 | -630,837 | 714,304,543 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -91,613 | 45,544,068 | -0.20 | 165.70 | -15,180,641 | 7,546,834,244 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -8,444 | 4,290,721 | -0.20 | 165.70 | -1,399,205 | 710,989,633 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -178,862 | 45,635,681 | -0.39 | 164.60 | -29,440,041 | 7,511,468,804 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -16,485 | 4,299,165 | -0.38 | 164.60 | -2,713,372 | 707,627,082 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -45,606 | 45,814,543 | -0.10 | 164.06 | -7,482,107 | 7,516,320,180 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -4,204 | 4,315,650 | -0.10 | 164.06 | -689,707 | 708,024,244 | |
| 2020-05-07 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 25,000 | 25,000 | |||||
| 2020-04-29 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2020-04-29 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2020-04-29 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 29,311,915 | 0.07 | 13.34 | 266,800 | 391,020,946 | |
| 2020-04-29 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 29,311,915 | 0.07 | 13.34 | 266,800 | 391,020,946 | |
| 2020-04-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -17,500 | 0 | -100.00 | ||||
| 2020-04-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -17,500 | 0 | -100.00 | ||||
| 2020-04-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 17,500 | 45,860,149 | 0.04 | 12.76 | 223,300 | 585,175,501 | |
| 2020-04-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 17,500 | 45,860,149 | 0.04 | 12.76 | 223,300 | 585,175,501 | |
| 2020-04-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2,883,427 | 0.01 | ||||
| 2020-04-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2,883,427 | 0.01 | ||||
| 2020-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 392 | 29,291,915 | 0.00 | 73.23 | 28,706 | 2,145,046,935 | |
| 2020-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 392 | 29,291,915 | 0.00 | 73.23 | 28,706 | 2,145,046,935 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 42,473 | 38,433,977 | 0.11 | 34.47 | 1,463,896 | 1,324,684,668 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,837 | 3,470,609 | 0.11 | 34.47 | 132,248 | 119,619,745 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 33,464 | 38,391,504 | 0.09 | 33.63 | 1,125,465 | 1,291,186,902 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,023 | 3,466,772 | 0.09 | 33.63 | 101,670 | 116,594,823 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2,201 | 38,358,040 | 0.01 | 32.85 | 72,302 | 1,260,053,942 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 199 | 3,463,749 | 0.01 | 32.85 | 6,537 | 113,783,462 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 46,225 | 38,355,839 | 0.12 | 32.61 | 1,507,268 | 1,250,676,513 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4,175 | 3,463,550 | 0.12 | 32.61 | 136,135 | 112,936,668 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 275 | 38,309,614 | 0.00 | 31.94 | 8,782 | 1,223,417,523 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 25 | 3,459,375 | 0.00 | 31.94 | 798 | 110,475,141 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 93,006 | 38,309,339 | 0.24 | 33.86 | 3,149,406 | 1,297,246,161 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 8,402 | 3,459,350 | 0.24 | 33.86 | 284,512 | 117,141,893 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24,223 | 38,216,333 | 0.06 | 32.32 | 782,873 | 1,235,128,953 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2,188 | 3,450,948 | 0.06 | 32.32 | 70,715 | 111,532,569 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 29,624 | 38,192,110 | 0.08 | 32.19 | 953,620 | 1,229,434,575 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2,676 | 3,448,760 | 0.08 | 32.19 | 86,143 | 111,018,343 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7,612 | 38,162,486 | 0.02 | 31.83 | 242,290 | 1,214,711,929 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 688 | 3,446,084 | 0.02 | 31.83 | 21,899 | 109,688,854 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 43,212 | 38,154,874 | 0.11 | 31.74 | 1,371,359 | 1,210,867,819 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,903 | 3,445,396 | 0.11 | 31.74 | 123,864 | 109,341,709 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,913 | 38,111,662 | 0.01 | 31.00 | 121,285 | 1,181,290,020 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 353 | 3,441,493 | 0.01 | 31.00 | 10,941 | 106,670,796 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 631,281 | 38,107,749 | 1.68 | 31.51 | 19,893,937 | 1,200,912,359 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 57,022 | 3,441,140 | 1.68 | 31.51 | 1,796,968 | 108,442,710 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5,503 | 37,476,468 | 0.01 | 31.19 | 171,613 | 1,168,714,898 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 497 | 3,384,118 | 0.01 | 31.19 | 15,499 | 105,534,735 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9,172 | 10,602,550 | 0.09 | 38.38 | 352,019 | 406,922,688 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 828 | 971,988 | 0.09 | 38.38 | 31,778 | 37,304,608 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6,237 | 10,593,378 | 0.06 | 37.75 | 235,433 | 399,876,714 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 563 | 971,160 | 0.06 | 37.75 | 21,252 | 36,659,153 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 17,058 | 10,587,141 | 0.16 | 36.69 | 625,914 | 388,477,141 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,542 | 970,597 | 0.16 | 36.69 | 56,581 | 35,614,407 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9,172 | 10,570,083 | 0.09 | 38.98 | 357,570 | 412,074,686 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 828 | 969,055 | 0.09 | 38.98 | 32,280 | 37,778,609 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 95,934 | 10,560,911 | 0.92 | 39.97 | 3,834,588 | 422,131,230 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8,666 | 968,227 | 0.90 | 39.97 | 346,390 | 38,701,098 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 14,731 | 7,841,556 | 0.19 | 83.14 | 1,224,797 | 651,979,900 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,331 | 994,296 | 0.13 | 83.14 | 110,665 | 82,669,945 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,321 | 7,826,825 | 0.02 | 82.92 | 109,537 | 648,995,633 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 119 | 992,965 | 0.01 | 82.92 | 9,867 | 82,336,062 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15,928 | 7,825,504 | 0.20 | 82.13 | 1,308,149 | 642,700,035 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,439 | 992,846 | 0.15 | 82.13 | 118,183 | 81,541,350 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 25,640 | 7,809,576 | 0.33 | 81.79 | 2,097,003 | 638,717,107 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,314 | 991,407 | 0.23 | 81.79 | 189,254 | 81,083,609 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,203 | 7,783,936 | 0.05 | 81.47 | 342,438 | 634,193,850 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 380 | 989,093 | 0.04 | 81.47 | 30,960 | 80,586,055 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 12,815 | 7,779,733 | 0.16 | 81.09 | 1,039,177 | 630,863,995 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,158 | 988,713 | 0.12 | 81.09 | 93,903 | 80,175,429 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3,298 | 7,766,918 | 0.04 | 80.91 | 266,845 | 628,431,432 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 298 | 987,555 | 0.03 | 80.91 | 24,112 | 79,904,359 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10,285 | 7,763,620 | 0.13 | 79.87 | 821,429 | 620,054,709 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 929 | 987,257 | 0.09 | 79.87 | 74,196 | 78,848,959 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 26,022 | 7,753,335 | 0.34 | 79.72 | 2,074,362 | 618,062,527 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,351 | 986,328 | 0.24 | 79.72 | 187,412 | 78,625,827 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,888 | 7,727,313 | 0.04 | 79.29 | 228,980 | 612,673,148 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 261 | 983,977 | 0.03 | 79.29 | 20,694 | 78,016,289 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,191 | 7,724,425 | 0.05 | 79.16 | 331,760 | 611,467,028 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 379 | 983,716 | 0.04 | 79.16 | 30,002 | 77,871,155 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 565 | 7,720,234 | 0.01 | 78.66 | 44,443 | 607,273,606 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 51 | 983,337 | 0.01 | 78.66 | 4,012 | 77,349,288 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 65,505 | 7,719,669 | 0.86 | 76.67 | 5,022,445 | 591,887,865 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5,917 | 983,286 | 0.61 | 76.67 | 453,672 | 75,391,192 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 27,866 | 7,654,164 | 0.37 | 76.10 | 2,120,480 | 582,448,202 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,517 | 977,369 | 0.26 | 76.10 | 191,533 | 74,373,480 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 62,129 | 7,626,298 | 0.82 | 79.76 | 4,955,720 | 608,311,660 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5,612 | 974,852 | 0.58 | 79.76 | 447,641 | 77,759,070 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 133,042 | 7,564,169 | 1.79 | 79.14 | 10,529,170 | 598,641,194 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 12,017 | 969,240 | 1.26 | 79.14 | 951,046 | 76,707,301 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7,612 | 7,431,127 | 0.10 | 77.94 | 593,260 | 579,163,461 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 688 | 957,223 | 0.07 | 77.94 | 53,621 | 74,603,568 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 8,309 | 7,423,515 | 0.11 | 77.89 | 647,203 | 578,230,946 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 750 | 956,535 | 0.08 | 77.89 | 58,419 | 74,506,233 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 32,228 | 7,415,206 | 0.44 | 75.66 | 2,438,422 | 561,046,350 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,911 | 955,785 | 0.31 | 75.66 | 220,251 | 72,316,222 | |
| 2020-03-16 |
|
4 | ZYME |
Zymeworks Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 18,000 | 18,000 | |||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1,876,724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3,248,692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1,876,724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3,248,692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1,876,724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3,248,692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1,876,724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3,248,692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1,876,724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3,248,692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1,876,724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3,248,692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1,876,724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3,248,692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1,876,724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3,248,692 | ||||||||
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 82,740 | 10,464,977 | 0.80 | 57.82 | 4,783,944 | 605,074,505 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7,460 | 959,561 | 0.78 | 57.82 | 431,330 | 55,480,857 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8,989 | 10,382,237 | 0.09 | 59.61 | 535,824 | 618,873,727 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 811 | 952,101 | 0.09 | 59.61 | 48,343 | 56,753,693 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 14,631 | 10,373,248 | 0.14 | 59.99 | 877,642 | 622,240,319 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,319 | 951,290 | 0.14 | 59.99 | 79,120 | 57,063,226 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 145,994 | 10,358,617 | 1.43 | 57.68 | 8,421,518 | 597,526,463 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 13,164 | 949,971 | 1.41 | 57.68 | 759,352 | 54,798,127 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 14,051 | 10,212,623 | 0.14 | 57.22 | 803,980 | 584,353,012 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,267 | 936,807 | 0.14 | 57.22 | 72,496 | 53,602,879 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 14,402 | 10,198,572 | 0.14 | 58.80 | 846,819 | 599,662,775 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,298 | 935,540 | 0.14 | 58.80 | 76,321 | 55,008,536 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8,623 | 10,184,170 | 0.08 | 60.77 | 524,043 | 618,919,508 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 777 | 934,242 | 0.08 | 60.77 | 47,220 | 56,776,409 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6,788 | 10,175,547 | 0.07 | 58.54 | 397,393 | 595,711,118 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 612 | 933,465 | 0.07 | 58.54 | 35,829 | 54,648,215 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7,122 | 10,168,759 | 0.07 | 58.39 | 415,826 | 593,714,180 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 642 | 932,853 | 0.07 | 58.39 | 37,484 | 54,465,649 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3,577 | 10,161,637 | 0.04 | 57.62 | 206,108 | 585,517,589 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 323 | 932,211 | 0.03 | 57.62 | 18,611 | 53,714,371 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 21,301 | 10,158,060 | 0.21 | 56.69 | 1,207,513 | 575,841,121 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,921 | 931,888 | 0.21 | 56.69 | 108,898 | 52,826,960 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5,804 | 10,136,759 | 0.06 | 56.62 | 328,631 | 573,958,500 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 523 | 929,967 | 0.06 | 56.62 | 29,613 | 52,656,126 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10,121 | 10,130,955 | 0.10 | 56.25 | 569,277 | 569,836,839 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 912 | 929,444 | 0.10 | 56.25 | 51,297 | 52,278,530 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 92 | 10,120,834 | 0.00 | 55.45 | 5,102 | 561,225,547 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8 | 928,532 | 0.00 | 55.45 | 444 | 51,489,421 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,813 | 10,120,742 | 0.02 | 55.77 | 101,117 | 564,468,192 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 164 | 928,524 | 0.02 | 55.77 | 9,147 | 51,786,940 | |
| 2020-02-07 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 10,000 | 10,000 | |||||
| 2020-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 316 | 29,291,523 | 0.00 | 87.32 | 27,593 | 2,557,735,788 | |
| 2020-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 316 | 29,291,523 | 0.00 | 87.32 | 27,593 | 2,557,735,788 | |
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Pre-funded Warrants |
A - Award | 9,765,333 | 9,765,333 | |||||
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Pre-funded Warrants |
A - Award | 1,160,148 | 1,161,048 | 128,905.33 | ||||
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
D - Sale to Issuer | -9,765,333 | 3,107,331 | -75.86 | ||||
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
D - Sale to Issuer | -1,160,148 | 290,409 | -79.98 | ||||
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 2,767,505 | 12,872,664 | 27.39 | 8.40 | 23,247,042 | 108,130,378 | |
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 250,037 | 1,450,557 | 20.83 | 8.40 | 2,100,311 | 12,184,679 | |
| 2019-12-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,743,993 | 10,118,929 | 20.82 | 46.00 | 80,223,678 | 465,470,734 | |
| 2019-12-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 158,180 | 928,360 | 20.54 | 46.00 | 7,276,280 | 42,704,560 | |
| 2019-10-15 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 22,000 | 22,000 | |||||
| 2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 7,642,042 | 0.00 | 67.28 | 24,894 | 514,156,586 | |
| 2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 7,642,042 | 0.00 | 67.28 | 24,894 | 514,156,586 | |
| 2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 1,217,279 | 0.03 | 67.28 | 24,894 | 81,898,531 | |
| 2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 244,595 | 0.15 | 67.28 | 24,894 | 16,456,352 | |
| 2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 160,223 | 0.23 | 67.28 | 24,894 | 10,779,803 | |
| 2019-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 364 | 29,291,207 | 0.00 | 74.23 | 27,020 | 2,174,286,296 | |
| 2019-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 364 | 29,291,207 | 0.00 | 74.23 | 27,020 | 2,174,286,296 | |
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Voting Common Stock |
C - Conversion | 2,081,895 | 2,081,895 | |||||
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Series C Convertible Preferred |
C - Conversion | -2,081,895 | 0 | -100.00 | ||||
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Voting Common Stock |
C - Conversion | 187,942 | 187,942 | |||||
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Series C Convertible Preferred |
C - Conversion | -187,942 | 0 | -100.00 | ||||
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 2,883,204 | 2,883,204 | 16.00 | 46,131,264 | 46,131,264 | ||
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 260,796 | 260,796 | 16.00 | 4,172,736 | 4,172,736 | ||
| 2019-09-20 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,494,025 | 37,470,965 | 4.15 | 40.00 | 59,761,000 | 1,498,838,600 | |
| 2019-09-20 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 68,475 | 3,383,621 | 2.07 | 40.00 | 2,739,000 | 135,344,840 | |
| 2019-09-20 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock Warrant (right to buy) |
X - Other | -1 | 138,815 | 0.00 | ||||
| 2019-09-20 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
X - Other | 1 | 8,374,936 | 0.00 | 0.01 | 0 | 83,749 | |
| 2019-09-19 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 12,100 | 12,100 | |||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | -95,289 | 0 | -100.00 | ||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | -95,289 | 0 | -100.00 | ||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
J - Other | 8,341 | 95,289 | 9.59 | ||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
J - Other | 8,340 | 95,289 | 9.59 | ||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
J - Other | -8,866 | 43,361 | -16.98 | ||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
J - Other | -7,815 | 165,610 | -4.51 | ||||
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 50,436 | 10,105,159 | 0.50 | 3.15 | 159,020 | 31,860,556 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 4,564 | 1,200,520 | 0.38 | 3.15 | 14,390 | 3,785,120 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 209,382 | 10,054,723 | 2.13 | 3.02 | 633,255 | 30,409,504 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 18,943 | 1,195,956 | 1.61 | 3.02 | 57,291 | 3,617,049 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5,869 | 9,845,341 | 0.06 | 2.96 | 17,358 | 29,118,581 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 531 | 1,177,013 | 0.05 | 2.96 | 1,570 | 3,481,134 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 65,568 | 9,839,472 | 0.67 | 2.85 | 186,666 | 28,011,993 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5,932 | 1,176,482 | 0.51 | 2.85 | 16,888 | 3,349,327 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 9,445 | 9,773,904 | 0.10 | 2.83 | 26,756 | 27,687,515 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 855 | 1,170,550 | 0.07 | 2.83 | 2,422 | 3,315,934 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 7,641,672 | 0.01 | 58.86 | 24,957 | 449,788,814 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 7,641,672 | 0.01 | 58.86 | 24,957 | 449,788,814 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 1,390,806 | 0.03 | 58.86 | 24,957 | 81,862,841 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 418,122 | 0.10 | 58.86 | 24,957 | 24,610,661 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 333,750 | 0.13 | 58.86 | 24,957 | 19,644,525 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 226,124 | 0.19 | 58.86 | 24,957 | 13,309,659 | |
| 2019-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2,964 | 4,290,995 | 0.07 | 2.61 | 7,736 | 11,199,497 | |
| 2019-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2,964 | 4,290,995 | 0.07 | 2.61 | 7,736 | 11,199,497 | |
| 2019-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 310 | 29,290,843 | 0.00 | 84.96 | 26,338 | 2,488,550,021 | |
| 2019-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 310 | 29,290,843 | 0.00 | 84.96 | 26,338 | 2,488,550,021 | |
| 2019-06-28 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 30,000 | 30,000 | |||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class B common stock |
P - Purchase | 1,904,850 | 5,444,957 | 53.81 | 17.00 | 32,382,450 | 92,564,269 | |
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class B common stock |
P - Purchase | 95,150 | 489,234 | 24.14 | 17.00 | 1,617,550 | 8,316,978 | |
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class B common stock |
C - Conversion | 3,540,107 | 3,540,107 | |||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series C2 Preferred Stock |
C - Conversion | -3,540,107 | 0 | -100.00 | ||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class B common stock |
C - Conversion | 394,084 | 394,084 | |||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series C2 Preferred Stock |
C - Conversion | -394,084 | 0 | -100.00 | ||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series B Preferred Stock |
C - Conversion | -920,361 | 0 | -100.00 | ||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series B Preferred Stock |
C - Conversion | -89,878 | 0 | -100.00 | ||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series A Preferred Stock |
C - Conversion | -2,302,669 | 0 | -100.00 | ||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series A Preferred Stock |
C - Conversion | -219,852 | 0 | -100.00 | ||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class A common stock |
C - Conversion | 3,223,030 | 3,223,030 | |||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class A common stock |
C - Conversion | 309,730 | 309,730 | |||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 13,166 | 13,166 | |||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1,910 | 7,641,248 | 0.03 | ||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1,910 | 7,641,248 | 0.03 | ||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1,910 | 1,390,382 | 0.14 | ||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1,910 | 417,698 | 0.46 | ||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1,910 | 333,326 | 0.58 | ||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1,910 | 225,700 | 0.85 | ||||
| 2019-06-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 74,229 | 181,733 | 69.05 | ||||
| 2019-06-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 74,229 | 181,733 | 69.05 | ||||
| 2019-06-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | -1,002,483 | 4,302,354 | -18.90 | ||||
| 2019-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
J - Other | 14,840 | 14,840 | |||||
| 2019-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
J - Other | 14,840 | 14,840 | |||||
| 2019-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
J - Other | -200,423 | 98,980 | -66.94 | ||||
| 2019-06-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | 31,229 | 102,876 | 43.59 | ||||
| 2019-06-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | 31,229 | 102,876 | 43.59 | ||||
| 2019-06-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | -421,756 | 3,315,146 | -11.29 | ||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 880 | 880 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 880 | 880 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 1,660 | 1,660 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 1,660 | 1,660 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 6,256 | 6,256 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 6,256 | 6,256 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | -6,009 | 0 | -100.00 | ||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | -11,337 | 0 | -100.00 | ||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | -42,724 | 0 | -100.00 | ||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
J - Other | 21,929 | 21,929 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
J - Other | 21,929 | 21,929 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
J - Other | -59,267 | 0 | -100.00 | ||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
J - Other | -178,967 | 347,757 | -33.98 | ||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
J - Other | 43,109 | 43,109 | |||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
J - Other | 43,109 | 43,109 | |||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
J - Other | -582,200 | 18,591 | -96.91 | ||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | 13,516 | 20,618 | 190.31 | ||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | 13,516 | 20,618 | 190.31 | ||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | -182,539 | 1,028,034 | -15.08 | ||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Shares Option (Right to Buy) |
A - Award | 129,220 | 129,220 | |||||
| 2019-06-07 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | 220,141 | 281,190 | 360.60 | ||||
| 2019-06-07 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | 220,141 | 281,190 | 360.60 | ||||
| 2019-06-07 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | -692,706 | 0 | -100.00 | ||||
| 2019-06-07 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | -1,603,238 | 2,826,766 | -36.19 | ||||
| 2019-06-05 |
|
4 | KOD |
Kodiak Sciences Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 24,747 | 24,747 | |||||
| 2019-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Non-Qualified Share Option (right to buy) |
A - Award | 37,520 | 37,520 | |||||
| 2019-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Non-Qualified Share Option (right to buy) |
A - Award | 37,520 | 37,520 | |||||
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -22,720 | 7,382,978 | -0.31 | 120.77 | -2,743,928 | 891,653,328 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -2,729 | 952,874 | -0.29 | 120.77 | -329,585 | 115,080,022 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -13,213 | 7,405,698 | -0.18 | 122.31 | -1,616,054 | 905,775,370 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1,587 | 955,603 | -0.17 | 122.31 | -194,103 | 116,877,796 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -15,355 | 7,418,911 | -0.21 | 120.12 | -1,844,459 | 891,167,750 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1,845 | 957,190 | -0.19 | 120.12 | -221,623 | 114,978,716 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -35,796 | 7,434,266 | -0.48 | 122.37 | -4,380,432 | 909,746,742 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -4,300 | 959,035 | -0.45 | 122.37 | -526,200 | 117,359,127 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -30,766 | 7,470,062 | -0.41 | 123.06 | -3,786,036 | 919,259,107 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -3,696 | 963,335 | -0.38 | 123.06 | -454,826 | 118,547,138 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -39,732 | 7,500,828 | -0.53 | 121.37 | -4,822,189 | 910,359,743 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -4,772 | 967,031 | -0.49 | 121.37 | -579,168 | 117,366,522 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -71,819 | 7,540,560 | -0.94 | 127.06 | -9,125,258 | 958,096,767 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -8,627 | 971,803 | -0.88 | 127.06 | -1,096,139 | 123,476,415 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -22,886 | 7,612,379 | -0.30 | 125.05 | -2,861,901 | 951,930,278 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -2,749 | 980,430 | -0.28 | 125.05 | -343,763 | 122,603,066 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -15,541 | 7,635,265 | -0.20 | 126.25 | -1,962,085 | 963,969,004 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1,867 | 983,179 | -0.19 | 126.25 | -235,713 | 124,128,512 | |
| 2019-05-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 7,038 | 7,038 | |||||
| 2019-05-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 7,038 | 7,038 | |||||
| 2019-05-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 2,963 | 45,842,649 | 0.01 | ||||
| 2019-05-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 2,963 | 45,842,649 | 0.01 | ||||
| 2019-05-17 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2,726 | 7,650,806 | 0.04 | ||||
| 2019-05-17 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2,726 | 7,650,806 | 0.04 | ||||
| 2019-05-01 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2019-05-01 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2019-05-01 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 45,839,686 | 0.02 | 8.38 | 83,800 | 384,136,569 | |
| 2019-05-01 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 45,839,686 | 0.02 | 8.38 | 83,800 | 384,136,569 | |
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 12,472 | 12,472 | |||||
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 12,472 | 12,472 | |||||
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 12,472 | 12,472 | |||||
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1,520 | 812,602 | 0.19 | ||||
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1,520 | 812,602 | 0.19 | ||||
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1,520 | 812,602 | 0.19 | ||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Class A Common Stock |
C - Conversion | 529,758 | 529,758 | |||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Series D Preferred Stock |
C - Conversion | -529,758 | 0 | -100.00 | ||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Class A Common Stock |
C - Conversion | 60,194 | 60,194 | |||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Series D Preferred Stock |
C - Conversion | -60,194 | 0 | -100.00 | ||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Class A Common Stock |
C - Conversion | 2,905,359 | 2,905,359 | |||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Series C Preferred Stock |
C - Conversion | -2,905,359 | 0 | -100.00 | ||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Class A Common Stock |
C - Conversion | 324,421 | 324,421 | |||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Series C Preferred Stock |
C - Conversion | -324,421 | 0 | -100.00 | ||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Common Stock |
P - Purchase | 820,729 | 820,729 | 14.00 | 11,490,206 | 11,490,206 | ||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Common Stock |
P - Purchase | 72,128 | 72,128 | 14.00 | 1,009,792 | 1,009,792 | ||
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9,232 | 7,639,338 | -0.12 | 65.32 | -603,070 | 499,031,352 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,417 | 1,214,575 | -0.12 | 65.32 | -92,564 | 79,340,776 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -244 | 241,891 | -0.10 | 65.32 | -15,939 | 15,801,263 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -142 | 157,519 | -0.09 | 65.32 | -9,276 | 10,289,755 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 49,893 | -0.02 | 65.32 | -719 | 3,259,205 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -158 | 171,091 | -0.09 | 65.32 | -10,321 | 11,176,331 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63,775 | 7,648,570 | -0.83 | 67.13 | -4,281,177 | 513,443,915 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9,791 | 1,215,992 | -0.80 | 67.13 | -657,264 | 81,628,813 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,688 | 242,135 | -0.69 | 67.13 | -113,314 | 16,254,377 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -979 | 157,661 | -0.62 | 67.13 | -65,720 | 10,583,688 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -74 | 49,904 | -0.15 | 67.13 | -4,968 | 3,350,026 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,093 | 171,249 | -0.63 | 67.13 | -73,372 | 11,495,843 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -173,085 | 7,712,345 | -2.19 | 64.62 | -11,184,701 | 498,369,420 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -26,575 | 1,225,783 | -2.12 | 64.62 | -1,717,269 | 79,209,730 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4,581 | 243,823 | -1.84 | 64.62 | -296,023 | 15,755,769 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,656 | 158,640 | -1.65 | 64.62 | -171,630 | 10,251,269 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -202 | 49,978 | -0.40 | 64.62 | -13,053 | 3,229,563 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,966 | 172,342 | -1.69 | 64.62 | -191,662 | 11,136,688 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -106,054 | 7,885,430 | -1.33 | 66.61 | -7,063,981 | 525,227,990 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16,282 | 1,252,358 | -1.28 | 66.61 | -1,084,502 | 83,416,310 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,807 | 248,404 | -1.12 | 66.61 | -186,967 | 16,545,545 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,628 | 161,296 | -1.00 | 66.61 | -108,437 | 10,743,507 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -124 | 50,180 | -0.25 | 66.61 | -8,259 | 3,342,359 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,817 | 175,308 | -1.03 | 66.61 | -121,026 | 11,676,810 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -60,618 | 7,991,484 | -0.75 | 67.42 | -4,086,914 | 538,792,244 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9,307 | 1,268,640 | -0.73 | 67.42 | -627,485 | 85,532,724 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,604 | 251,211 | -0.63 | 67.42 | -108,143 | 16,936,847 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -930 | 162,924 | -0.57 | 67.42 | -62,701 | 10,984,466 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -71 | 50,304 | -0.14 | 67.42 | -4,787 | 3,391,536 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,039 | 177,125 | -0.58 | 67.42 | -70,050 | 11,941,909 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10,832 | 8,052,102 | -0.13 | 69.12 | -748,735 | 556,581,420 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,663 | 1,277,947 | -0.13 | 69.12 | -114,951 | 88,334,892 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -287 | 252,815 | -0.11 | 69.12 | -19,838 | 17,475,205 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -166 | 163,854 | -0.10 | 69.12 | -11,474 | 11,325,998 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 | 50,375 | -0.03 | 69.12 | -899 | 3,482,046 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -185 | 178,164 | -0.10 | 69.12 | -12,788 | 12,315,141 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -102,618 | 8,062,934 | -1.26 | 68.70 | -7,049,918 | 553,928,404 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15,755 | 1,279,610 | -1.22 | 68.70 | -1,082,378 | 87,909,975 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,716 | 253,102 | -1.06 | 68.70 | -186,591 | 17,388,259 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,575 | 164,020 | -0.95 | 68.70 | -108,203 | 11,268,272 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -120 | 50,388 | -0.24 | 68.70 | -8,244 | 3,461,686 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,758 | 178,349 | -0.98 | 68.70 | -120,776 | 12,252,683 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15,543 | 8,165,552 | -0.19 | 67.68 | -1,051,888 | 552,611,897 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,386 | 1,295,365 | -0.18 | 67.68 | -161,475 | 87,665,122 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -411 | 255,818 | -0.16 | 67.68 | -27,815 | 17,312,739 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -239 | 165,595 | -0.14 | 67.68 | -16,175 | 11,206,807 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18 | 50,508 | -0.04 | 67.68 | -1,218 | 3,418,179 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -266 | 180,107 | -0.15 | 67.68 | -18,002 | 12,188,921 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,813 | 8,181,095 | -0.02 | 67.87 | -123,047 | 555,244,373 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -278 | 1,297,751 | -0.02 | 67.87 | -18,868 | 88,077,322 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -48 | 256,229 | -0.02 | 67.87 | -3,258 | 17,390,057 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -28 | 165,834 | -0.02 | 67.87 | -1,900 | 11,255,021 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 50,526 | 0.00 | 67.87 | -136 | 3,429,159 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -31 | 180,373 | -0.02 | 67.87 | -2,104 | 12,241,771 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18,661 | 8,182,908 | -0.23 | 67.90 | -1,267,017 | 555,590,813 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,865 | 1,298,029 | -0.22 | 67.90 | -194,523 | 88,131,626 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -494 | 256,277 | -0.19 | 67.90 | -33,541 | 17,400,311 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -286 | 165,862 | -0.17 | 67.90 | -19,418 | 11,261,449 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -22 | 50,528 | -0.04 | 67.90 | -1,494 | 3,430,674 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -320 | 180,404 | -0.18 | 67.90 | -21,727 | 12,248,800 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42,863 | 8,201,569 | -0.52 | 68.72 | -2,945,370 | 563,578,195 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6,581 | 1,300,894 | -0.50 | 68.72 | -452,219 | 89,392,102 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,134 | 256,771 | -0.44 | 68.72 | -77,924 | 17,644,250 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -658 | 166,148 | -0.39 | 68.72 | -45,215 | 11,417,009 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -50 | 50,550 | -0.10 | 68.72 | -3,436 | 3,473,589 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -734 | 180,724 | -0.40 | 68.72 | -50,437 | 12,418,612 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -21,116 | 8,244,432 | -0.26 | 68.63 | -1,449,147 | 565,798,055 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,242 | 1,307,475 | -0.25 | 68.63 | -222,492 | 89,729,264 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -559 | 257,905 | -0.22 | 68.63 | -38,363 | 17,699,479 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -324 | 166,806 | -0.19 | 68.63 | -22,235 | 11,447,545 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 50,600 | -0.05 | 68.63 | -1,716 | 3,472,572 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -362 | 181,458 | -0.20 | 68.63 | -24,843 | 12,453,081 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -66,784 | 8,265,548 | -0.80 | 66.64 | -4,450,459 | 550,812,813 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10,253 | 1,310,717 | -0.78 | 66.64 | -683,256 | 87,345,657 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,768 | 258,464 | -0.68 | 66.64 | -117,819 | 17,223,938 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,025 | 167,130 | -0.61 | 66.64 | -68,306 | 11,137,476 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -78 | 50,625 | -0.15 | 66.64 | -5,198 | 3,373,630 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,145 | 181,820 | -0.63 | 66.64 | -76,302 | 12,116,412 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -80,146 | 8,332,332 | -0.95 | 68.90 | -5,521,963 | 574,087,676 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -12,305 | 1,320,970 | -0.92 | 68.90 | -847,800 | 91,013,248 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,121 | 260,232 | -0.81 | 68.90 | -146,134 | 17,929,673 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,230 | 168,155 | -0.73 | 68.90 | -84,746 | 11,585,678 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -93 | 50,703 | -0.18 | 68.90 | -6,408 | 3,493,376 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,374 | 182,965 | -0.75 | 68.90 | -94,667 | 12,606,069 | |
| 2019-04-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4,161 | 89,233 | 4.89 | 2.59 | 10,777 | 231,113 | |
| 2019-04-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4,161 | 89,233 | 4.89 | 2.59 | 10,777 | 231,113 | |
| 2019-04-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4,161 | 4,288,031 | 0.10 | 2.59 | 10,777 | 11,106,000 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 8,412,478 | 0.00 | 66.84 | 19,918 | 562,290,030 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 8,412,478 | 0.00 | 66.84 | 19,918 | 562,290,030 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 1,507,172 | 0.02 | 66.84 | 19,918 | 100,739,376 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 436,250 | 0.07 | 66.84 | 19,918 | 29,158,950 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 343,282 | 0.09 | 66.84 | 19,918 | 22,944,969 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 224,693 | 0.13 | 66.84 | 19,918 | 15,018,480 | |
| 2019-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 220 | 811,082 | 0.03 | 86.01 | 18,922 | 69,761,163 | |
| 2019-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 220 | 811,082 | 0.03 | 86.01 | 18,922 | 69,761,163 | |
| 2019-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 220 | 811,082 | 0.03 | 86.01 | 18,922 | 69,761,163 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -46,678 | 8,412,180 | -0.55 | 74.71 | -3,487,122 | 628,439,478 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7,167 | 1,332,977 | -0.53 | 74.71 | -535,417 | 99,581,246 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,235 | 262,055 | -0.47 | 74.71 | -92,262 | 19,577,055 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -716 | 169,087 | -0.42 | 74.71 | -53,489 | 12,631,797 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -55 | 50,498 | -0.11 | 74.71 | -4,109 | 3,772,499 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -800 | 184,041 | -0.43 | 74.71 | -59,765 | 13,748,949 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -41,281 | 8,458,858 | -0.49 | 74.34 | -3,068,962 | 628,858,572 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6,338 | 1,340,144 | -0.47 | 74.34 | -471,187 | 99,630,593 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,092 | 263,290 | -0.41 | 74.34 | -81,183 | 19,573,821 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -634 | 169,803 | -0.37 | 74.34 | -47,134 | 12,623,698 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -48 | 50,553 | -0.09 | 74.34 | -3,568 | 3,758,272 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -707 | 184,841 | -0.38 | 74.34 | -52,561 | 13,741,671 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -86,620 | 8,500,139 | -1.01 | 74.63 | -6,464,529 | 634,373,024 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13,298 | 1,346,482 | -0.98 | 74.63 | -992,442 | 100,489,163 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,293 | 264,382 | -0.86 | 74.63 | -171,129 | 19,731,067 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,329 | 170,437 | -0.77 | 74.63 | -99,184 | 12,719,867 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -101 | 50,601 | -0.20 | 74.63 | -7,538 | 3,776,398 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,485 | 185,548 | -0.79 | 74.63 | -110,827 | 13,847,614 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -90,251 | 8,586,759 | -1.04 | 74.19 | -6,695,487 | 637,029,325 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13,856 | 1,359,780 | -1.01 | 74.19 | -1,027,941 | 100,878,543 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,388 | 266,675 | -0.89 | 74.19 | -177,160 | 19,783,925 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,385 | 171,766 | -0.80 | 74.19 | -102,750 | 12,742,873 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -106 | 50,702 | -0.21 | 74.19 | -7,864 | 3,761,450 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,547 | 187,033 | -0.82 | 74.19 | -114,768 | 13,875,492 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -413 | 8,677,010 | 0.00 | 74.56 | -30,795 | 647,001,251 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63 | 1,373,636 | 0.00 | 74.56 | -4,698 | 102,425,168 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 269,063 | 0.00 | 74.56 | -820 | 20,062,683 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 173,151 | 0.00 | 74.56 | -447 | 12,911,004 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7 | 188,580 | 0.00 | 74.56 | -522 | 14,061,468 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42,124 | 8,677,423 | -0.48 | 74.50 | -3,138,238 | 646,468,014 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6,467 | 1,373,699 | -0.47 | 74.50 | -481,792 | 102,340,576 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,115 | 269,074 | -0.41 | 74.50 | -83,068 | 20,046,013 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -647 | 173,157 | -0.37 | 74.50 | -48,202 | 12,900,196 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -49 | 50,808 | -0.10 | 74.50 | -3,650 | 3,785,196 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -722 | 188,587 | -0.38 | 74.50 | -53,789 | 14,049,732 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,068 | 8,719,547 | -0.04 | 76.57 | -234,915 | 667,649,610 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -471 | 1,380,166 | -0.03 | 76.57 | -36,064 | 105,678,345 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -81 | 270,189 | -0.03 | 76.57 | -6,202 | 20,688,183 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -47 | 173,804 | -0.03 | 76.57 | -3,599 | 13,308,051 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 50,857 | -0.01 | 76.57 | -306 | 3,894,085 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -52 | 189,309 | -0.03 | 76.57 | -3,982 | 14,495,258 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -41,281 | 8,458,858 | -0.49 | 74.34 | -3,068,962 | 628,858,572 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6,338 | 1,340,144 | -0.47 | 74.34 | -471,187 | 99,630,593 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,092 | 263,290 | -0.41 | 74.34 | -81,183 | 19,573,821 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -634 | 169,803 | -0.37 | 74.34 | -47,134 | 12,623,698 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -48 | 50,553 | -0.09 | 74.34 | -3,568 | 3,758,272 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -707 | 184,841 | -0.38 | 74.34 | -52,561 | 13,741,671 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,648 | 8,722,615 | -0.02 | 76.03 | -125,301 | 663,197,864 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -253 | 1,380,637 | -0.02 | 76.03 | -19,236 | 104,972,592 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -44 | 270,270 | -0.02 | 76.03 | -3,345 | 20,549,169 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 173,851 | -0.01 | 76.03 | -1,901 | 13,218,239 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 50,861 | 0.00 | 76.03 | -152 | 3,867,064 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -28 | 189,361 | -0.01 | 76.03 | -2,129 | 14,397,496 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -51,987 | 8,724,263 | -0.59 | 76.50 | -3,977,031 | 667,410,482 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7,982 | 1,380,890 | -0.57 | 76.50 | -610,627 | 105,638,775 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,375 | 270,314 | -0.51 | 76.50 | -105,188 | 20,679,156 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -798 | 173,876 | -0.46 | 76.50 | -61,047 | 13,301,601 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -61 | 50,863 | -0.12 | 76.50 | -4,667 | 3,891,045 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -891 | 189,389 | -0.47 | 76.50 | -68,162 | 14,488,353 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -247 | 8,776,250 | 0.00 | 75.40 | -18,624 | 661,729,250 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -39 | 1,388,872 | 0.00 | 75.40 | -2,941 | 104,720,949 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7 | 271,689 | 0.00 | 75.40 | -528 | 20,485,351 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 174,674 | 0.00 | 75.40 | -302 | 13,170,420 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 174,674 | 0.00 | 75.40 | -302 | 13,170,420 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 50,924 | 0.00 | 75.40 | -75 | 3,839,670 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63,047 | 8,776,497 | -0.71 | 75.92 | -4,786,390 | 666,292,344 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9,679 | 1,388,911 | -0.69 | 75.92 | -734,808 | 105,443,068 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,668 | 271,696 | -0.61 | 75.92 | -126,631 | 20,626,563 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -967 | 174,678 | -0.55 | 75.92 | -73,413 | 13,261,169 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -73 | 50,925 | -0.14 | 75.92 | -5,542 | 3,866,114 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,080 | 190,284 | -0.56 | 75.92 | -81,991 | 14,445,943 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,832 | 8,839,544 | -0.03 | 76.05 | -215,369 | 672,232,294 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -435 | 1,398,590 | -0.03 | 76.05 | -33,081 | 106,360,392 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -75 | 273,364 | -0.03 | 76.05 | -5,704 | 20,788,867 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -43 | 175,645 | -0.02 | 76.05 | -3,270 | 13,357,504 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3 | 50,998 | -0.01 | 76.05 | -228 | 3,878,311 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -49 | 191,364 | -0.03 | 76.05 | -3,726 | 14,552,907 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -61,122 | 8,842,376 | -0.69 | 75.63 | -4,622,669 | 668,750,665 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9,384 | 1,399,025 | -0.67 | 75.63 | -709,714 | 105,808,541 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,618 | 273,439 | -0.59 | 75.63 | -122,370 | 20,680,246 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -938 | 175,688 | -0.53 | 75.63 | -70,941 | 13,287,319 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -71 | 51,001 | -0.14 | 75.63 | -5,370 | 3,857,216 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,047 | 191,413 | -0.54 | 75.63 | -79,185 | 14,476,603 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,296 | 8,903,498 | -0.04 | 74.03 | -244,007 | 659,137,531 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -506 | 1,408,409 | -0.04 | 74.03 | -37,460 | 104,266,349 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -87 | 275,057 | -0.03 | 74.03 | -6,441 | 20,362,827 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -51 | 176,626 | -0.03 | 74.03 | -3,776 | 13,075,852 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 51,072 | -0.01 | 74.03 | -296 | 3,780,927 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -56 | 192,460 | -0.03 | 74.03 | -4,146 | 14,248,064 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -37,107 | 8,906,794 | -0.41 | 75.08 | -2,786,101 | 668,747,923 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5,697 | 1,408,915 | -0.40 | 75.08 | -427,747 | 105,785,424 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -982 | 275,144 | -0.36 | 75.08 | -73,731 | 20,658,609 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -569 | 176,677 | -0.32 | 75.08 | -42,722 | 13,265,422 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -43 | 51,076 | -0.08 | 75.08 | -3,229 | 3,834,934 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -637 | 192,516 | -0.33 | 75.08 | -47,828 | 14,454,660 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18,703 | 8,943,901 | -0.21 | 73.55 | -1,375,551 | 657,797,981 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,872 | 1,414,612 | -0.20 | 73.55 | -211,227 | 104,040,610 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -495 | 276,126 | -0.18 | 73.55 | -36,406 | 20,308,267 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -287 | 177,246 | -0.16 | 73.55 | -21,108 | 13,035,929 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -22 | 51,119 | -0.04 | 73.55 | -1,618 | 3,759,654 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -321 | 193,153 | -0.17 | 73.55 | -23,609 | 14,205,843 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,647 | 8,962,604 | -0.02 | 73.72 | -121,421 | 660,745,573 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -253 | 1,417,484 | -0.02 | 73.72 | -18,652 | 104,500,464 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -44 | 276,621 | -0.02 | 73.72 | -3,244 | 20,393,192 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 177,533 | -0.01 | 73.72 | -1,843 | 13,088,177 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 51,141 | 0.00 | 73.72 | -147 | 3,770,242 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -29 | 193,474 | -0.01 | 73.72 | -2,138 | 14,263,387 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8,486 | 8,964,251 | -0.09 | 77.04 | -653,755 | 690,598,726 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,303 | 1,417,737 | -0.09 | 77.04 | -100,382 | 109,221,324 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -225 | 276,665 | -0.08 | 77.04 | -17,334 | 21,314,050 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -130 | 177,558 | -0.07 | 77.04 | -10,015 | 13,678,926 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 51,143 | -0.02 | 77.04 | -770 | 3,940,016 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -146 | 193,503 | -0.08 | 77.04 | -11,248 | 14,907,316 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -22,914 | 8,972,737 | -0.25 | 76.49 | -1,752,680 | 686,320,167 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,518 | 1,419,040 | -0.25 | 76.49 | -269,090 | 108,541,660 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -607 | 276,890 | -0.22 | 76.49 | -46,429 | 21,179,178 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -352 | 177,688 | -0.20 | 76.49 | -26,924 | 13,591,266 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -27 | 51,153 | -0.05 | 76.49 | -2,065 | 3,912,667 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -393 | 193,649 | -0.20 | 76.49 | -30,060 | 14,812,115 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -58,412 | 8,995,651 | -0.65 | 77.15 | -4,506,626 | 694,036,064 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8,968 | 1,422,558 | -0.63 | 77.15 | -691,903 | 109,753,764 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,546 | 277,497 | -0.55 | 77.15 | -119,278 | 21,409,560 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -896 | 178,040 | -0.50 | 77.15 | -69,129 | 13,736,213 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -68 | 51,180 | -0.13 | 77.15 | -5,246 | 3,948,660 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,001 | 194,042 | -0.51 | 77.15 | -77,230 | 14,970,806 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6,909 | 9,054,063 | -0.08 | 77.64 | -536,386 | 702,919,424 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,060 | 1,431,526 | -0.07 | 77.64 | -82,294 | 111,137,666 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -183 | 279,043 | -0.07 | 77.64 | -14,207 | 21,663,727 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -107 | 178,936 | -0.06 | 77.64 | -8,307 | 13,891,840 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 | 51,248 | -0.02 | 77.64 | -621 | 3,978,679 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -118 | 195,043 | -0.06 | 77.64 | -9,161 | 15,142,319 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -493 | 9,060,972 | -0.01 | 76.20 | -37,565 | 690,423,414 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -76 | 1,432,586 | -0.01 | 76.20 | -5,791 | 109,159,472 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 | 279,226 | 0.00 | 76.20 | -991 | 21,276,323 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 | 179,043 | 0.00 | 76.20 | -610 | 13,642,629 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51,256 | 0.00 | 76.20 | -76 | 3,905,579 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 195,161 | 0.00 | 76.20 | -686 | 14,870,780 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -742 | 9,061,465 | -0.01 | 76.20 | -56,540 | 690,483,633 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -114 | 1,432,662 | -0.01 | 76.20 | -8,687 | 109,168,844 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -20 | 279,239 | -0.01 | 76.20 | -1,524 | 21,278,012 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 179,051 | -0.01 | 76.20 | -838 | 13,643,686 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51,257 | 0.00 | 76.20 | -76 | 3,905,783 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 | 195,170 | -0.01 | 76.20 | -991 | 14,871,954 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -31,482 | 9,062,207 | -0.35 | 76.66 | -2,413,501 | 694,735,069 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4,833 | 1,432,776 | -0.34 | 76.66 | -370,512 | 109,840,763 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -833 | 279,259 | -0.30 | 76.66 | -63,860 | 21,408,805 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -484 | 179,062 | -0.27 | 76.66 | -37,105 | 13,727,412 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -37 | 51,258 | -0.07 | 76.66 | -2,837 | 3,929,587 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -539 | 195,183 | -0.28 | 76.66 | -41,321 | 14,963,295 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -620 | 9,093,689 | -0.01 | 77.81 | -48,239 | 707,539,019 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -95 | 1,437,609 | -0.01 | 77.81 | -7,392 | 111,853,887 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16 | 280,092 | -0.01 | 77.81 | -1,245 | 21,792,698 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 179,546 | -0.01 | 77.81 | -778 | 13,969,666 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51,295 | 0.00 | 77.81 | -78 | 3,991,033 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 195,722 | -0.01 | 77.81 | -856 | 15,228,248 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6,506 | 9,094,309 | -0.07 | 78.13 | -508,342 | 710,577,468 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -999 | 1,437,704 | -0.07 | 78.13 | -78,056 | 112,333,996 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -172 | 280,108 | -0.06 | 78.13 | -13,439 | 21,886,043 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -100 | 179,556 | -0.06 | 78.13 | -7,813 | 14,029,482 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 | 51,296 | -0.02 | 78.13 | -625 | 4,007,977 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -112 | 195,733 | -0.06 | 78.13 | -8,751 | 15,293,461 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 9,100,815 | 0.09 | 17.59 | 145,118 | 160,083,336 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 9,100,815 | 0.09 | 17.59 | 145,118 | 160,083,336 | |
| 2019-02-27 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2019-02-27 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2019-02-27 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 29,288,793 | 0.07 | 2.80 | 56,000 | 82,008,620 | |
| 2019-02-27 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 29,288,793 | 0.07 | 2.80 | 56,000 | 82,008,620 | |
| 2019-02-06 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 1,818,475 | 8,837,349 | 25.91 | ||||
| 2019-02-06 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 181,525 | 916,043 | 24.71 | ||||
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13,634 | 9,092,565 | -0.15 | 70.55 | -961,887 | 641,485,916 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,093 | 1,430,453 | -0.15 | 70.55 | -147,662 | 100,919,317 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -361 | 280,280 | -0.13 | 70.55 | -25,469 | 19,773,922 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -210 | 179,656 | -0.12 | 70.55 | -14,816 | 12,674,839 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16 | 51,304 | -0.03 | 70.55 | -1,129 | 3,619,528 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -234 | 195,845 | -0.12 | 70.55 | -16,509 | 13,816,982 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -24,660 | 9,106,199 | -0.27 | 71.35 | -1,759,553 | 649,750,064 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,786 | 1,432,546 | -0.26 | 71.35 | -270,141 | 102,215,738 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -653 | 280,641 | -0.23 | 71.35 | -46,593 | 20,024,437 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -378 | 179,866 | -0.21 | 71.35 | -26,971 | 12,833,889 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -29 | 51,320 | -0.06 | 71.35 | -2,069 | 3,661,810 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -423 | 196,079 | -0.22 | 71.35 | -30,182 | 13,990,727 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -75,736 | 9,130,859 | -0.82 | 72.20 | -5,468,397 | 659,279,065 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11,627 | 1,436,332 | -0.80 | 72.20 | -839,509 | 103,708,054 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,004 | 281,294 | -0.71 | 72.20 | -144,696 | 20,310,383 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,162 | 180,244 | -0.64 | 72.20 | -83,900 | 13,014,230 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -89 | 51,349 | -0.17 | 72.20 | -6,426 | 3,707,572 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,298 | 196,502 | -0.66 | 72.20 | -93,720 | 14,188,113 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -65,426 | 9,206,595 | -0.71 | 72.02 | -4,711,967 | 663,057,131 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10,044 | 1,447,959 | -0.69 | 72.02 | -723,367 | 104,281,718 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,732 | 283,298 | -0.61 | 72.02 | -124,738 | 20,403,065 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,004 | 181,406 | -0.55 | 72.02 | -72,308 | 13,064,824 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -76 | 51,438 | -0.15 | 72.02 | -5,474 | 3,704,554 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,121 | 197,800 | -0.56 | 72.02 | -80,734 | 14,245,516 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,648 | 9,272,021 | -0.02 | 73.46 | -121,054 | 681,076,303 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -253 | 1,458,003 | -0.02 | 73.46 | -18,584 | 107,097,610 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -44 | 285,030 | -0.02 | 73.46 | -3,232 | 20,936,879 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 182,410 | -0.01 | 73.46 | -1,836 | 13,398,927 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 51,514 | 0.00 | 73.46 | -147 | 3,783,961 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -28 | 198,921 | -0.01 | 73.46 | -2,057 | 14,611,742 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -29,260 | 9,273,669 | -0.31 | 70.52 | -2,063,313 | 653,946,680 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4,492 | 1,458,256 | -0.31 | 70.52 | -316,760 | 102,831,109 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -774 | 285,074 | -0.27 | 70.52 | -54,580 | 20,102,421 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -450 | 182,435 | -0.25 | 70.52 | -31,732 | 12,864,678 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -34 | 51,516 | -0.07 | 70.52 | -2,398 | 3,632,728 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -502 | 198,949 | -0.25 | 70.52 | -35,399 | 14,029,187 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42,521 | 9,302,929 | -0.45 | 71.00 | -3,018,995 | 660,508,889 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6,529 | 1,462,748 | -0.44 | 71.00 | -463,560 | 103,855,254 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,125 | 285,848 | -0.39 | 71.00 | -79,875 | 20,295,237 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -652 | 182,885 | -0.36 | 71.00 | -46,292 | 12,984,853 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -50 | 51,550 | -0.10 | 71.00 | -3,550 | 3,660,055 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -729 | 199,451 | -0.36 | 71.00 | -51,759 | 14,161,041 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10,547 | 9,345,450 | -0.11 | 71.61 | -755,298 | 669,251,973 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,619 | 1,469,277 | -0.11 | 71.61 | -115,941 | 105,218,746 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -279 | 286,973 | -0.10 | 71.61 | -19,980 | 20,550,883 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -162 | 183,537 | -0.09 | 71.61 | -11,601 | 13,143,562 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -12 | 51,600 | -0.02 | 71.61 | -859 | 3,695,210 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -181 | 200,180 | -0.09 | 71.61 | -12,962 | 14,335,410 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13,595 | 9,355,997 | -0.15 | 72.23 | -981,964 | 675,781,792 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,087 | 1,470,896 | -0.14 | 72.23 | -150,744 | 106,242,524 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -360 | 287,252 | -0.13 | 72.23 | -26,003 | 20,748,155 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -209 | 183,699 | -0.11 | 72.23 | -15,096 | 13,268,542 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16 | 51,612 | -0.03 | 72.23 | -1,156 | 3,727,924 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -233 | 200,361 | -0.12 | 72.23 | -16,830 | 14,472,035 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -132,363 | 9,369,592 | -1.39 | 72.79 | -9,634,226 | 681,978,871 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -20,322 | 1,472,983 | -1.36 | 72.79 | -1,479,165 | 107,213,130 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,503 | 287,612 | -1.20 | 72.79 | -254,971 | 20,934,242 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,031 | 183,908 | -1.09 | 72.79 | -147,829 | 13,386,001 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -155 | 51,628 | -0.30 | 72.79 | -11,282 | 3,757,816 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,268 | 200,594 | -1.12 | 72.79 | -165,080 | 14,600,515 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -149,754 | 9,501,955 | -1.55 | 70.79 | -10,601,295 | 672,656,697 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -22,991 | 1,493,305 | -1.52 | 70.79 | -1,627,565 | 105,713,152 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,963 | 291,115 | -1.34 | 70.79 | -280,546 | 20,608,438 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,298 | 185,939 | -1.22 | 70.79 | -162,679 | 13,162,882 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -175 | 51,783 | -0.34 | 70.79 | -12,388 | 3,665,791 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,566 | 202,862 | -1.25 | 70.79 | -181,651 | 14,360,885 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -493 | 9,651,709 | -0.01 | 70.07 | -34,545 | 676,311,658 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -76 | 1,516,296 | -0.01 | 70.07 | -5,325 | 106,249,438 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 | 295,078 | 0.00 | 70.07 | -911 | 20,676,617 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 | 188,237 | 0.00 | 70.07 | -561 | 13,190,087 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51,958 | 0.00 | 70.07 | -70 | 3,640,785 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 205,428 | 0.00 | 70.07 | -631 | 14,394,689 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -23,462 | 9,652,202 | -0.24 | 70.22 | -1,647,574 | 677,807,546 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,602 | 1,516,372 | -0.24 | 70.22 | -252,944 | 106,484,343 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -621 | 295,091 | -0.21 | 70.22 | -43,609 | 20,722,205 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -360 | 188,245 | -0.19 | 70.22 | -25,280 | 13,219,147 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -27 | 51,959 | -0.05 | 70.22 | -1,896 | 3,648,722 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -402 | 205,437 | -0.20 | 70.22 | -28,230 | 14,426,423 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8,392 | 9,675,664 | -0.09 | 70.28 | -589,772 | 679,985,347 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,288 | 1,519,974 | -0.08 | 70.28 | -90,518 | 106,820,581 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -222 | 295,712 | -0.08 | 70.28 | -15,602 | 20,782,018 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -129 | 188,605 | -0.07 | 70.28 | -9,066 | 13,254,763 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 51,986 | -0.02 | 70.28 | -703 | 3,653,467 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -144 | 205,839 | -0.07 | 70.28 | -10,120 | 14,465,933 | |
| 2019-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3,658 | 85,072 | 4.49 | 3.52 | 12,876 | 299,453 | |
| 2019-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3,658 | 85,072 | 4.49 | 3.52 | 12,876 | 299,453 | |
| 2019-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3,658 | 85,072 | 4.49 | 3.52 | 12,876 | 299,453 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 295,934 | 0.10 | 64.41 | 19,967 | 19,061,109 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 295,934 | 0.10 | 64.41 | 19,967 | 19,061,109 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 295,934 | 0.10 | 64.41 | 19,967 | 19,061,109 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 1,695,159 | 0.02 | 64.41 | 19,967 | 109,185,191 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 225,893 | 0.14 | 64.41 | 19,967 | 14,549,768 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 362,631 | 0.09 | 64.41 | 19,967 | 23,357,063 | |
| 2019-01-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 298 | 810,862 | 0.04 | 63.59 | 18,950 | 51,562,715 | |
| 2019-01-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 298 | 810,862 | 0.04 | 63.59 | 18,950 | 51,562,715 | |
| 2019-01-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 298 | 29,421,884 | 0.00 | 63.59 | 18,950 | 1,870,937,604 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15,243 | 9,683,746 | -0.16 | 73.09 | -1,114,047 | 707,744,323 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,340 | 1,520,952 | -0.15 | 73.09 | -171,021 | 111,159,994 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -403 | 295,624 | -0.14 | 73.09 | -29,454 | 21,605,917 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -234 | 188,424 | -0.12 | 73.09 | -17,102 | 13,771,119 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18 | 51,686 | -0.03 | 73.09 | -1,316 | 3,777,513 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -262 | 205,673 | -0.13 | 73.09 | -19,148 | 15,031,776 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -12,627 | 9,698,989 | -0.13 | 71.81 | -906,797 | 696,524,166 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,939 | 1,523,292 | -0.13 | 71.81 | -139,248 | 109,393,844 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -334 | 296,027 | -0.11 | 71.81 | -23,986 | 21,258,913 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -194 | 188,658 | -0.10 | 71.81 | -13,932 | 13,548,304 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15 | 51,704 | -0.03 | 71.81 | -1,077 | 3,713,076 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -216 | 205,935 | -0.10 | 71.81 | -15,512 | 14,789,037 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -34,794 | 9,711,616 | -0.36 | 74.88 | -2,605,510 | 727,243,681 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5,342 | 1,525,231 | -0.35 | 74.88 | -400,030 | 114,215,246 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -921 | 296,361 | -0.31 | 74.88 | -68,968 | 22,192,667 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -534 | 188,852 | -0.28 | 74.88 | -39,988 | 14,141,974 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -41 | 51,719 | -0.08 | 74.88 | -3,070 | 3,872,920 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -597 | 206,151 | -0.29 | 74.88 | -44,706 | 15,437,391 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7,718 | 9,746,410 | -0.08 | 73.83 | -569,813 | 719,568,679 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,185 | 1,530,573 | -0.08 | 73.83 | -87,487 | 113,000,827 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -204 | 297,282 | -0.07 | 73.83 | -15,061 | 21,948,063 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -118 | 189,386 | -0.06 | 73.83 | -8,712 | 13,982,198 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 51,760 | -0.02 | 73.83 | -664 | 3,821,394 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -132 | 206,748 | -0.06 | 73.83 | -9,745 | 15,264,019 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -84,418 | 9,754,128 | -0.86 | 76.15 | -6,428,768 | 742,815,864 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -12,961 | 1,531,758 | -0.84 | 76.15 | -987,032 | 116,649,499 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,234 | 297,486 | -0.75 | 76.15 | -170,128 | 22,654,749 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,296 | 189,504 | -0.68 | 76.15 | -98,696 | 14,431,488 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -99 | 51,769 | -0.19 | 76.15 | -7,539 | 3,942,416 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,447 | 206,880 | -0.69 | 76.15 | -110,195 | 15,754,740 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -76,364 | 9,838,546 | -0.77 | 75.46 | -5,762,481 | 742,423,568 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11,724 | 1,544,719 | -0.75 | 75.46 | -884,701 | 116,565,577 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,021 | 299,720 | -0.67 | 75.46 | -152,506 | 22,617,081 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,172 | 190,800 | -0.61 | 75.46 | -88,440 | 14,397,902 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -89 | 51,868 | -0.17 | 75.46 | -6,716 | 3,913,996 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,309 | 208,327 | -0.62 | 75.46 | -98,778 | 15,720,501 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,538 | 9,914,910 | -0.03 | 77.75 | -197,318 | 770,839,635 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -390 | 1,556,443 | -0.03 | 77.75 | -30,321 | 121,006,439 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -67 | 301,741 | -0.02 | 77.75 | -5,209 | 23,459,005 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -39 | 191,972 | -0.02 | 77.75 | -3,032 | 14,924,959 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3 | 51,957 | -0.01 | 77.75 | -233 | 4,039,423 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -43 | 209,636 | -0.02 | 77.75 | -3,343 | 16,298,256 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5,493 | 9,917,448 | -0.06 | 73.81 | -405,449 | 732,025,680 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -843 | 1,556,833 | -0.05 | 73.81 | -62,223 | 114,912,802 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -146 | 301,808 | -0.05 | 73.81 | -10,777 | 22,277,022 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -84 | 192,011 | -0.04 | 73.81 | -6,200 | 14,172,697 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 51,960 | -0.01 | 73.81 | -443 | 3,835,266 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -95 | 209,679 | -0.05 | 73.81 | -7,012 | 15,476,805 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18,604 | 9,922,941 | -0.19 | 75.83 | -1,410,758 | 752,465,547 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,856 | 1,557,676 | -0.18 | 75.83 | -216,573 | 118,119,973 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -492 | 301,954 | -0.16 | 75.83 | -37,309 | 22,897,444 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -286 | 192,095 | -0.15 | 75.83 | -21,688 | 14,566,737 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -21 | 51,966 | -0.04 | 75.83 | -1,592 | 3,940,629 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -319 | 209,774 | -0.15 | 75.83 | -24,190 | 15,907,351 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -371 | 9,941,545 | 0.00 | 77.11 | -28,608 | 766,592,535 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -57 | 1,560,532 | 0.00 | 77.11 | -4,395 | 120,332,623 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 302,446 | 0.00 | 77.11 | -771 | 23,321,611 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 192,381 | 0.00 | 77.11 | -463 | 14,834,499 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 192,381 | 0.00 | 77.11 | -463 | 14,834,499 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51,987 | 0.00 | 77.11 | -77 | 4,008,718 | |
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
J - Other | 1,569 | 1,569 | |||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
J - Other | 1,569 | 1,569 | |||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
J - Other | -10,731 | 0 | -100.00 | ||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | 71,647 | 71,647 | |||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | 71,647 | 71,647 | |||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | -489,977 | 0 | -100.00 | ||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 11,178,823 | 35,976,940 | 45.08 | 17.00 | 190,039,991 | 611,607,980 | |
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 585,882 | 3,736,902 | 18.59 | 17.00 | 9,959,994 | 63,527,334 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -247 | 9,941,916 | 0.00 | 76.62 | -18,925 | 761,724,749 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -38 | 1,560,589 | 0.00 | 76.62 | -2,911 | 119,568,428 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 302,456 | 0.00 | 76.62 | -460 | 23,173,423 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 192,387 | 0.00 | 76.62 | -306 | 14,740,211 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 192,387 | 0.00 | 76.62 | -306 | 14,740,211 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51,988 | 0.00 | 76.62 | -77 | 3,983,191 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -32,598 | 9,942,163 | -0.33 | 77.52 | -2,527,147 | 770,762,210 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5,005 | 1,560,627 | -0.32 | 77.52 | -388,011 | 120,986,984 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -863 | 302,462 | -0.28 | 77.52 | -66,904 | 23,448,246 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -500 | 192,391 | -0.26 | 77.52 | -38,762 | 14,915,035 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -38 | 51,989 | -0.07 | 77.52 | -2,946 | 4,030,426 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -559 | 210,103 | -0.27 | 77.52 | -43,336 | 16,288,151 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -89,047 | 9,974,761 | -0.88 | 78.05 | -6,950,074 | 778,525,109 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13,671 | 1,565,632 | -0.87 | 78.05 | -1,067,015 | 122,196,795 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,357 | 303,325 | -0.77 | 78.05 | -183,963 | 23,674,365 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,367 | 192,891 | -0.70 | 78.05 | -106,694 | 15,055,046 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -104 | 52,027 | -0.20 | 78.05 | -8,117 | 4,060,681 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,526 | 210,662 | -0.72 | 78.05 | -119,104 | 16,442,064 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -44,659 | 10,063,808 | -0.44 | 80.09 | -3,576,721 | 806,006,357 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6,856 | 1,579,303 | -0.43 | 80.09 | -549,094 | 126,485,746 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,182 | 305,682 | -0.39 | 80.09 | -94,666 | 24,481,949 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -685 | 194,258 | -0.35 | 80.09 | -54,861 | 15,558,046 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -52 | 52,131 | -0.10 | 80.09 | -4,165 | 4,175,151 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -765 | 212,188 | -0.36 | 80.09 | -61,269 | 16,994,052 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -129,121 | 10,108,467 | -1.26 | 79.07 | -10,209,675 | 799,282,551 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -19,824 | 1,586,159 | -1.23 | 79.07 | -1,567,496 | 125,418,544 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,417 | 306,864 | -1.10 | 79.07 | -270,184 | 24,263,921 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,981 | 194,943 | -1.01 | 79.07 | -156,639 | 15,414,260 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -151 | 52,183 | -0.29 | 79.07 | -11,940 | 4,126,141 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,214 | 212,953 | -1.03 | 79.07 | -175,062 | 16,838,321 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -39,591 | 10,237,588 | -0.39 | 79.63 | -3,152,536 | 815,194,562 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6,078 | 1,605,983 | -0.38 | 79.63 | -483,977 | 127,880,572 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,048 | 310,281 | -0.34 | 79.63 | -83,450 | 24,706,931 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -608 | 196,924 | -0.31 | 79.63 | -48,414 | 15,680,586 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -46 | 52,334 | -0.09 | 79.63 | -3,663 | 4,167,231 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -678 | 215,167 | -0.31 | 79.63 | -53,988 | 17,133,232 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -30,257 | 10,277,179 | -0.29 | 77.61 | -2,348,376 | 797,656,054 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4,646 | 1,612,061 | -0.29 | 77.61 | -360,596 | 125,118,986 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -801 | 311,329 | -0.26 | 77.61 | -62,169 | 24,163,582 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -465 | 197,532 | -0.23 | 77.61 | -36,091 | 15,331,308 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -35 | 52,380 | -0.07 | 77.61 | -2,717 | 4,065,437 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -518 | 215,845 | -0.24 | 77.61 | -40,204 | 16,752,659 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11,994 | 10,307,436 | -0.12 | 78.80 | -945,149 | 812,244,510 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,841 | 1,616,707 | -0.11 | 78.80 | -145,074 | 127,399,422 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -317 | 312,130 | -0.10 | 78.80 | -24,980 | 24,596,406 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -184 | 197,997 | -0.09 | 78.80 | -14,500 | 15,602,520 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -14 | 52,415 | -0.03 | 78.80 | -1,103 | 4,130,396 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -206 | 216,363 | -0.10 | 78.80 | -16,233 | 17,049,794 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -77,976 | 10,319,430 | -0.75 | 76.81 | -5,989,017 | 792,593,109 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11,972 | 1,618,548 | -0.73 | 76.81 | -919,520 | 124,314,036 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,064 | 312,447 | -0.66 | 76.81 | -158,527 | 23,997,773 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,197 | 198,181 | -0.60 | 76.81 | -91,937 | 15,221,470 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -91 | 52,429 | -0.17 | 76.81 | -6,989 | 4,026,857 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,335 | 216,569 | -0.61 | 76.81 | -102,536 | 16,633,777 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13,595 | 10,397,406 | -0.13 | 74.01 | -1,006,150 | 769,499,541 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,087 | 1,630,520 | -0.13 | 74.01 | -154,456 | 120,672,829 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -360 | 314,511 | -0.11 | 74.01 | -26,643 | 23,276,582 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -209 | 199,378 | -0.10 | 74.01 | -15,468 | 14,755,727 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16 | 52,520 | -0.03 | 74.01 | -1,184 | 3,886,942 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -233 | 217,904 | -0.11 | 74.01 | -17,244 | 16,126,814 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -57,979 | 10,411,001 | -0.55 | 74.71 | -4,331,524 | 777,790,268 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8,901 | 1,632,607 | -0.54 | 74.71 | -664,980 | 121,969,620 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,534 | 314,871 | -0.48 | 74.71 | -114,603 | 23,523,540 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -890 | 199,587 | -0.44 | 74.71 | -66,491 | 14,910,845 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -68 | 52,536 | -0.13 | 74.71 | -5,080 | 3,924,886 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -994 | 218,137 | -0.45 | 74.71 | -74,260 | 16,296,688 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -56,764 | 10,468,980 | -0.54 | 75.27 | -4,272,831 | 788,037,813 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8,715 | 1,641,508 | -0.53 | 75.27 | -656,009 | 123,562,217 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,502 | 316,405 | -0.47 | 75.27 | -113,061 | 23,816,943 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -871 | 200,477 | -0.43 | 75.27 | -65,563 | 15,090,626 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -66 | 52,604 | -0.13 | 75.27 | -4,968 | 3,959,692 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -973 | 219,131 | -0.44 | 75.27 | -73,241 | 16,494,779 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -36,652 | 10,525,744 | -0.35 | 73.76 | -2,703,294 | 776,333,617 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5,627 | 1,650,223 | -0.34 | 73.76 | -415,023 | 121,713,353 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -970 | 317,907 | -0.30 | 73.76 | -71,543 | 23,447,453 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -563 | 201,348 | -0.28 | 73.76 | -41,524 | 14,850,563 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -43 | 52,670 | -0.08 | 73.76 | -3,171 | 3,884,713 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -628 | 220,104 | -0.28 | 73.76 | -46,319 | 16,233,925 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -77,558 | 10,562,396 | -0.73 | 74.24 | -5,758,092 | 784,177,629 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11,907 | 1,655,850 | -0.71 | 74.24 | -884,004 | 122,934,278 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,052 | 318,877 | -0.64 | 74.24 | -152,345 | 23,674,194 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,190 | 201,911 | -0.59 | 74.24 | -88,348 | 14,990,357 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -91 | 52,713 | -0.17 | 74.24 | -6,756 | 3,913,540 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,329 | 220,732 | -0.60 | 74.24 | -98,668 | 16,387,673 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8,204 | 10,639,954 | -0.08 | 74.05 | -607,484 | 787,859,866 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,260 | 1,667,757 | -0.08 | 74.05 | -93,300 | 123,492,903 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -217 | 320,929 | -0.07 | 74.05 | -16,068 | 23,763,926 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -126 | 203,101 | -0.06 | 74.05 | -9,330 | 15,039,081 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 52,804 | -0.02 | 74.05 | -740 | 3,909,994 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -141 | 222,061 | -0.06 | 74.05 | -10,441 | 16,443,017 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -24,487 | 10,648,158 | -0.23 | 74.36 | -1,820,848 | 791,794,899 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,759 | 1,669,017 | -0.22 | 74.36 | -279,518 | 124,107,770 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -648 | 321,146 | -0.20 | 74.36 | -48,185 | 23,880,352 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -376 | 203,227 | -0.18 | 74.36 | -27,959 | 15,111,919 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -28 | 52,814 | -0.05 | 74.36 | -2,082 | 3,927,238 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -419 | 222,202 | -0.19 | 74.36 | -31,157 | 16,522,896 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -55,365 | 10,672,645 | -0.52 | 76.35 | -4,227,024 | 814,838,302 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8,499 | 1,672,776 | -0.51 | 76.35 | -648,884 | 127,713,604 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,466 | 321,794 | -0.45 | 76.35 | -111,927 | 24,568,425 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -850 | 203,603 | -0.42 | 76.35 | -64,896 | 15,544,743 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -65 | 52,842 | -0.12 | 76.35 | -4,963 | 4,034,397 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -949 | 222,621 | -0.42 | 76.35 | -72,455 | 16,996,735 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16,646 | 10,728,010 | -0.15 | 77.66 | -1,292,763 | 833,159,785 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,556 | 1,681,275 | -0.15 | 77.66 | -198,504 | 130,571,347 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -440 | 323,260 | -0.14 | 77.66 | -34,171 | 25,105,050 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -255 | 204,453 | -0.12 | 77.66 | -19,804 | 15,878,249 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -19 | 52,907 | -0.04 | 77.66 | -1,476 | 4,108,869 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -285 | 223,570 | -0.13 | 77.66 | -22,134 | 17,362,916 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -38,330 | 10,744,656 | -0.36 | 79.13 | -3,033,110 | 850,240,746 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5,885 | 1,683,831 | -0.35 | 79.13 | -465,689 | 133,244,073 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,014 | 323,700 | -0.31 | 79.13 | -80,239 | 25,614,867 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -588 | 204,708 | -0.29 | 79.13 | -46,529 | 16,198,851 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -45 | 52,926 | -0.08 | 79.13 | -3,561 | 4,188,114 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -657 | 223,855 | -0.29 | 79.13 | -51,989 | 17,713,982 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,296 | 10,782,986 | -0.03 | 80.09 | -263,978 | 863,613,662 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -506 | 1,689,716 | -0.03 | 80.09 | -40,526 | 135,330,030 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -87 | 324,714 | -0.03 | 80.09 | -6,968 | 26,006,474 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -51 | 205,296 | -0.02 | 80.09 | -4,085 | 16,442,239 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 52,971 | -0.01 | 80.09 | -320 | 4,242,469 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -56 | 224,512 | -0.02 | 80.09 | -4,485 | 17,981,256 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -53,013 | 10,786,282 | -0.49 | 80.07 | -4,244,714 | 863,650,049 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8,139 | 1,690,222 | -0.48 | 80.07 | -651,684 | 135,334,892 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,403 | 324,801 | -0.43 | 80.07 | -112,337 | 26,006,589 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -814 | 205,347 | -0.39 | 80.07 | -65,176 | 16,441,991 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -62 | 52,975 | -0.12 | 80.07 | -4,964 | 4,241,671 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -908 | 224,568 | -0.40 | 80.07 | -72,703 | 17,981,003 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -99,280 | 10,839,295 | -0.91 | 78.09 | -7,752,428 | 846,402,609 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15,242 | 1,698,361 | -0.89 | 78.09 | -1,190,194 | 132,619,066 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,628 | 326,204 | -0.80 | 78.09 | -205,211 | 25,472,129 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,524 | 206,161 | -0.73 | 78.09 | -119,004 | 16,098,391 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -115 | 53,037 | -0.22 | 78.09 | -8,980 | 4,141,474 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,702 | 225,476 | -0.75 | 78.09 | -132,903 | 17,606,632 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15,014 | 10,938,575 | -0.14 | 81.26 | -1,220,038 | 888,868,604 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,305 | 1,713,603 | -0.13 | 81.26 | -187,304 | 139,247,380 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -397 | 328,832 | -0.12 | 81.26 | -32,260 | 26,720,888 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -230 | 207,685 | -0.11 | 81.26 | -18,690 | 16,876,483 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18 | 53,152 | -0.03 | 81.26 | -1,463 | 4,319,132 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -257 | 227,178 | -0.11 | 81.26 | -20,884 | 18,460,484 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -46,511 | 10,953,589 | -0.42 | 81.16 | -3,774,912 | 889,011,904 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7,140 | 1,715,908 | -0.41 | 81.16 | -579,495 | 139,266,010 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,231 | 329,229 | -0.37 | 81.16 | -99,910 | 26,720,785 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -714 | 207,915 | -0.34 | 81.16 | -57,949 | 16,874,735 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -54 | 53,170 | -0.10 | 81.16 | -4,383 | 4,315,368 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -796 | 227,435 | -0.35 | 81.16 | -64,605 | 18,459,011 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7,533 | 11,000,100 | -0.07 | 80.51 | -606,473 | 885,604,851 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,156 | 1,723,048 | -0.07 | 80.51 | -93,068 | 138,720,527 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -199 | 330,460 | -0.06 | 80.51 | -16,021 | 26,604,938 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -116 | 208,629 | -0.06 | 80.51 | -9,339 | 16,796,470 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 53,224 | -0.02 | 80.51 | -725 | 4,285,000 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -129 | 228,231 | -0.06 | 80.51 | -10,386 | 18,374,604 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11,877 | 11,007,633 | -0.11 | 80.38 | -954,711 | 884,828,765 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,824 | 1,724,204 | -0.11 | 80.38 | -146,619 | 138,597,035 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -314 | 330,659 | -0.09 | 80.38 | -25,240 | 26,579,429 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -182 | 208,745 | -0.09 | 80.38 | -14,630 | 16,779,591 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -14 | 53,233 | -0.03 | 80.38 | -1,125 | 4,279,039 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -204 | 228,360 | -0.09 | 80.38 | -16,398 | 18,356,308 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -19,367 | 11,019,510 | -0.18 | 85.11 | -1,648,296 | 937,853,967 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,973 | 1,726,028 | -0.17 | 85.11 | -253,028 | 146,899,654 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -513 | 330,973 | -0.15 | 85.11 | -43,661 | 28,168,616 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -297 | 208,927 | -0.14 | 85.11 | -25,277 | 17,781,464 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -23 | 53,247 | -0.04 | 85.11 | -1,957 | 4,531,772 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -332 | 228,564 | -0.15 | 85.11 | -28,256 | 19,452,739 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -112,010 | 11,038,877 | -1.00 | 82.06 | -9,191,025 | 905,799,468 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -17,198 | 1,729,001 | -0.98 | 82.06 | -1,411,189 | 141,873,869 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,964 | 331,486 | -0.89 | 82.06 | -243,212 | 27,200,216 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,720 | 209,224 | -0.82 | 82.06 | -141,135 | 17,167,959 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -129 | 53,270 | -0.24 | 82.06 | -10,585 | 4,371,091 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,919 | 228,896 | -0.83 | 82.06 | -157,464 | 18,782,153 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8,157 | 11,150,887 | -0.07 | 82.55 | -673,321 | 920,452,198 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,252 | 1,746,199 | -0.07 | 82.55 | -103,347 | 144,140,346 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -216 | 334,450 | -0.06 | 82.55 | -17,830 | 27,607,242 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -125 | 210,944 | -0.06 | 82.55 | -10,318 | 17,412,415 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 53,399 | -0.02 | 82.55 | -743 | 4,407,831 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -140 | 230,815 | -0.06 | 82.55 | -11,556 | 19,052,670 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4,120 | 11,159,044 | -0.04 | 83.90 | -345,678 | 936,271,689 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -633 | 1,747,451 | -0.04 | 83.90 | -53,110 | 146,615,508 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -109 | 334,666 | -0.03 | 83.90 | -9,145 | 28,079,314 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63 | 211,069 | -0.03 | 83.90 | -5,286 | 17,709,217 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5 | 53,408 | -0.01 | 83.90 | -420 | 4,481,065 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -71 | 230,955 | -0.03 | 83.90 | -5,957 | 19,377,702 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -62,929 | 11,163,164 | -0.56 | 83.20 | -5,235,598 | 928,758,500 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9,661 | 1,748,084 | -0.55 | 83.20 | -803,781 | 145,437,967 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,665 | 334,775 | -0.49 | 83.20 | -138,526 | 27,852,778 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -966 | 211,132 | -0.46 | 83.20 | -80,370 | 17,565,866 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -74 | 53,413 | -0.14 | 83.20 | -6,157 | 4,443,881 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,078 | 231,026 | -0.46 | 83.20 | -89,688 | 19,221,017 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -17,602 | 11,226,093 | -0.16 | 85.87 | -1,511,565 | 964,036,246 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,702 | 1,757,745 | -0.15 | 85.87 | -232,033 | 150,945,649 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -466 | 336,440 | -0.14 | 85.87 | -40,018 | 28,891,650 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -270 | 212,098 | -0.13 | 85.87 | -23,186 | 18,213,831 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -21 | 53,487 | -0.04 | 85.87 | -1,803 | 4,593,175 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -302 | 232,104 | -0.13 | 85.87 | -25,934 | 19,931,838 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4,120 | 11,243,695 | -0.04 | 82.00 | -337,840 | 921,982,990 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -633 | 1,760,447 | -0.04 | 82.00 | -51,906 | 144,356,654 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -109 | 336,906 | -0.03 | 82.00 | -8,938 | 27,626,292 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63 | 212,368 | -0.03 | 82.00 | -5,166 | 17,414,176 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5 | 53,508 | -0.01 | 82.00 | -410 | 4,387,656 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -71 | 232,406 | -0.03 | 82.00 | -5,822 | 19,057,292 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,565 | 11,247,815 | -0.01 | 83.85 | -131,227 | 943,138,286 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -240 | 1,761,080 | -0.01 | 83.85 | -20,124 | 147,667,967 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42 | 337,015 | -0.01 | 83.85 | -3,522 | 28,258,977 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -24 | 212,431 | -0.01 | 83.85 | -2,012 | 17,812,509 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 53,513 | 0.00 | 83.85 | -168 | 4,487,108 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -27 | 232,477 | -0.01 | 83.85 | -2,264 | 19,493,382 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9,301 | 11,249,380 | -0.08 | 84.84 | -789,121 | 954,426,648 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,428 | 1,761,320 | -0.08 | 84.84 | -121,155 | 149,434,968 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -246 | 337,057 | -0.07 | 84.84 | -20,871 | 28,596,792 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -143 | 212,455 | -0.07 | 84.84 | -12,132 | 18,025,235 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 53,515 | -0.02 | 84.84 | -933 | 4,540,352 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -159 | 232,504 | -0.07 | 84.84 | -13,490 | 19,726,244 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -21,423 | 11,258,681 | -0.19 | 89.34 | -1,913,901 | 1,005,834,798 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,289 | 1,762,748 | -0.19 | 89.34 | -293,835 | 157,481,438 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -567 | 337,303 | -0.17 | 89.34 | -50,655 | 30,134,178 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -329 | 212,598 | -0.15 | 89.34 | -29,392 | 18,993,208 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 53,526 | -0.05 | 89.34 | -2,233 | 4,781,938 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -367 | 232,663 | -0.16 | 89.34 | -32,787 | 20,785,787 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -30,555 | 11,280,104 | -0.27 | 85.15 | -2,601,670 | 960,468,143 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4,692 | 1,766,037 | -0.26 | 85.15 | -399,510 | 150,372,929 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -809 | 337,870 | -0.24 | 85.15 | -68,884 | 28,768,651 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -470 | 212,927 | -0.22 | 85.15 | -40,019 | 18,130,117 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -37 | 53,551 | -0.07 | 85.15 | -3,150 | 4,559,712 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -522 | 233,030 | -0.22 | 85.15 | -44,447 | 19,841,829 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -36,174 | 11,310,659 | -0.32 | 85.78 | -3,102,970 | 970,217,018 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5,554 | 1,770,729 | -0.31 | 85.78 | -476,417 | 151,891,363 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -957 | 338,679 | -0.28 | 85.78 | -82,091 | 29,051,546 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -555 | 213,397 | -0.26 | 85.78 | -47,607 | 18,304,981 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42 | 53,588 | -0.08 | 85.78 | -3,603 | 4,596,725 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -620 | 233,552 | -0.26 | 85.78 | -53,183 | 20,033,857 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,663 | 11,346,833 | -0.03 | 87.30 | -319,780 | 990,579,656 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -562 | 1,776,283 | -0.03 | 87.30 | -49,063 | 155,069,684 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -97 | 339,636 | -0.03 | 87.30 | -8,468 | 29,650,257 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -56 | 213,952 | -0.03 | 87.30 | -4,889 | 18,678,031 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 53,630 | -0.01 | 87.30 | -349 | 4,681,904 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63 | 234,172 | -0.03 | 87.30 | -5,500 | 20,443,239 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4,306 | 11,350,496 | -0.04 | 88.38 | -380,544 | 1,003,104,624 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -661 | 1,776,845 | -0.04 | 88.38 | -58,416 | 157,029,388 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -114 | 339,733 | -0.03 | 88.38 | -10,075 | 30,024,040 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -66 | 214,008 | -0.03 | 88.38 | -5,833 | 18,913,043 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5 | 53,634 | -0.01 | 88.38 | -442 | 4,739,926 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -74 | 234,235 | -0.03 | 88.38 | -6,540 | 20,700,612 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15,798 | 11,354,802 | -0.14 | 83.94 | -1,326,160 | 953,176,583 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,425 | 1,777,506 | -0.14 | 83.94 | -203,566 | 149,212,386 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -418 | 339,847 | -0.12 | 83.94 | -35,089 | 28,528,388 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -242 | 214,074 | -0.11 | 83.94 | -20,315 | 17,970,399 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18 | 53,639 | -0.03 | 83.94 | -1,511 | 4,502,715 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -271 | 234,309 | -0.12 | 83.94 | -22,749 | 19,669,022 | |
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Secured Bridge Notes 30% 12/1/2020 |
C - Conversion | -3,660,993 | 0 | -100.00 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Secured Bridge Notes 30% 12/1/2020 |
C - Conversion | -294,948 | 0 | -100.00 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Series B Redeemable Convertible Preferred Shares |
C - Conversion | -4,627,208 | 0 | -100.00 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Series B Redeemable Convertible Preferred Shares |
C - Conversion | -372,792 | 0 | -100.00 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,248,102 | 8,374,935 | 36.69 | 10.00 | 22,481,020 | 83,749,350 | |
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 251,898 | 770,180 | 48.60 | 10.00 | 2,518,980 | 7,701,800 | |
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
J - Other | 767,427 | 6,126,833 | 14.32 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
J - Other | 86,501 | 518,282 | 20.03 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
C - Conversion | 732,198 | 5,359,406 | 15.82 | 5.00 | 3,660,990 | 26,797,030 | |
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
C - Conversion | 58,989 | 431,781 | 15.82 | 5.00 | 294,945 | 2,158,905 | |
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
C - Conversion | 4,627,208 | 4,627,208 | |||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
C - Conversion | 372,792 | 372,792 | |||||
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 340,265 | 0.08 | 70.18 | 19,931 | 23,879,798 | |
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 340,265 | 0.08 | 70.18 | 19,931 | 23,879,798 | |
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 11,544,497 | 0.00 | 70.18 | 19,931 | 810,192,799 | |
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 1,953,828 | 0.01 | 70.18 | 19,931 | 137,119,649 | |
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 227,554 | 0.12 | 70.18 | 19,931 | 15,969,740 | |
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 388,213 | 0.07 | 70.18 | 19,931 | 27,244,788 | |
| 2018-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2,340 | 81,414 | 2.96 | 8.71 | 20,381 | 709,116 | |
| 2018-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2,340 | 81,414 | 2.96 | 8.71 | 20,381 | 709,116 | |
| 2018-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2,340 | 4,280,212 | 0.05 | 8.71 | 20,381 | 37,280,647 | |
| 2018-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 275 | 810,564 | 0.03 | 69.08 | 18,997 | 55,993,761 | |
| 2018-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 275 | 810,564 | 0.03 | 69.08 | 18,997 | 55,993,761 | |
| 2018-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 275 | 1,269,837 | 0.02 | 69.08 | 18,997 | 87,720,340 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 131,007 | 24,798,117 | 0.53 | 19.09 | 2,501,238 | 473,455,569 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 14,555 | 3,151,020 | 0.46 | 19.09 | 277,890 | 60,160,534 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 38,207 | 24,667,110 | 0.16 | 19.01 | 726,353 | 468,946,428 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4,245 | 3,136,465 | 0.14 | 19.01 | 80,702 | 59,627,336 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 920,495 | 24,628,903 | 3.88 | 18.64 | 17,154,897 | 458,999,014 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 102,267 | 3,132,220 | 3.38 | 18.64 | 1,905,909 | 58,373,931 | |
| 2018-08-06 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
P - Purchase | 5,231,900 | 5,250,491 | 28,142.11 | 108.00 | 565,045,200 | 567,053,028 | |
| 2018-08-06 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
P - Purchase | 582,200 | 600,791 | 3,131.62 | 108.00 | 62,877,600 | 64,885,428 | |
| 2018-07-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 16,383 | 632,599 | 2.66 | 1.32 | 21,626 | 835,031 | |
| 2018-07-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 16,383 | 632,599 | 2.66 | 1.32 | 21,626 | 835,031 | |
| 2018-07-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 16,383 | 34,222,983 | 0.05 | 1.32 | 21,626 | 45,174,338 | |
| 2018-07-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 283 | 810,289 | 0.03 | 67.00 | 18,961 | 54,289,363 | |
| 2018-07-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 283 | 810,289 | 0.03 | 67.00 | 18,961 | 54,289,363 | |
| 2018-07-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 283 | 810,289 | 0.03 | 67.00 | 18,961 | 54,289,363 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 339,981 | 0.12 | 50.40 | 19,958 | 17,135,042 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 339,981 | 0.12 | 50.40 | 19,958 | 17,135,042 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 339,981 | 0.12 | 50.40 | 19,958 | 17,135,042 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 1,953,544 | 0.02 | 50.40 | 19,958 | 98,458,618 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 227,270 | 0.17 | 50.40 | 19,958 | 11,454,408 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 387,929 | 0.10 | 50.40 | 19,958 | 19,551,622 | |
| 2018-06-21 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 100,000 | 100,000 | |||||
| 2018-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20,000 | 20,000 | |||||
| 2018-06-08 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 30,000 | 30,000 | |||||
| 2018-06-08 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
A - Award | 34,884 | 34,884 | |||||
| 2018-06-08 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
A - Award | 18,580 | 73,180,602 | 0.03 | ||||
| 2018-06-08 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
A - Award | 18,580 | 73,180,602 | 0.03 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class B1 Common Shares |
C - Conversion | 14,658,102 | 14,658,102 | |||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series A Preferred |
C - Conversion | -14,658,102 | 0 | -100.00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class B1 Common Shares |
C - Conversion | 1,399,516 | 1,399,516 | |||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series A Preferred |
C - Conversion | -1,399,516 | 0 | -100.00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
C - Conversion | 3,284,771 | 7,018,874 | 87.97 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series B Preferred |
C - Conversion | -3,284,771 | 0 | -100.00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
C - Conversion | 313,621 | 734,518 | 74.51 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series B Preferred |
C - Conversion | -313,621 | 0 | -100.00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
C - Conversion | 3,734,103 | 3,734,103 | |||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series C Preferred |
C - Conversion | -3,734,103 | 0 | -100.00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
C - Conversion | 420,897 | 420,897 | |||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series C Preferred |
C - Conversion | -420,897 | 0 | -100.00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
P - Purchase | 2,700,597 | 2,700,597 | 18.00 | 48,610,746 | 48,610,746 | ||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
P - Purchase | 299,403 | 299,403 | 18.00 | 5,389,254 | 5,389,254 | ||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series C Preferred |
P - Purchase | 3,734,103 | 3,734,103 | |||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series C Preferred |
P - Purchase | 420,897 | 420,897 | |||||
| 2018-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9,260 | 9,260 | |||||
| 2018-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9,260 | 9,260 | |||||
| 2018-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,700 | 45,829,686 | 0.01 | 56.77 | 210,049 | 2,601,751,274 | |
| 2018-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,700 | 45,829,686 | 0.01 | 56.77 | 210,049 | 2,601,751,274 | |
| 2018-05-11 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 2,174 | 7,648,080 | 0.03 | ||||
| 2018-05-11 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 2,174 | 7,648,080 | 0.03 | ||||
| 2018-05-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Non-Qualified Stock Option (right to buy) |
A - Award | 30,000 | 30,000 | |||||
| 2018-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 126,399 | 45,825,986 | 0.28 | 54.02 | 6,828,339 | 2,475,615,998 | |
| 2018-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 129,715 | 45,699,587 | 0.28 | 53.70 | 6,966,305 | 2,454,282,610 | |
| 2018-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 204,537 | 45,569,872 | 0.45 | 52.68 | 10,775,582 | 2,400,748,453 | |
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 810,006 | 2.53 | 9.92 | 198,400 | 8,035,260 | |
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 810,006 | 2.53 | 9.92 | 198,400 | 8,035,260 | |
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 810,006 | 2.53 | 9.92 | 198,400 | 8,035,260 | |
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15,000 | 15,000 | |||||
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9,105 | 45,365,335 | 0.02 | 54.42 | 495,488 | 2,468,749,775 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21,442 | 45,356,230 | 0.05 | 52.26 | 1,120,576 | 2,370,352,865 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 37,400 | 45,334,788 | 0.08 | 52.33 | 1,957,022 | 2,372,224,385 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,000 | 45,297,388 | 0.00 | 51.88 | 103,750 | 2,349,802,002 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,951 | 45,295,388 | 0.01 | 52.33 | 311,418 | 2,370,321,243 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 37,963 | 45,289,437 | 0.08 | 52.06 | 1,976,213 | 2,357,600,519 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 57,270 | 45,251,474 | 0.13 | 51.37 | 2,941,708 | 2,324,369,113 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10,500 | 45,194,204 | 0.02 | 51.36 | 539,280 | 2,321,174,317 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 22,700 | 45,183,704 | 0.05 | 51.30 | 1,164,424 | 2,317,752,317 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 72,533 | 45,161,004 | 0.16 | 51.26 | 3,717,693 | 2,314,736,292 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 100,000 | 45,088,471 | 0.22 | 51.14 | 5,114,000 | 2,305,824,407 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 44,988,471 | 0.02 | 10.08 | 100,800 | 453,483,788 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 44,988,471 | 0.02 | 10.08 | 100,800 | 453,483,788 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 168,097 | 44,978,471 | 0.38 | 51.25 | 8,614,786 | 2,305,097,162 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 52,700 | 44,810,374 | 0.12 | 51.07 | 2,691,173 | 2,288,282,078 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 248,121 | 44,757,674 | 0.56 | 51.03 | 12,661,069 | 2,283,885,637 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 154,218 | 44,509,553 | 0.35 | 50.90 | 7,849,897 | 2,265,594,110 | |
| 2018-04-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13,349 | 616,216 | 2.21 | 1.62 | 21,625 | 998,270 | |
| 2018-04-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13,349 | 616,216 | 2.21 | 1.62 | 21,625 | 998,270 | |
| 2018-04-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13,349 | 616,216 | 2.21 | 1.62 | 21,625 | 998,270 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 339,585 | 0.19 | 31.29 | 19,963 | 10,625,615 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 1,382,967 | 0.05 | 31.29 | 19,963 | 43,273,037 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 1,382,967 | 0.05 | 31.29 | 19,963 | 43,273,037 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 1,382,967 | 0.05 | 31.29 | 19,963 | 43,273,037 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 1,382,967 | 0.05 | 31.29 | 19,963 | 43,273,037 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 339,585 | 0.19 | 31.29 | 19,963 | 10,625,615 | |
| 2018-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 228 | 790,006 | 0.03 | 83.33 | 18,999 | 65,831,200 | |
| 2018-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 228 | 1,249,279 | 0.02 | 83.33 | 18,999 | 104,102,419 | |
| 2018-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 228 | 790,006 | 0.03 | 83.33 | 18,999 | 65,831,200 | |
| 2018-03-29 |
|
4 | NVTA |
Invitae Corp
Common Stock |
P - Purchase | 999,514 | 7,480,182 | 15.42 | 4.50 | 4,497,813 | 33,660,819 | |
| 2018-03-29 |
|
4 | NVTA |
Invitae Corp
Common Stock |
P - Purchase | 111,597 | 845,858 | 15.20 | 4.50 | 502,186 | 3,806,361 | |
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock Warrant (right to buy) |
M - Exercise | -439,036 | 0 | -100.00 | ||||
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock Warrant (right to buy) |
M - Exercise | -17,626,445 | 0 | -100.00 | ||||
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock Warrant (right to buy) |
M - Exercise | -2,250,846 | 0 | -100.00 | ||||
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 439,036 | 602,867 | 267.98 | 0.47 | 206,347 | 283,347 | |
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 17,626,445 | 34,193,251 | 106.40 | 0.47 | 8,284,429 | 16,070,828 | |
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 2,250,846 | 4,102,796 | 121.54 | 0.47 | 1,057,898 | 1,928,314 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 338,947 | 2.49 | 18.50 | 152,625 | 6,270,520 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 338,947 | 2.49 | 18.50 | 152,625 | 6,270,520 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 1,382,329 | 0.60 | 18.50 | 152,625 | 25,573,086 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 1,382,329 | 0.60 | 18.50 | 152,625 | 25,573,086 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 1,382,329 | 0.60 | 18.50 | 152,625 | 25,573,086 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 338,947 | 2.49 | 18.50 | 152,625 | 6,270,520 | |
| 2018-02-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,456,543 | 44,355,335 | 8.45 | 52.00 | 179,740,236 | 2,306,477,420 | |
| 2018-02-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 389,610 | 5,278,174 | 7.97 | 52.00 | 20,259,720 | 274,465,048 | |
| 2018-01-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 1,645,148 | 5,121,404 | 47.33 | 101.00 | 166,159,948 | 517,261,804 | |
| 2018-01-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 335,050 | 708,025 | 89.83 | 101.00 | 33,840,050 | 71,510,525 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -4,136 | 58,131 | -6.64 | 7.91 | -32,715 | 459,799 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -265,708 | 3,734,776 | -6.64 | 7.91 | -2,101,671 | 29,540,958 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -25,517 | 358,671 | -6.64 | 7.91 | -201,832 | 2,836,980 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -4,548 | 62,267 | -6.81 | 8.12 | -36,910 | 505,340 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -292,168 | 4,000,484 | -6.81 | 8.12 | -2,371,148 | 32,466,728 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -28,058 | 384,188 | -6.81 | 8.12 | -227,710 | 3,117,955 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -3,649 | 66,815 | -5.18 | 8.63 | -31,476 | 576,340 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -234,437 | 4,292,652 | -5.18 | 8.63 | -2,022,230 | 37,027,987 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -22,514 | 412,246 | -5.18 | 8.63 | -194,204 | 3,555,993 | |
| 2018-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9,333 | 163,831 | 6.04 | 2.21 | 20,626 | 362,067 | |
| 2018-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9,333 | 163,831 | 6.04 | 2.21 | 20,626 | 362,067 | |
| 2018-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9,333 | 163,831 | 6.04 | 2.21 | 20,626 | 362,067 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 330,697 | 0.18 | 34.20 | 19,973 | 11,309,837 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 330,697 | 0.18 | 34.20 | 19,973 | 11,309,837 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 1,374,079 | 0.04 | 34.20 | 19,973 | 46,993,502 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 1,374,079 | 0.04 | 34.20 | 19,973 | 46,993,502 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 1,374,079 | 0.04 | 34.20 | 19,973 | 46,993,502 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 330,697 | 0.18 | 34.20 | 19,973 | 11,309,837 | |
| 2018-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 200 | 789,778 | 0.03 | 94.71 | 18,942 | 74,799,874 | |
| 2018-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 200 | 789,778 | 0.03 | 94.71 | 18,942 | 74,799,874 | |
| 2018-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 200 | 789,778 | 0.03 | 94.71 | 18,942 | 74,799,874 | |
| 2017-11-29 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
M - Exercise | -39,378 | 0 | -100.00 | ||||
| 2017-11-29 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
F - Taxes | -1,941 | 489,977 | -0.39 | 28.00 | -54,348 | 13,719,356 | |
| 2017-11-29 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 39,378 | 491,918 | 8.70 | 1.38 | 54,342 | 678,847 | |
| 2017-11-20 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
P - Purchase | 1,618,684 | 1,618,684 | 13.00 | 21,041,273 | 21,041,273 | ||
| 2017-11-20 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
P - Purchase | 304,392 | 304,392 | 13.00 | 3,956,792 | 3,956,792 | ||
| 2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -5,996 | 0 | -100.00 | ||||
| 2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -249,801 | 0 | -100.00 | ||||
| 2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -24,466 | 0 | -100.00 | ||||
| 2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 5,996 | 35,999 | 19.98 | 7.86 | 47,129 | 282,952 | |
| 2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 249,801 | 2,372,218 | 11.77 | 7.86 | 1,963,436 | 18,645,633 | |
| 2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 24,466 | 141,244 | 20.95 | 7.86 | 192,303 | 1,110,178 | |
| 2017-10-30 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7,204,652 | 16,557,473 | 77.03 | 1.50 | 10,806,978 | 24,836,210 | |
| 2017-10-30 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 795,348 | 1,842,617 | 75.94 | 1.50 | 1,193,022 | 2,763,926 | |
| 2017-10-16 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
M - Exercise | -1,426,590 | 0 | -100.00 | ||||
| 2017-10-16 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
F - Taxes | -55,457 | 23,708,408 | -0.23 | 35.40 | -1,963,178 | 839,277,643 | |
| 2017-10-16 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1,426,590 | 23,763,865 | 6.39 | 1.38 | 1,968,694 | 32,794,134 | |
| 2017-10-16 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | 7,102 | 7,102 | |||||
| 2017-10-16 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | 7,102 | 7,102 | |||||
| 2017-10-16 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | -49,200 | 0 | -100.00 | ||||
| 2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Series A Convertible Prefered |
C - Conversion | -9,913,242 | 0 | -100.00 | ||||
| 2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Series A Convertible Prefered |
C - Conversion | -760,829 | 0 | -100.00 | ||||
| 2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 797,191 | 1,878,242 | 73.74 | 17.00 | 13,552,247 | 31,930,114 | |
| 2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 87,809 | 170,778 | 105.83 | 17.00 | 1,492,753 | 2,903,226 | |
| 2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Common Stock |
C - Conversion | 1,081,051 | 1,081,051 | |||||
| 2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Common Stock |
C - Conversion | 82,969 | 82,969 | |||||
| 2017-10-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9,045 | 154,498 | 6.22 | 2.28 | 20,623 | 352,255 | |
| 2017-10-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9,045 | 154,498 | 6.22 | 2.28 | 20,623 | 352,255 | |
| 2017-10-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9,045 | 154,498 | 6.22 | 2.28 | 20,623 | 352,255 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 330,113 | 0.19 | 32.09 | 19,960 | 10,593,326 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 330,113 | 0.19 | 32.09 | 19,960 | 10,593,326 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 1,373,495 | 0.05 | 32.09 | 19,960 | 44,075,455 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 1,373,495 | 0.05 | 32.09 | 19,960 | 44,075,455 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 1,373,495 | 0.05 | 32.09 | 19,960 | 44,075,455 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 330,113 | 0.19 | 32.09 | 19,960 | 10,593,326 | |
| 2017-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 162 | 789,578 | 0.02 | 116.74 | 18,912 | 92,175,336 | |
| 2017-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 162 | 789,578 | 0.02 | 116.74 | 18,912 | 92,175,336 | |
| 2017-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 162 | 789,578 | 0.02 | 116.74 | 18,912 | 92,175,336 | |
| 2017-09-08 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2,029 | 789,416 | 0.26 | 132.00 | 267,828 | 104,202,912 | |
| 2017-09-08 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 85,402 | 29,247,347 | 0.29 | 132.00 | 11,273,064 | 3,860,649,804 | |
| 2017-09-08 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 12,569 | 4,386,818 | 0.29 | 132.00 | 1,659,108 | 579,059,976 | |
| 2017-08-14 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 158,279 | 3,476,256 | 4.77 | 71.00 | 11,237,809 | 246,814,176 | |
| 2017-08-14 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 17,777 | 372,975 | 5.00 | 71.00 | 1,262,167 | 26,481,225 | |
| 2017-08-02 |
|
4 | NVTA |
Invitae Corp
Series A Convertible Preferred |
P - Purchase | 3,109,063 | 3,109,063 | 8.50 | 26,427,036 | 26,427,036 | ||
| 2017-08-02 |
|
4 | NVTA |
Invitae Corp
Series A Convertible Preferred |
P - Purchase | 349,760 | 349,760 | 8.50 | 2,972,960 | 2,972,960 | ||
| 2017-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 11,787 | 145,453 | 8.82 | 1.75 | 20,627 | 254,543 | |
| 2017-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 11,787 | 145,453 | 8.82 | 1.75 | 20,627 | 254,543 | |
| 2017-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 11,787 | 145,453 | 8.82 | 1.75 | 20,627 | 254,543 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1,372,873 | 0.04 | 32.55 | 19,986 | 44,687,016 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1,372,873 | 0.04 | 32.55 | 19,986 | 44,687,016 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1,372,873 | 0.04 | 32.55 | 19,986 | 44,687,016 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1,372,873 | 0.04 | 32.55 | 19,986 | 44,687,016 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1,372,873 | 0.04 | 32.55 | 19,986 | 44,687,016 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 329,491 | 0.19 | 32.55 | 19,986 | 10,724,932 | |
| 2017-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 150 | 1,246,660 | 0.01 | 125.91 | 18,886 | 156,966,961 | |
| 2017-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 150 | 1,246,660 | 0.01 | 125.91 | 18,886 | 156,966,961 | |
| 2017-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 150 | 787,387 | 0.02 | 125.91 | 18,886 | 99,139,897 | |
| 2017-06-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20,000 | 20,000 | |||||
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 22,560 | 7,317,906 | 0.31 | 117.95 | 2,660,914 | 863,134,572 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2,564 | 647,367 | 0.40 | 117.95 | 302,419 | 76,355,837 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 197,126 | 7,295,346 | 2.78 | 117.51 | 23,163,488 | 857,246,927 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 22,399 | 644,803 | 3.60 | 117.51 | 2,632,017 | 75,768,221 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 32,172 | 7,098,220 | 0.46 | 117.22 | 3,771,228 | 832,059,027 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,656 | 622,404 | 0.59 | 117.22 | 428,559 | 72,958,695 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 65,264 | 7,066,048 | 0.93 | 117.01 | 7,636,802 | 826,826,541 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7,416 | 618,748 | 1.21 | 117.01 | 867,776 | 72,402,178 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 898 | 7,000,784 | 0.01 | 116.96 | 105,030 | 818,811,697 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 102 | 611,332 | 0.02 | 116.96 | 11,930 | 71,501,391 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 31,974 | 6,999,886 | 0.46 | 116.71 | 3,731,542 | 816,925,196 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,634 | 611,230 | 0.60 | 116.71 | 424,108 | 71,333,903 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 12,726 | 6,967,912 | 0.18 | 116.37 | 1,480,897 | 810,840,590 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,446 | 607,596 | 0.24 | 116.37 | 168,268 | 70,704,610 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 385,774 | 6,955,186 | 5.87 | 116.37 | 44,891,517 | 809,356,911 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 43,835 | 606,150 | 7.80 | 116.37 | 5,100,965 | 70,536,100 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,976 | 6,569,412 | 0.03 | 116.18 | 229,562 | 763,202,753 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 224 | 562,315 | 0.04 | 116.18 | 26,023 | 65,327,058 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 169,897 | 6,567,436 | 2.66 | 115.77 | 19,668,568 | 760,296,304 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 19,305 | 562,091 | 3.56 | 115.77 | 2,234,894 | 65,071,926 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 207,814 | 6,397,539 | 3.36 | 115.71 | 24,046,636 | 740,273,952 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 23,614 | 542,786 | 4.55 | 115.71 | 2,732,430 | 62,807,016 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 18,678 | 6,189,725 | 0.30 | 115.06 | 2,149,048 | 712,175,522 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2,122 | 519,172 | 0.41 | 115.06 | 244,152 | 59,734,736 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 64,455 | 6,171,047 | 1.06 | 114.33 | 7,369,301 | 705,551,231 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7,324 | 517,050 | 1.44 | 114.33 | 837,371 | 59,115,619 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 160,000 | 980,146 | 19.51 | 117.71 | 18,832,960 | 115,369,065 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 103,200 | 820,146 | 14.39 | 117.63 | 12,139,416 | 96,473,774 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 32,008 | 716,946 | 4.67 | 117.60 | 3,764,067 | 84,311,201 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 300 | 684,938 | 0.04 | 116.75 | 35,025 | 79,966,512 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,747 | 7,645,906 | 0.05 | 116.75 | 437,462 | 892,659,526 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 426 | 684,638 | 0.06 | 116.75 | 49,736 | 79,931,486 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 44,898 | 7,642,159 | 0.59 | 117.50 | 5,275,484 | 897,948,333 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5,102 | 684,212 | 0.75 | 117.50 | 599,481 | 80,394,431 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5,373 | 7,597,261 | 0.07 | 117.21 | 629,790 | 890,504,591 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 611 | 679,110 | 0.09 | 117.21 | 71,618 | 79,601,132 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 217,305 | 7,591,888 | 2.95 | 117.05 | 25,434,638 | 888,598,604 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24,692 | 678,499 | 3.78 | 117.05 | 2,890,095 | 79,415,458 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 8,950 | 7,374,583 | 0.12 | 116.95 | 1,046,720 | 862,471,494 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,017 | 653,807 | 0.16 | 116.95 | 118,940 | 76,463,971 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 39,473 | 7,365,633 | 0.54 | 116.65 | 4,604,506 | 859,197,407 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4,485 | 652,790 | 0.69 | 116.65 | 523,173 | 76,147,627 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4,310 | 7,326,160 | 0.06 | 116.54 | 502,277 | 853,773,836 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 490 | 648,305 | 0.08 | 116.54 | 57,103 | 75,551,974 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,944 | 7,321,850 | 0.05 | 118.00 | 465,392 | 863,978,300 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 448 | 647,815 | 0.07 | 118.00 | 52,864 | 76,442,170 | |
| 2017-06-14 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 30,000 | 30,000 | |||||
| 2017-06-09 |
|
4/A | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 100,000 | 100,000 | |||||
| 2017-06-08 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 100,000 | 100,000 | |||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 328,877 | 2.57 | 18.13 | 149,572 | 5,962,540 | |
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 1,372,259 | 0.60 | 18.13 | 149,572 | 24,879,056 | |
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 1,372,259 | 0.60 | 18.13 | 149,572 | 24,879,056 | |
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 1,372,259 | 0.60 | 18.13 | 149,572 | 24,879,056 | |
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 1,372,259 | 0.60 | 18.13 | 149,572 | 24,879,056 | |
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 328,877 | 2.57 | 18.13 | 149,572 | 5,962,540 | |
| 2017-05-31 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15,000 | 15,000 | |||||
| 2017-05-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9,260 | 9,260 | |||||
| 2017-05-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9,260 | 9,260 | |||||
| 2017-05-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,700 | 40,898,792 | 0.01 | 66.60 | 246,420 | 2,723,859,547 | |
| 2017-05-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,700 | 40,898,792 | 0.01 | 66.60 | 246,420 | 2,723,859,547 | |
| 2017-05-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2017-05-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2017-05-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 40,895,092 | 0.02 | 10.20 | 102,000 | 417,129,938 | |
| 2017-05-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 40,895,092 | 0.02 | 10.20 | 102,000 | 417,129,938 | |
| 2017-05-12 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 2,030 | 6,559,338 | 0.03 | ||||
| 2017-05-12 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 2,030 | 6,106,592 | 0.03 | ||||
| 2017-05-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Non-Qualified Stock Option (right to buy) |
A - Award | 36,000 | 36,000 | |||||
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 787,237 | 2.61 | 7.26 | 145,200 | 5,715,341 | |
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 787,237 | 2.61 | 7.26 | 145,200 | 5,715,341 | |
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 787,237 | 2.61 | 7.26 | 145,200 | 5,715,341 | |
| 2017-04-21 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (right to buy) |
A - Award | 399,984 | 399,984 | |||||
| 2017-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8,487 | 133,666 | 6.78 | 2.43 | 20,623 | 324,808 | |
| 2017-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8,487 | 133,666 | 6.78 | 2.43 | 20,623 | 324,808 | |
| 2017-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8,487 | 133,666 | 6.78 | 2.43 | 20,623 | 324,808 | |
| 2017-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 142 | 767,237 | 0.02 | 133.67 | 18,981 | 102,556,570 | |
| 2017-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 142 | 1,226,510 | 0.01 | 133.67 | 18,981 | 163,947,592 | |
| 2017-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 142 | 767,237 | 0.02 | 133.67 | 18,981 | 102,556,570 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 320,627 | 0.20 | 31.49 | 19,965 | 10,096,544 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 1,364,009 | 0.05 | 31.49 | 19,965 | 42,952,643 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 1,364,009 | 0.05 | 31.49 | 19,965 | 42,952,643 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 1,364,009 | 0.05 | 31.49 | 19,965 | 42,952,643 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 1,364,009 | 0.05 | 31.49 | 19,965 | 42,952,643 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 320,627 | 0.20 | 31.49 | 19,965 | 10,096,544 | |
| 2017-03-28 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 151,177 | 4,527,089 | 3.45 | 12.00 | 1,814,124 | 54,325,068 | |
| 2017-03-28 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 15,489 | 434,760 | 3.69 | 12.00 | 185,868 | 5,217,120 | |
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
D - Sale to Issuer | -6,050,000 | 0 | -100.00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
D - Sale to Issuer | -5,674,000 | 0 | -100.00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
D - Sale to Issuer | -243,450,000 | 0 | -100.00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
D - Sale to Issuer | -228,326,000 | 0 | -100.00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
D - Sale to Issuer | -25,000,000 | 0 | -100.00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
D - Sale to Issuer | -25,000,000 | 0 | -100.00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 121,672 | 767,095 | 18.85 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 111,514 | 645,423 | 20.89 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 4,896,067 | 29,141,653 | 20.19 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 4,487,412 | 24,245,586 | 22.71 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 502,779 | 4,353,957 | 13.06 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 491,338 | 3,851,178 | 14.62 | ||||
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 32,051 | 9,764,459 | 0.33 | 17.76 | 569,226 | 173,416,792 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3,389 | 1,169,695 | 0.29 | 17.76 | 60,189 | 20,773,783 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 235,169 | 9,732,408 | 2.48 | 17.60 | 4,138,880 | 171,286,488 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 24,871 | 1,166,306 | 2.18 | 17.60 | 437,720 | 20,526,519 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 35,360 | 9,497,239 | 0.37 | 16.31 | 576,555 | 154,855,331 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3,739 | 1,141,435 | 0.33 | 16.31 | 60,966 | 18,611,440 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5,006 | 9,461,879 | 0.05 | 15.62 | 78,207 | 147,819,151 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 529 | 1,137,696 | 0.05 | 15.62 | 8,264 | 17,773,770 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 15,148 | 9,456,873 | 0.16 | 15.13 | 229,189 | 143,082,488 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,602 | 1,137,167 | 0.14 | 15.13 | 24,238 | 17,205,337 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 9,143 | 9,441,725 | 0.10 | 16.20 | 148,089 | 152,927,620 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 967 | 1,135,565 | 0.09 | 16.20 | 15,662 | 18,392,746 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 8,671 | 9,432,582 | 0.09 | 15.35 | 133,078 | 144,766,552 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 917 | 1,134,598 | 0.08 | 15.35 | 14,074 | 17,413,243 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,442 | 9,423,911 | 0.03 | 16.85 | 41,156 | 158,823,999 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 258 | 1,133,681 | 0.02 | 16.85 | 4,348 | 19,106,266 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 11,305 | 9,421,469 | 0.12 | 15.32 | 173,204 | 144,346,327 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,195 | 1,133,423 | 0.11 | 15.32 | 18,309 | 17,365,174 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5,697 | 9,410,164 | 0.06 | 16.74 | 95,365 | 157,521,440 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 603 | 1,132,228 | 0.05 | 16.74 | 10,094 | 18,952,931 | |
| 2017-01-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 14,169 | 125,179 | 12.76 | 1.50 | 21,254 | 187,768 | |
| 2017-01-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 14,169 | 125,179 | 12.76 | 1.50 | 21,254 | 187,768 | |
| 2017-01-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 14,169 | 125,179 | 12.76 | 1.50 | 21,254 | 187,768 | |
| 2017-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 189 | 993,182 | 0.02 | 100.27 | 18,951 | 99,586,359 | |
| 2017-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 189 | 993,182 | 0.02 | 100.27 | 18,951 | 99,586,359 | |
| 2017-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 189 | 533,909 | 0.04 | 100.27 | 18,951 | 53,535,055 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 14,045,614 | 0.00 | 29.39 | 19,985 | 412,800,595 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 14,045,614 | 0.00 | 29.39 | 19,985 | 412,800,595 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 14,045,614 | 0.00 | 29.39 | 19,985 | 412,800,595 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 14,045,614 | 0.00 | 29.39 | 19,985 | 412,800,595 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 1,363,375 | 0.05 | 29.39 | 19,985 | 40,069,591 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 319,993 | 0.21 | 29.39 | 19,985 | 9,404,594 | |
| 2016-11-21 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 1,594,671 | 3,317,977 | 92.54 | 32.00 | 51,029,472 | 106,175,264 | |
| 2016-11-21 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 165,824 | 355,198 | 87.56 | 32.00 | 5,306,368 | 11,366,336 | |
| 2016-11-18 |
|
4 | NVTA |
Invitae Corp
Common Stock |
P - Purchase | 664,259 | 6,480,668 | 11.42 | 6.00 | 3,985,554 | 38,884,008 | |
| 2016-11-18 |
|
4 | NVTA |
Invitae Corp
Common Stock |
P - Purchase | 69,074 | 734,261 | 10.38 | 6.00 | 414,444 | 4,405,566 | |
| 2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 294,178 | 40,885,092 | 0.72 | 59.46 | 17,493,177 | 2,431,215,642 | |
| 2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 32,122 | 4,874,864 | 0.66 | 59.46 | 1,910,122 | 289,881,838 | |
| 2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 50,667 | 40,590,914 | 0.12 | 58.74 | 2,976,321 | 2,384,423,943 | |
| 2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,533 | 4,842,742 | 0.11 | 58.74 | 325,024 | 284,476,225 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 18,616 | 40,540,247 | 0.05 | 55.99 | 1,042,351 | 2,269,937,618 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,039 | 4,837,209 | 0.04 | 55.99 | 114,168 | 270,845,974 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 16,854 | 40,521,631 | 0.04 | 56.42 | 950,861 | 2,286,129,117 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,846 | 4,835,170 | 0.04 | 56.42 | 104,147 | 272,788,203 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 143,016 | 40,504,777 | 0.35 | 56.48 | 8,078,001 | 2,287,839,420 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 15,662 | 4,833,324 | 0.33 | 56.48 | 884,640 | 273,001,606 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 361 | 40,361,761 | 0.00 | 56.49 | 20,393 | 2,280,035,879 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 39 | 4,817,662 | 0.00 | 56.49 | 2,203 | 272,149,726 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 456 | 40,361,400 | 0.00 | 56.55 | 25,788 | 2,282,558,254 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 50 | 4,817,623 | 0.00 | 56.55 | 2,828 | 272,451,034 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 341,438 | 40,360,944 | 0.85 | 56.91 | 19,430,383 | 2,296,840,421 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 37,392 | 4,817,573 | 0.78 | 56.91 | 2,127,885 | 274,156,035 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 95,280 | 40,019,506 | 0.24 | 55.84 | 5,320,673 | 2,234,789,264 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10,434 | 4,780,181 | 0.22 | 55.84 | 582,661 | 266,937,257 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,335 | 39,924,226 | 0.01 | 55.87 | 186,336 | 2,230,686,279 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 365 | 4,769,747 | 0.01 | 55.87 | 20,394 | 266,500,074 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6,289 | 39,920,891 | 0.02 | 56.12 | 352,915 | 2,240,208,704 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 689 | 4,769,382 | 0.01 | 56.12 | 38,664 | 267,639,594 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 26,381 | 39,914,602 | 0.07 | 56.13 | 1,480,758 | 2,240,394,636 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,889 | 4,768,693 | 0.06 | 56.13 | 162,159 | 267,665,307 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 289,278 | 39,888,221 | 0.73 | 56.26 | 16,274,202 | 2,244,031,537 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 31,679 | 4,765,804 | 0.67 | 56.26 | 1,782,197 | 268,114,601 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,884 | 39,598,943 | 0.01 | 51.83 | 149,479 | 2,052,425,095 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 316 | 4,734,125 | 0.01 | 51.83 | 16,378 | 245,371,119 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,434 | 39,596,059 | 0.01 | 53.33 | 129,815 | 2,111,812,251 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 266 | 4,733,809 | 0.01 | 53.33 | 14,187 | 252,472,496 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 32,717 | 39,593,625 | 0.08 | 53.66 | 1,755,578 | 2,124,574,121 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,583 | 4,733,543 | 0.08 | 53.66 | 192,262 | 253,999,551 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 40,332 | 39,560,908 | 0.10 | 54.37 | 2,192,976 | 2,151,049,207 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,417 | 4,729,960 | 0.09 | 54.37 | 240,166 | 257,182,588 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 924 | 39,520,576 | 0.00 | 54.51 | 50,365 | 2,154,183,605 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 101 | 4,725,543 | 0.00 | 54.51 | 5,505 | 257,579,425 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,803 | 39,519,652 | 0.00 | 54.61 | 98,455 | 2,158,021,973 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 197 | 4,725,442 | 0.00 | 54.61 | 10,757 | 258,038,903 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 85,353 | 39,517,849 | 0.22 | 54.93 | 4,688,039 | 2,170,529,712 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9,347 | 4,725,245 | 0.20 | 54.93 | 513,387 | 259,535,499 | |
| 2016-10-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,928,596 | 9,309,333 | 45.90 | 2.00 | 5,857,192 | 18,618,666 | |
| 2016-10-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 321,404 | 1,003,781 | 47.10 | 2.00 | 642,808 | 2,007,562 | |
| 2016-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8,299 | 111,010 | 8.08 | 2.56 | 21,245 | 284,186 | |
| 2016-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8,299 | 111,010 | 8.08 | 2.56 | 21,245 | 284,186 | |
| 2016-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8,299 | 111,010 | 8.08 | 2.56 | 21,245 | 284,186 | |
| 2016-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 201 | 992,993 | 0.02 | 94.29 | 18,952 | 93,629,310 | |
| 2016-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 201 | 992,993 | 0.02 | 94.29 | 18,952 | 93,629,310 | |
| 2016-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 201 | 533,720 | 0.04 | 94.29 | 18,952 | 50,324,459 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1,362,695 | 0.05 | 28.92 | 19,955 | 39,409,139 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1,362,695 | 0.05 | 28.92 | 19,955 | 39,409,139 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1,362,695 | 0.05 | 28.92 | 19,955 | 39,409,139 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1,362,695 | 0.05 | 28.92 | 19,955 | 39,409,139 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1,362,695 | 0.05 | 28.92 | 19,955 | 39,409,139 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 319,313 | 0.22 | 28.92 | 19,955 | 9,234,532 | |
| 2016-09-21 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 12,550 | 1,131,625 | 1.12 | 13.15 | 165,029 | 14,880,529 | |
| 2016-09-21 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,476,348 | 9,404,467 | 35.74 | 12.25 | 30,335,263 | 115,204,721 | |
| 2016-09-21 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 294,707 | 1,119,075 | 35.75 | 12.25 | 3,610,161 | 13,708,669 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 24,339 | 39,432,496 | 0.06 | 51.55 | 1,254,571 | 2,032,575,609 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,730 | 4,715,898 | 0.06 | 51.55 | 140,720 | 243,084,264 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 58,541 | 39,408,157 | 0.15 | 51.41 | 3,009,341 | 2,025,803,896 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6,565 | 4,713,168 | 0.14 | 51.41 | 337,478 | 242,283,700 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 899 | 39,349,616 | 0.00 | 50.64 | 45,523 | 1,992,546,505 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 101 | 4,706,603 | 0.00 | 50.64 | 5,114 | 238,328,256 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21,804 | 39,348,717 | 0.06 | 50.42 | 1,099,388 | 1,984,017,399 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,445 | 4,706,502 | 0.05 | 50.42 | 123,280 | 237,308,420 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21,290 | 39,326,913 | 0.05 | 50.41 | 1,073,191 | 1,982,398,896 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,388 | 4,704,057 | 0.05 | 50.41 | 120,375 | 237,123,046 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 90 | 39,305,623 | 0.00 | 50.00 | 4,500 | 1,965,281,150 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10 | 4,701,669 | 0.00 | 50.00 | 500 | 235,083,450 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 899 | 39,305,533 | 0.00 | 49.84 | 44,802 | 1,958,791,237 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 101 | 4,701,659 | 0.00 | 49.84 | 5,033 | 234,307,176 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8,380 | 39,304,634 | 0.02 | 50.99 | 427,266 | 2,004,001,791 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 940 | 4,701,558 | 0.02 | 50.99 | 47,927 | 239,715,517 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,338 | 39,296,254 | 0.01 | 50.48 | 118,029 | 1,983,788,861 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 262 | 4,700,618 | 0.01 | 50.48 | 13,227 | 237,300,828 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33,241 | 39,293,916 | 0.08 | 51.25 | 1,703,751 | 2,013,990,018 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,728 | 4,700,356 | 0.08 | 51.25 | 191,077 | 240,914,397 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 23,440 | 39,260,675 | 0.06 | 50.33 | 1,179,656 | 1,975,856,286 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,637 | 4,696,628 | 0.06 | 50.33 | 132,711 | 236,365,319 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 170,652 | 39,237,235 | 0.44 | 50.38 | 8,597,226 | 1,976,720,891 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19,201 | 4,693,991 | 0.41 | 50.38 | 967,321 | 236,477,164 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7,944 | 39,066,583 | 0.02 | 51.05 | 405,541 | 1,994,349,062 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 894 | 4,674,790 | 0.02 | 51.05 | 45,639 | 238,648,030 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 28,271 | 39,058,639 | 0.07 | 50.55 | 1,428,963 | 1,974,226,720 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,181 | 4,673,896 | 0.07 | 50.55 | 160,784 | 236,243,008 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33,893 | 39,030,368 | 0.09 | 50.48 | 1,710,844 | 1,970,167,110 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,813 | 4,670,715 | 0.08 | 50.48 | 192,472 | 235,767,418 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 48,036 | 38,996,475 | 0.12 | 50.10 | 2,406,829 | 1,953,906,681 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,405 | 4,666,902 | 0.12 | 50.10 | 270,816 | 233,833,725 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 101,290 | 38,948,439 | 0.26 | 50.05 | 5,069,433 | 1,949,318,739 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11,397 | 4,661,497 | 0.25 | 50.05 | 570,405 | 233,301,865 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,581 | 38,847,149 | 0.01 | 49.46 | 276,030 | 1,921,337,258 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 628 | 4,650,100 | 0.01 | 49.46 | 31,060 | 229,988,831 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 944 | 38,841,568 | 0.00 | 49.18 | 46,427 | 1,910,267,156 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 106 | 4,649,472 | 0.00 | 49.18 | 5,213 | 228,665,682 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13,825 | 38,840,624 | 0.04 | 48.61 | 672,033 | 1,888,042,733 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,556 | 4,649,366 | 0.03 | 48.61 | 75,637 | 226,005,681 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 12,955 | 38,826,799 | 0.03 | 48.95 | 634,191 | 1,900,703,822 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,457 | 4,647,810 | 0.03 | 48.95 | 71,325 | 227,526,102 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 548 | 38,813,844 | 0.00 | 47.27 | 25,904 | 1,834,718,762 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 62 | 4,646,353 | 0.00 | 47.27 | 2,931 | 219,631,712 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11,681 | 38,813,296 | 0.03 | 48.16 | 562,550 | 1,869,225,047 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,314 | 4,646,291 | 0.03 | 48.16 | 63,281 | 223,762,587 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8,598 | 38,801,615 | 0.02 | 48.44 | 416,460 | 1,879,426,065 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 967 | 4,644,977 | 0.02 | 48.44 | 46,838 | 224,987,822 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,930 | 38,793,017 | 0.02 | 48.29 | 286,332 | 1,873,132,464 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 667 | 4,644,010 | 0.01 | 48.29 | 32,206 | 224,237,416 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 84,331 | 4,643,343 | 1.85 | 46.17 | 3,893,638 | 214,387,325 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,600 | 4,559,012 | 0.08 | 45.10 | 162,369 | 205,623,295 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 35,263 | 4,555,412 | 0.78 | 45.39 | 1,600,457 | 206,753,296 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8,360 | 4,520,149 | 0.19 | 46.10 | 385,414 | 208,388,813 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,735 | 4,511,789 | 0.06 | 44.98 | 123,025 | 202,948,842 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9,074 | 4,509,054 | 0.20 | 45.80 | 415,623 | 206,531,357 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -850 | 9,418,390 | -0.01 | 4.29 | -3,645 | 40,392,649 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -140 | 1,551,387 | -0.01 | 4.29 | -600 | 6,653,433 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -343,583 | 9,419,240 | -3.52 | 4.83 | -1,658,681 | 45,472,323 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -56,417 | 1,551,527 | -3.51 | 4.83 | -272,359 | 7,490,152 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -296,856 | 9,762,823 | -2.95 | 5.25 | -1,559,711 | 51,294,848 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -48,744 | 1,607,944 | -2.94 | 5.25 | -256,106 | 8,448,299 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -2,834,561 | 10,059,679 | -21.98 | 5.00 | -14,172,805 | 50,298,395 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -465,439 | 1,656,688 | -21.93 | 5.00 | -2,327,195 | 8,283,440 | |
| 2016-08-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 89,896 | 11,348,958 | 0.80 | 27.02 | 2,428,621 | 306,602,314 | |
| 2016-08-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 10,104 | 1,758,289 | 0.58 | 27.02 | 272,969 | 47,501,760 | |
| 2016-08-12 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,169,877 | 22,337,275 | 5.53 | 33.00 | 38,605,941 | 737,130,075 | |
| 2016-08-12 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 133,153 | 3,029,953 | 4.60 | 33.00 | 4,394,049 | 99,988,449 | |
| 2016-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13,038 | 102,711 | 14.54 | 1.63 | 21,252 | 167,419 | |
| 2016-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13,038 | 102,711 | 14.54 | 1.63 | 21,252 | 167,419 | |
| 2016-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13,038 | 102,711 | 14.54 | 1.63 | 21,252 | 167,419 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 13,937,394 | 0.01 | 26.74 | 19,948 | 372,685,916 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 13,937,394 | 0.01 | 26.74 | 19,948 | 372,685,916 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 1,362,005 | 0.05 | 26.74 | 19,948 | 36,420,014 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 1,362,005 | 0.05 | 26.74 | 19,948 | 36,420,014 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 318,623 | 0.23 | 26.74 | 19,948 | 8,519,979 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 318,623 | 0.23 | 26.74 | 19,948 | 8,519,979 | |
| 2016-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 237 | 23,803,844 | 0.00 | 79.98 | 18,955 | 1,903,831,443 | |
| 2016-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 237 | 533,519 | 0.04 | 79.98 | 18,955 | 42,670,850 | |
| 2016-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 237 | 533,519 | 0.04 | 79.98 | 18,955 | 42,670,850 | |
| 2016-06-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 70,000 | 70,000 | |||||
| 2016-06-13 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 26,500 | 26,500 | |||||
| 2016-06-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20,000 | 20,000 | |||||
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -2,318 | 30,003 | -7.17 | 9.56 | -22,157 | 286,787 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -158,684 | 2,122,417 | -6.96 | 9.56 | -1,516,797 | 20,287,335 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -9,056 | 116,778 | -7.20 | 9.56 | -86,563 | 1,116,234 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -5,111 | 32,321 | -13.65 | 9.40 | -48,043 | 303,817 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -349,919 | 2,281,101 | -13.30 | 9.40 | -3,289,239 | 21,442,349 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -19,970 | 125,834 | -13.70 | 9.40 | -187,718 | 1,182,840 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -2,154 | 37,432 | -5.44 | 9.21 | -19,844 | 344,839 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -147,529 | 2,631,020 | -5.31 | 9.21 | -1,359,096 | 24,238,009 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -8,417 | 145,804 | -5.46 | 9.21 | -77,541 | 1,343,205 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -4,201 | 39,586 | -9.59 | 9.44 | -39,648 | 373,605 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -275,506 | 2,778,549 | -9.02 | 9.44 | -2,600,171 | 26,223,390 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -16,493 | 154,221 | -9.66 | 9.44 | -155,658 | 1,455,507 | |
| 2016-05-31 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15,000 | 15,000 | |||||
| 2016-05-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9,260 | 9,260 | |||||
| 2016-05-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9,260 | 9,260 | |||||
| 2016-05-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,700 | 38,787,087 | 0.01 | 38.82 | 143,634 | 1,505,714,717 | |
| 2016-05-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,700 | 38,787,087 | 0.01 | 38.82 | 143,634 | 1,505,714,717 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 13,932,918 | 0.06 | 10.73 | 88,522 | 149,500,210 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 13,932,918 | 0.06 | 10.73 | 88,522 | 149,500,210 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 13,932,918 | 0.06 | 10.73 | 88,522 | 149,500,210 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 13,932,918 | 0.06 | 10.73 | 88,522 | 149,500,210 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 13,932,918 | 0.06 | 10.73 | 88,522 | 149,500,210 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 317,877 | 2.66 | 10.73 | 88,522 | 3,410,820 | |
| 2016-05-13 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 2,294 | 2,294 | |||||
| 2016-05-13 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 835 | 6,104,562 | 0.01 | ||||
| 2016-05-13 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 835 | 6,104,562 | 0.01 | ||||
| 2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Series B Preferred Stock |
C - Conversion | -1,232,130 | 0 | -100.00 | ||||
| 2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Series B Preferred Stock |
C - Conversion | -101,204 | 0 | -100.00 | ||||
| 2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Common Stock |
P - Purchase | 179,531 | 976,214 | 22.53 | 18.00 | 3,231,558 | 17,571,852 | |
| 2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Common Stock |
P - Purchase | 20,469 | 85,906 | 31.28 | 18.00 | 368,442 | 1,546,308 | |
| 2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Common Stock |
C - Conversion | 796,683 | 796,683 | |||||
| 2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Common Stock |
C - Conversion | 65,437 | 65,437 | |||||
| 2016-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 10,788 | 7,110,113 | 0.15 | 1.97 | 21,252 | 14,006,923 | |
| 2016-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 10,788 | 89,673 | 13.68 | 1.97 | 21,252 | 176,656 | |
| 2016-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 10,788 | 89,673 | 13.68 | 1.97 | 21,252 | 176,656 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 13,883,418 | 0.01 | 25.48 | 19,976 | 353,749,491 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 13,883,418 | 0.01 | 25.48 | 19,976 | 353,749,491 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 13,883,418 | 0.01 | 25.48 | 19,976 | 353,749,491 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 13,883,418 | 0.01 | 25.48 | 19,976 | 353,749,491 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 309,627 | 0.25 | 25.48 | 19,976 | 7,889,296 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 309,627 | 0.25 | 25.48 | 19,976 | 7,889,296 | |
| 2016-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 262 | 533,282 | 0.05 | 72.47 | 18,987 | 38,646,947 | |
| 2016-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 262 | 533,282 | 0.05 | 72.47 | 18,987 | 38,646,947 | |
| 2016-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 262 | 533,282 | 0.05 | 72.47 | 18,987 | 38,646,947 | |
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 137 | 3,268,830 | 0.00 | 6.74 | 923 | 22,031,914 | |
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -3,479 | 0 | -100.00 | ||||
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -310,003 | 0 | -100.00 | ||||
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -137 | 0 | -100.00 | ||||
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -137 | 0 | -100.00 | ||||
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 3,479 | 43,787 | 8.63 | 6.74 | 23,448 | 295,124 | |
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 310,003 | 3,054,055 | 11.30 | 6.74 | 2,089,420 | 20,584,331 | |
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 137 | 137 | 6.74 | 923 | 923 | ||
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 262,253 | 21,167,398 | 1.25 | 28.55 | 7,486,904 | 604,295,345 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 28,647 | 2,896,800 | 1.00 | 28.55 | 817,826 | 82,699,005 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 10,818 | 20,905,145 | 0.05 | 27.82 | 300,959 | 581,585,315 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,182 | 2,868,153 | 0.04 | 27.82 | 32,883 | 79,792,590 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 318,969 | 20,894,327 | 1.55 | 27.72 | 8,840,959 | 579,134,330 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 34,844 | 2,866,971 | 1.23 | 27.72 | 965,782 | 79,464,695 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 60,587 | 20,575,358 | 0.30 | 27.56 | 1,669,705 | 567,032,176 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 6,618 | 2,832,127 | 0.23 | 27.56 | 182,384 | 78,050,022 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 28,433 | 20,514,771 | 0.14 | 26.55 | 755,024 | 544,759,487 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,106 | 2,825,509 | 0.11 | 26.55 | 82,478 | 75,029,979 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 180,122 | 20,486,338 | 0.89 | 26.49 | 4,772,224 | 542,773,234 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 19,676 | 2,822,403 | 0.70 | 26.49 | 521,304 | 74,777,874 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 13,433 | 20,306,216 | 0.07 | 26.28 | 353,086 | 533,748,888 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,467 | 2,802,727 | 0.05 | 26.28 | 38,560 | 73,669,679 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 14,775 | 20,292,783 | 0.07 | 25.61 | 378,343 | 519,637,294 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,614 | 2,801,260 | 0.06 | 25.61 | 41,330 | 71,731,865 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 16,057 | 2,799,646 | 0.58 | 26.35 | 423,057 | 73,762,833 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 37,882 | 2,783,589 | 1.38 | 25.98 | 983,985 | 72,303,724 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 408,607 | 2,745,707 | 17.48 | 25.92 | 10,593,014 | 71,181,630 | |
| 2016-03-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 92,140 | 38,783,387 | 0.24 | 31.73 | 2,923,547 | 1,230,573,599 | |
| 2016-03-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10,034 | 4,496,280 | 0.22 | 31.73 | 318,373 | 142,664,267 | |
| 2016-03-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19,741 | 38,691,247 | 0.05 | 32.41 | 639,713 | 1,253,801,466 | |
| 2016-03-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,150 | 4,486,246 | 0.05 | 32.41 | 69,671 | 145,378,148 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 206,421,153 | 0.01 | 3.86 | 77,200 | 796,785,651 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 90,179 | 19,757,285 | 0.46 | 62.59 | 5,644,024 | 1,236,547,221 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 9,821 | 3,358,951 | 0.29 | 62.59 | 614,666 | 210,226,330 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 127,964 | 19,667,106 | 0.65 | 61.38 | 7,854,149 | 1,207,123,699 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 13,936 | 3,349,130 | 0.42 | 61.38 | 855,361 | 205,562,231 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 24,431 | 19,539,142 | 0.13 | 61.03 | 1,490,975 | 1,192,434,758 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2,660 | 3,335,194 | 0.08 | 61.03 | 162,334 | 203,540,219 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 20,659 | 19,514,711 | 0.11 | 60.95 | 1,259,178 | 1,189,433,344 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2,250 | 3,332,534 | 0.07 | 60.95 | 137,139 | 203,119,947 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 97,484 | 19,494,052 | 0.50 | 60.85 | 5,931,960 | 1,186,224,761 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 10,616 | 3,330,284 | 0.32 | 60.85 | 645,990 | 202,649,780 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 533,020 | 3.90 | 3.86 | 77,200 | 2,057,457 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 533,020 | 3.90 | 3.86 | 77,200 | 2,057,457 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1,182 | 19,376,568 | 0.01 | 65.29 | 77,176 | 1,265,142,628 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 129 | 3,299,668 | 0.00 | 65.29 | 8,423 | 215,443,243 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 179,176 | 19,375,386 | 0.93 | 65.80 | 11,789,387 | 1,274,857,773 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 19,513 | 3,299,539 | 0.59 | 65.80 | 1,283,912 | 217,102,407 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 180,358 | 19,196,210 | 0.95 | 67.15 | 12,110,607 | 1,288,979,431 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 19,642 | 3,280,026 | 0.60 | 67.15 | 1,318,913 | 220,245,874 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 198,484 | 38,671,506 | 0.52 | 31.60 | 6,272,531 | 1,222,104,667 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21,616 | 4,484,096 | 0.48 | 31.60 | 683,113 | 141,707,299 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 32,810 | 38,473,022 | 0.09 | 31.86 | 1,045,205 | 1,225,608,131 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,573 | 4,462,480 | 0.08 | 31.86 | 113,823 | 142,158,102 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8,627 | 38,440,212 | 0.02 | 31.50 | 271,712 | 1,210,693,697 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 940 | 4,458,907 | 0.02 | 31.50 | 29,606 | 140,435,505 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 273,381 | 38,431,585 | 0.72 | 31.89 | 8,719,077 | 1,225,717,756 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 29,772 | 4,457,967 | 0.67 | 31.89 | 949,533 | 142,180,171 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 145,272 | 38,158,204 | 0.38 | 31.74 | 4,611,296 | 1,211,236,790 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 15,821 | 4,428,195 | 0.36 | 31.74 | 502,198 | 140,561,980 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 63,560 | 38,012,932 | 0.17 | 31.50 | 2,002,401 | 1,197,563,211 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6,922 | 4,412,374 | 0.16 | 31.50 | 218,071 | 139,007,872 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 387,336 | 37,949,372 | 1.03 | 32.31 | 12,514,051 | 1,226,068,311 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 42,182 | 4,405,452 | 0.97 | 32.31 | 1,362,816 | 142,331,343 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 107,260 | 37,562,036 | 0.29 | 33.77 | 3,622,063 | 1,268,432,394 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11,681 | 4,363,270 | 0.27 | 33.77 | 394,456 | 147,343,265 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 128,975 | 6,928,119 | 1.90 | 8.16 | 1,051,920 | 56,505,739 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 14,046 | 824,368 | 1.73 | 8.16 | 114,559 | 6,723,545 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 185,413 | 6,799,144 | 2.80 | 7.91 | 1,466,320 | 53,770,350 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 20,192 | 810,322 | 2.56 | 7.91 | 159,686 | 6,408,351 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 11,840 | 6,613,731 | 0.18 | 7.70 | 91,160 | 50,921,099 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,289 | 790,130 | 0.16 | 7.70 | 9,924 | 6,083,448 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 68,132 | 6,601,891 | 1.04 | 8.03 | 546,807 | 52,984,797 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 7,420 | 788,841 | 0.95 | 8.03 | 59,551 | 6,331,001 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 30,986 | 6,533,759 | 0.48 | 7.88 | 244,126 | 51,476,874 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3,374 | 781,421 | 0.43 | 7.88 | 26,582 | 6,156,503 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,874 | 37,454,776 | 0.01 | 32.34 | 157,646 | 1,211,448,511 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 547 | 4,351,589 | 0.01 | 32.34 | 17,692 | 140,749,100 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 147,831 | 37,449,902 | 0.40 | 33.15 | 4,900,997 | 1,241,565,366 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 16,608 | 4,351,042 | 0.38 | 33.15 | 550,600 | 144,248,790 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 23,289 | 37,302,071 | 0.06 | 32.96 | 767,582 | 1,229,438,958 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,616 | 4,334,434 | 0.06 | 32.96 | 86,221 | 142,858,610 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 95,682 | 37,278,782 | 0.26 | 32.41 | 3,100,652 | 1,208,048,754 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10,749 | 4,331,818 | 0.25 | 32.41 | 348,330 | 140,376,028 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 165,237 | 37,183,100 | 0.45 | 32.30 | 5,337,915 | 1,201,185,172 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 18,563 | 4,321,069 | 0.43 | 32.30 | 599,670 | 139,590,406 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 36,589 | 37,017,863 | 0.10 | 31.15 | 1,139,842 | 1,153,202,679 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,111 | 4,302,506 | 0.10 | 31.15 | 128,068 | 134,034,248 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 97,272 | 36,981,274 | 0.26 | 32.12 | 3,124,484 | 1,187,879,200 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10,927 | 4,298,395 | 0.25 | 32.12 | 350,987 | 138,069,176 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 53,734 | 36,884,002 | 0.15 | 32.47 | 1,744,598 | 1,197,523,958 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6,037 | 4,287,468 | 0.14 | 32.47 | 196,005 | 139,202,510 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 286,671,473 | 0.00 | 4.18 | 41,800 | 1,198,286,757 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 88,732 | 36,830,268 | 0.24 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9,968 | 4,281,431 | 0.23 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 48,996 | 36,741,536 | 0.13 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,504 | 4,271,463 | 0.13 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 36,692,540 | 0.03 | 4.18 | 41,800 | 153,374,817 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 14,157 | 36,682,540 | 0.04 | 33.72 | 477,445 | 1,237,118,662 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,590 | 4,255,959 | 0.04 | 33.72 | 53,623 | 143,532,217 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 40,921 | 36,668,383 | 0.11 | 33.68 | 1,378,043 | 1,234,833,465 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,597 | 4,254,369 | 0.11 | 33.68 | 154,807 | 143,268,854 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 218,550 | 36,627,462 | 0.60 | 32.49 | 7,101,280 | 1,190,125,135 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 23,908 | 4,249,772 | 0.57 | 32.49 | 776,835 | 138,086,567 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 41,104 | 36,408,912 | 0.11 | 31.68 | 1,302,257 | 1,153,507,150 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,496 | 4,225,864 | 0.11 | 31.68 | 142,442 | 133,883,823 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 59,492 | 36,367,808 | 0.16 | 32.24 | 1,918,022 | 1,172,498,130 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6,508 | 4,221,368 | 0.15 | 32.24 | 209,818 | 136,096,904 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 301,066 | 36,308,316 | 0.84 | 32.76 | 9,862,139 | 1,189,366,031 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 32,934 | 4,214,860 | 0.79 | 32.76 | 1,078,832 | 138,067,855 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21,814 | 36,007,250 | 0.06 | 31.24 | 681,563 | 1,125,021,321 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,386 | 4,181,926 | 0.06 | 31.24 | 74,549 | 130,661,351 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 172,462 | 35,985,436 | 0.48 | 30.34 | 5,232,928 | 1,091,888,092 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 18,866 | 4,179,540 | 0.45 | 30.34 | 572,442 | 126,817,692 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 54,439 | 35,812,974 | 0.15 | 30.55 | 1,663,024 | 1,094,029,055 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,955 | 4,160,674 | 0.14 | 30.55 | 181,916 | 127,101,934 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 6,022 | 19,015,852 | 0.03 | 74.00 | 445,628 | 1,407,173,048 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 678 | 3,260,384 | 0.02 | 74.00 | 50,172 | 241,268,416 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 20,492 | 19,009,830 | 0.11 | 69.70 | 1,428,282 | 1,324,975,646 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2,308 | 3,259,706 | 0.07 | 69.70 | 160,866 | 227,199,878 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 23,157 | 18,989,338 | 0.12 | 70.50 | 1,632,684 | 1,338,843,276 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2,608 | 3,257,398 | 0.08 | 70.50 | 183,877 | 229,662,846 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 8,111 | 18,966,181 | 0.04 | 71.96 | 583,702 | 1,364,886,043 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 914 | 3,254,790 | 0.03 | 71.96 | 65,775 | 234,228,359 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 39,815 | 35,758,535 | 0.11 | 30.13 | 1,199,793 | 1,077,554,845 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,485 | 4,154,719 | 0.11 | 30.13 | 135,152 | 125,199,133 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 128,255 | 35,718,720 | 0.36 | 29.86 | 3,830,118 | 1,066,678,851 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 14,447 | 4,150,234 | 0.35 | 29.86 | 431,435 | 123,939,683 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 67,407 | 35,590,465 | 0.19 | 28.52 | 1,922,670 | 1,015,157,510 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7,593 | 4,135,787 | 0.18 | 28.52 | 216,577 | 117,966,293 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,134 | 35,523,058 | 0.01 | 28.46 | 117,674 | 1,011,163,846 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 466 | 4,128,194 | 0.01 | 28.46 | 13,265 | 117,509,042 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 43,056 | 35,518,924 | 0.12 | 29.77 | 1,281,975 | 1,057,561,755 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,850 | 4,127,728 | 0.12 | 29.77 | 144,407 | 122,901,450 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 218,768 | 35,475,868 | 0.62 | 30.21 | 6,610,053 | 1,071,899,804 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 24,643 | 4,122,878 | 0.60 | 30.21 | 744,586 | 124,572,346 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 456,849 | 35,257,100 | 1.31 | 29.20 | 13,339,991 | 1,029,507,320 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49,677 | 4,098,235 | 1.23 | 29.20 | 1,450,568 | 119,668,462 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 226,865 | 34,800,251 | 0.66 | 29.94 | 6,791,816 | 1,041,839,474 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 24,669 | 4,048,558 | 0.61 | 29.94 | 738,533 | 121,204,515 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 726,291 | 34,573,386 | 2.15 | 31.25 | 22,694,197 | 1,080,304,220 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 78,976 | 4,023,889 | 2.00 | 31.25 | 2,467,739 | 125,733,252 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 902 | 33,847,095 | 0.00 | 29.50 | 26,609 | 998,489,302 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 98 | 3,944,913 | 0.00 | 29.50 | 2,891 | 116,374,934 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 106,444 | 33,846,193 | 0.32 | 29.19 | 3,107,590 | 988,126,066 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11,575 | 3,944,815 | 0.29 | 29.19 | 337,927 | 115,167,296 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 151,144 | 33,739,749 | 0.45 | 30.27 | 4,574,645 | 1,021,194,235 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 16,435 | 3,933,240 | 0.42 | 30.27 | 497,435 | 119,046,588 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 631 | 33,588,605 | 0.00 | 27.93 | 17,626 | 938,227,145 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 69 | 3,916,805 | 0.00 | 27.93 | 1,927 | 109,407,722 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 72,073 | 33,587,974 | 0.22 | 27.28 | 1,966,043 | 916,229,549 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7,909 | 3,916,736 | 0.20 | 27.28 | 215,746 | 106,842,683 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 87,049 | 33,515,901 | 0.26 | 28.07 | 2,443,831 | 940,932,108 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9,551 | 3,908,827 | 0.24 | 28.07 | 268,137 | 109,737,191 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 15,187 | 18,958,070 | 0.08 | 69.45 | 1,054,742 | 1,316,643,649 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1,651 | 3,253,876 | 0.05 | 69.45 | 114,662 | 225,982,664 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 8,250 | 18,942,883 | 0.04 | 70.86 | 584,597 | 1,342,296,478 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 897 | 3,252,225 | 0.03 | 70.86 | 63,562 | 230,453,314 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 67,373 | 18,934,633 | 0.36 | 69.54 | 4,684,923 | 1,316,659,468 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7,326 | 3,251,328 | 0.23 | 69.54 | 509,429 | 226,087,920 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 124,057 | 18,867,260 | 0.66 | 70.21 | 8,710,228 | 1,324,698,625 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 13,490 | 3,244,002 | 0.42 | 70.21 | 947,153 | 227,766,246 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 397,079 | 18,743,203 | 2.16 | 71.10 | 28,233,945 | 1,332,718,580 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 43,178 | 3,230,512 | 1.35 | 71.10 | 3,070,133 | 229,702,648 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 149,927 | 18,346,124 | 0.82 | 67.94 | 10,186,595 | 1,246,503,545 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 16,450 | 3,187,334 | 0.52 | 67.94 | 1,117,674 | 216,559,265 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 38,117 | 18,196,197 | 0.21 | 63.98 | 2,438,547 | 1,164,107,162 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 4,183 | 3,170,884 | 0.13 | 63.98 | 267,609 | 202,858,255 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 168,055 | 18,158,080 | 0.93 | 64.87 | 10,902,350 | 1,177,981,834 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 18,441 | 3,166,701 | 0.59 | 64.87 | 1,196,336 | 205,435,611 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 541,340 | 17,990,025 | 3.10 | 65.80 | 35,621,958 | 1,183,803,012 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 59,401 | 3,148,260 | 1.92 | 65.80 | 3,908,782 | 207,165,897 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 49,021 | 17,448,685 | 0.28 | 66.68 | 3,268,823 | 1,163,514,958 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 5,379 | 3,088,859 | 0.17 | 66.68 | 358,683 | 205,971,605 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 72,894 | 17,399,664 | 0.42 | 67.68 | 4,933,706 | 1,177,666,678 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7,999 | 3,083,480 | 0.26 | 67.68 | 541,399 | 208,700,102 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 6,939 | 17,326,770 | 0.04 | 60.85 | 422,220 | 1,054,288,905 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 761 | 3,075,481 | 0.02 | 60.85 | 46,305 | 187,135,023 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 57,865 | 17,319,831 | 0.34 | 61.73 | 3,572,047 | 1,069,165,292 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 6,349 | 3,074,720 | 0.21 | 61.73 | 391,928 | 189,804,618 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 136,793 | 17,261,966 | 0.80 | 58.13 | 7,952,133 | 1,003,482,965 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 15,010 | 3,068,371 | 0.49 | 58.13 | 872,570 | 178,372,384 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 114,908 | 17,125,173 | 0.68 | 59.01 | 6,780,526 | 1,010,527,346 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 12,609 | 3,053,361 | 0.41 | 59.01 | 744,036 | 180,173,642 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 65,309 | 17,010,265 | 0.39 | 60.40 | 3,944,513 | 1,027,380,882 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7,166 | 3,040,752 | 0.24 | 60.40 | 432,810 | 183,654,427 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 113,546 | 16,944,956 | 0.67 | 61.40 | 6,971,475 | 1,040,383,019 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 12,459 | 3,033,586 | 0.41 | 61.40 | 764,955 | 186,255,507 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 289,755 | 16,831,410 | 1.75 | 62.56 | 18,126,986 | 1,052,967,960 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 31,795 | 3,021,127 | 1.06 | 62.56 | 1,989,086 | 189,000,799 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 176,647 | 16,541,655 | 1.08 | 63.37 | 11,194,368 | 1,048,267,836 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 19,383 | 2,989,332 | 0.65 | 63.37 | 1,228,328 | 189,438,154 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 235,734 | 16,365,008 | 1.46 | 64.46 | 15,195,814 | 1,054,916,236 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 25,869 | 2,969,949 | 0.88 | 64.46 | 1,667,560 | 191,447,961 | |
| 2016-02-09 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 45,000 | 12,894,240 | 0.35 | 6.33 | 284,656 | 81,565,094 | |
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary stock warrant (right to buy) |
X - Other | -56,853 | 0 | -100.00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary stock warrant (right to buy) |
X - Other | -2,296,890 | 0 | -100.00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary stock warrant (right to buy) |
X - Other | -238,850 | 0 | -100.00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A-2 Preferred shares |
C - Conversion | -26,292,961 | 0 | -100.00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A-2 Preferred shares |
C - Conversion | -1,912,167 | 0 | -100.00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A Preferred shares |
C - Conversion | -582,747 | 0 | -100.00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A Preferred shares |
C - Conversion | -44,572,171 | 0 | -100.00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A Preferred shares |
C - Conversion | -4,382,118 | 0 | -100.00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 1,723,306 | 1,723,306 | 24.00 | 41,359,344 | 41,359,344 | ||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 189,374 | 189,374 | 24.00 | 4,544,976 | 4,544,976 | ||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
X - Other | 56,853 | 639,600 | 9.76 | 0.68 | 38,376 | 431,730 | |
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
X - Other | 2,296,890 | 73,162,022 | 3.24 | 0.68 | 1,550,401 | 49,384,365 | |
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
X - Other | 238,850 | 6,533,135 | 3.79 | 0.68 | 161,224 | 4,409,866 | |
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 26,292,961 | 70,865,132 | 58.99 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 1,912,167 | 6,294,285 | 43.64 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 582,747 | 582,747 | |||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 44,572,171 | 44,572,171 | |||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 4,382,118 | 4,382,118 | |||||
| 2016-02-04 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24,800 | 12,849,240 | 0.19 | 6.65 | 164,915 | 85,444,876 | |
| 2016-02-04 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 91,187 | 12,824,440 | 0.72 | 6.29 | 573,311 | 80,629,819 | |
| 2016-02-04 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 91,728 | 12,733,253 | 0.73 | 6.52 | 598,360 | 83,061,556 | |
| 2016-01-29 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 25,000 | 12,641,525 | 0.20 | 6.88 | 172,015 | 86,981,277 | |
| 2016-01-29 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 63,345 | 12,616,525 | 0.50 | 6.98 | 441,971 | 88,028,018 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3,581 | 6,502,773 | 0.06 | 11.00 | 39,377 | 71,504,492 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 395 | 778,047 | 0.05 | 11.00 | 4,343 | 8,555,405 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 66,345 | 6,499,192 | 1.03 | 10.80 | 716,745 | 70,212,721 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 7,318 | 777,652 | 0.95 | 10.80 | 79,059 | 8,401,208 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,522 | 6,432,847 | 0.04 | 11.20 | 28,257 | 72,075,548 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 278 | 770,334 | 0.04 | 11.20 | 3,115 | 8,631,053 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 4,503 | 6,430,325 | 0.07 | 10.98 | 49,423 | 70,576,032 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 497 | 770,056 | 0.06 | 10.98 | 5,455 | 8,451,750 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,833 | 6,425,822 | 0.04 | 11.23 | 31,822 | 72,178,688 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 312 | 769,559 | 0.04 | 11.23 | 3,505 | 8,644,148 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 25,650 | 6,422,989 | 0.40 | 10.69 | 274,219 | 68,666,891 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,810 | 769,247 | 0.37 | 10.69 | 30,041 | 8,223,866 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 156 | 6,397,339 | 0.00 | 10.60 | 1,654 | 67,811,793 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 17 | 766,437 | 0.00 | 10.60 | 180 | 8,124,232 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 4,021 | 6,397,183 | 0.06 | 10.69 | 42,999 | 68,409,556 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 440 | 766,420 | 0.06 | 10.69 | 4,705 | 8,195,866 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 17,221 | 6,393,162 | 0.27 | 10.78 | 185,666 | 68,927,237 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,887 | 765,980 | 0.25 | 10.78 | 20,345 | 8,258,337 | |
| 2016-01-25 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,200 | 12,553,180 | 0.03 | 7.00 | 22,389 | 87,829,579 | |
| 2016-01-25 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 103,600 | 12,549,980 | 0.83 | 7.29 | 755,368 | 91,504,414 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,734 | 6,375,941 | 0.03 | 8.90 | 15,433 | 56,745,875 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 190 | 764,093 | 0.02 | 8.90 | 1,691 | 6,800,428 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 27,996 | 6,374,207 | 0.44 | 8.96 | 250,766 | 57,095,047 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3,067 | 763,903 | 0.40 | 8.96 | 27,472 | 6,842,432 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 13,789 | 6,346,211 | 0.22 | 8.96 | 123,493 | 56,836,031 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,511 | 760,836 | 0.20 | 8.96 | 13,532 | 6,813,971 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 57,453 | 6,332,422 | 0.92 | 9.89 | 567,934 | 62,597,258 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 6,294 | 759,325 | 0.84 | 9.89 | 62,217 | 7,506,079 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 14,313 | 6,274,969 | 0.23 | 9.15 | 131,017 | 57,439,184 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,568 | 753,031 | 0.21 | 9.15 | 14,353 | 6,893,020 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 10,123 | 6,260,656 | 0.16 | 9.21 | 93,282 | 57,691,319 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,109 | 751,463 | 0.15 | 9.21 | 10,219 | 6,924,656 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 45,903 | 6,250,533 | 0.74 | 9.08 | 416,602 | 56,727,962 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5,029 | 750,354 | 0.67 | 9.08 | 45,642 | 6,809,988 | |
| 2016-01-20 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Comon Stock |
P - Purchase | 1,325 | 12,446,380 | 0.01 | 6.94 | 9,197 | 86,396,547 | |
| 2016-01-20 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Comon Stock |
P - Purchase | 51,370 | 12,445,055 | 0.41 | 6.87 | 352,974 | 85,512,462 | |
| 2016-01-20 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 92,200 | 12,393,685 | 0.75 | 7.12 | 656,750 | 88,281,458 | |
| 2016-01-20 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 25,000 | 12,301,485 | 0.20 | 7.49 | 187,332 | 92,178,718 | |
| 2016-01-20 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 175,000 | 12,276,485 | 1.45 | 7.45 | 1,303,890 | 91,469,634 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 47,193 | 6,204,630 | 0.77 | 8.56 | 403,930 | 53,106,049 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5,196 | 745,325 | 0.70 | 8.56 | 44,473 | 6,379,311 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 4,949 | 6,157,437 | 0.08 | 8.95 | 44,308 | 55,126,918 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 545 | 740,129 | 0.07 | 8.95 | 4,879 | 6,626,301 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3,279 | 6,152,488 | 0.05 | 8.82 | 28,937 | 54,295,091 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 361 | 739,584 | 0.05 | 8.82 | 3,186 | 6,526,755 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 20,851 | 6,149,209 | 0.34 | 8.10 | 168,891 | 49,807,978 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,296 | 739,223 | 0.31 | 8.10 | 18,597 | 5,987,632 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,998 | 6,128,358 | 0.05 | 8.08 | 24,213 | 49,495,071 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 330 | 736,927 | 0.04 | 8.08 | 2,665 | 5,951,717 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 12,706 | 6,125,360 | 0.21 | 7.91 | 100,517 | 48,457,723 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,399 | 736,597 | 0.19 | 7.91 | 11,067 | 5,827,219 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 90,550 | 6,112,654 | 1.50 | 8.17 | 739,947 | 49,950,775 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 9,970 | 735,198 | 1.37 | 8.17 | 81,472 | 6,007,817 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 47,193 | 6,204,630 | 0.77 | 8.56 | 403,930 | 53,106,049 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5,196 | 745,325 | 0.70 | 8.56 | 44,473 | 6,379,311 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 4,949 | 6,157,437 | 0.08 | 8.95 | 44,308 | 55,126,918 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 545 | 740,129 | 0.07 | 8.95 | 4,879 | 6,626,301 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3,279 | 6,152,488 | 0.05 | 8.82 | 28,937 | 54,295,091 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 361 | 739,584 | 0.05 | 8.82 | 3,186 | 6,526,755 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 20,851 | 6,149,209 | 0.34 | 8.10 | 168,891 | 49,807,978 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,296 | 739,223 | 0.31 | 8.10 | 18,597 | 5,987,632 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,998 | 6,128,358 | 0.05 | 8.08 | 24,213 | 49,495,071 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 330 | 736,927 | 0.04 | 8.08 | 2,665 | 5,951,717 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 12,706 | 6,125,360 | 0.21 | 7.91 | 100,517 | 48,457,723 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,399 | 736,597 | 0.19 | 7.91 | 11,067 | 5,827,219 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 90,550 | 6,112,654 | 1.50 | 8.17 | 739,947 | 49,950,775 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 9,970 | 735,198 | 1.37 | 8.17 | 81,472 | 6,007,817 | |
| 2016-01-08 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,801,161 | 20,278,008 | 9.75 | 29.00 | 52,233,669 | 588,062,232 | |
| 2016-01-08 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 785,045 | 2,337,100 | 50.58 | 29.00 | 22,766,305 | 67,775,900 | |
| 2016-01-08 |
|
4/A | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,801,161 | 20,278,008 | 9.75 | 29.00 | 52,233,669 | 588,062,232 | |
| 2016-01-08 |
|
4/A | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 785,045 | 2,337,100 | 50.58 | 29.00 | 22,766,305 | 67,775,900 | |
| 2016-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 7,082 | 78,885 | 9.86 | 3.00 | 21,246 | 236,655 | |
| 2016-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 7,082 | 78,885 | 9.86 | 3.00 | 21,246 | 236,655 | |
| 2016-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 7,082 | 6,348,612 | 0.11 | 3.00 | 21,246 | 19,045,836 | |
| 2016-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 175 | 513,020 | 0.03 | 108.45 | 18,979 | 55,637,019 | |
| 2016-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 175 | 513,020 | 0.03 | 108.45 | 18,979 | 55,637,019 | |
| 2016-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 175 | 666,111 | 0.03 | 108.45 | 18,979 | 72,239,738 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 308,843 | 0.18 | 35.20 | 19,994 | 10,871,274 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 308,843 | 0.18 | 35.20 | 19,994 | 10,871,274 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 482,740 | 0.12 | 35.20 | 19,994 | 16,992,448 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 11,423,179 | 0.00 | 35.20 | 19,994 | 402,095,901 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 196,132 | 0.29 | 35.20 | 19,994 | 6,903,846 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 356,791 | 0.16 | 35.20 | 19,994 | 12,559,043 | |
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
5,284,918 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
9,241,559 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
4,936,111 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
5,284,918 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
9,241,559 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
4,936,111 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
5,284,918 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
9,241,559 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
4,936,111 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
5,284,918 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
9,241,559 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
4,936,111 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
5,284,918 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
9,241,559 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
4,936,111 | ||||||||
| 2015-12-15 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 15,000 | 15,000 | |||||
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 150,000 | 33,428,852 | 0.45 | 44.00 | 6,600,000 | 1,470,869,488 | |
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 31,647 | 33,278,852 | 0.10 | 43.87 | 1,388,259 | 1,459,843,401 | |
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 57,461 | 33,247,205 | 0.17 | 43.93 | 2,524,015 | 1,460,406,753 | |
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 75,612 | 33,189,744 | 0.23 | 43.93 | 3,321,363 | 1,457,905,971 | |
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,000 | 33,114,132 | 0.01 | 43.00 | 172,000 | 1,423,907,676 | |
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10,638 | 33,110,132 | 0.03 | 43.84 | 466,321 | 1,451,395,880 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9,400 | 33,099,494 | 0.03 | 44.00 | 413,600 | 1,456,377,736 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 800 | 33,090,094 | 0.00 | 43.00 | 34,400 | 1,422,874,042 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 407,800 | 33,089,294 | 1.25 | 43.71 | 17,823,388 | 1,446,207,301 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 98,700 | 32,681,494 | 0.30 | 44.00 | 4,342,800 | 1,437,985,736 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 196,490 | 32,582,794 | 0.61 | 41.31 | 8,117,179 | 1,346,024,545 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 221,434 | 32,386,304 | 0.69 | 42.51 | 9,412,318 | 1,376,618,715 | |
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
16,392,657 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
26,372,015 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
16,392,657 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
26,372,015 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
16,392,657 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
26,372,015 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
16,392,657 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
26,372,015 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
16,392,657 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
26,372,015 | ||||||||
| 2015-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6,945 | 71,803 | 10.71 | 3.06 | 21,252 | 219,717 | |
| 2015-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6,945 | 71,803 | 10.71 | 3.06 | 21,252 | 219,717 | |
| 2015-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6,945 | 71,803 | 10.71 | 3.06 | 21,252 | 219,717 | |
| 2015-10-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 172 | 512,845 | 0.03 | 110.33 | 18,977 | 56,582,189 | |
| 2015-10-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 172 | 972,118 | 0.02 | 110.33 | 18,977 | 107,253,779 | |
| 2015-10-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 172 | 16,282,190 | 0.00 | 110.33 | 18,977 | 1,796,414,023 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 308,275 | 0.30 | 21.34 | 19,974 | 6,578,588 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 308,275 | 0.30 | 21.34 | 19,974 | 6,578,588 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 11,422,611 | 0.01 | 21.34 | 19,974 | 243,758,519 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 1,911,734 | 0.05 | 21.34 | 19,974 | 40,796,404 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 195,564 | 0.48 | 21.34 | 19,974 | 4,173,336 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 356,223 | 0.26 | 21.34 | 19,974 | 7,601,799 | |
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -892,000 | 0 | -100.00 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -31,967,000 | 0 | -100.00 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -7,587,000 | 0 | -100.00 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -65,000 | 0 | -100.00 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -64,000 | 0 | -100.00 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 101,652 | 512,673 | 24.73 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 3,642,962 | 16,128,927 | 29.18 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 864,614 | 2,943,733 | 41.59 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 7,406 | 61,049 | 13.81 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 7,292 | 58,632 | 14.20 | ||||
| 2015-09-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
J - Other | 137 | 137 | |||||
| 2015-09-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
J - Other | 137 | 137 | |||||
| 2015-09-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
J - Other | -274 | 0 | -100.00 | ||||
| 2015-09-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 139,220 | 2,744,052 | 5.34 | 45.00 | 6,264,900 | 123,482,340 | |
| 2015-09-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 10,780 | 170,714 | 6.74 | 45.00 | 485,100 | 7,682,130 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 346,000 | 32,164,870 | 1.09 | 48.44 | 16,761,728 | 1,558,204,612 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 50,000 | 31,818,870 | 0.16 | 47.40 | 2,370,000 | 1,508,214,438 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 160,453 | 31,768,870 | 0.51 | 48.60 | 7,798,690 | 1,544,100,511 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33,320 | 31,608,417 | 0.11 | 47.98 | 1,598,614 | 1,516,495,987 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 14,386 | 31,575,097 | 0.05 | 47.54 | 683,847 | 1,500,941,181 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,600 | 31,560,711 | 0.01 | 47.24 | 75,577 | 1,490,798,589 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 20,500 | 31,559,111 | 0.06 | 46.31 | 949,351 | 1,461,496,119 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,950 | 31,538,611 | 0.01 | 44.68 | 87,130 | 1,409,201,909 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 89,843 | 31,536,661 | 0.29 | 45.28 | 4,067,696 | 1,427,841,249 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 212,983 | 31,446,818 | 0.68 | 46.81 | 9,969,500 | 1,471,990,959 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9,818 | 31,233,835 | 0.03 | 46.74 | 458,905 | 1,459,906,929 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,331 | 31,224,017 | 0.01 | 45.63 | 106,368 | 1,424,814,344 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,513 | 31,221,686 | 0.01 | 45.43 | 159,601 | 1,418,448,028 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13,897 | 31,218,173 | 0.04 | 45.00 | 625,359 | 1,404,805,298 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 40,649 | 31,204,276 | 0.13 | 42.14 | 1,713,148 | 1,315,101,092 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8,063 | 31,163,627 | 0.03 | 44.40 | 357,971 | 1,383,565,315 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 15,391 | 31,155,564 | 0.05 | 40.67 | 625,950 | 1,267,093,672 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 191,321 | 31,140,173 | 0.62 | 41.06 | 7,856,214 | 1,278,708,924 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 88,640 | 30,948,852 | 0.29 | 42.44 | 3,761,802 | 1,313,441,425 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 183,073 | 30,860,212 | 0.60 | 43.28 | 7,923,253 | 1,335,605,287 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 274,814 | 30,677,139 | 0.90 | 44.63 | 12,265,553 | 1,369,188,203 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,100 | 30,402,325 | 0.01 | 40.55 | 125,706 | 1,232,823,399 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11,300 | 30,399,225 | 0.04 | 41.13 | 464,823 | 1,250,466,041 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 43,612 | 30,387,925 | 0.14 | 43.60 | 1,901,322 | 1,324,801,095 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,338,927 | 30,344,313 | 12.36 | 41.00 | 136,896,007 | 1,244,116,833 | |
| 2015-09-11 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,213,469 | 6,022,104 | 58.12 | 15.50 | 34,308,770 | 93,342,612 | |
| 2015-09-11 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 266,563 | 725,228 | 58.12 | 15.50 | 4,131,726 | 11,241,034 | |
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
7,220,154 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
12,371,376 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
6,628,338 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
7,220,154 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
12,371,376 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
6,628,338 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
7,220,154 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
12,371,376 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
6,628,338 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
7,220,154 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
12,371,376 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
6,628,338 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
7,220,154 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
12,371,376 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
6,628,338 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4,725,965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8,075,935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4,725,965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8,075,935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4,725,965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8,075,935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4,725,965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8,075,935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4,725,965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8,075,935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4,725,965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8,075,935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4,725,965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8,075,935 | ||||||||
| 2015-08-10 | 3/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
2,260 | ||||||||
| 2015-08-10 | 3/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
2,260 | ||||||||
| 2015-07-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 2,329 | 2,329 | |||||
| 2015-07-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 696 | 6,103,727 | 0.01 | ||||
| 2015-07-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 696 | 6,103,727 | 0.01 | ||||
| 2015-07-23 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -229,436 | 90,538 | -71.70 | 1.09 | -250,659 | 98,913 | |
| 2015-07-23 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -9,411,311 | 3,153,539 | -74.90 | 1.09 | -10,281,857 | 3,445,241 | |
| 2015-07-23 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -1,359,253 | 467,436 | -74.41 | 1.09 | -1,484,984 | 510,674 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 307,339 | 0.24 | 27.34 | 19,958 | 8,402,648 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 1,350,721 | 0.05 | 27.34 | 19,958 | 36,928,712 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 481,236 | 0.15 | 27.34 | 19,958 | 13,156,992 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 11,421,675 | 0.01 | 27.34 | 19,958 | 312,268,594 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 194,628 | 0.38 | 27.34 | 19,958 | 5,321,130 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 355,287 | 0.21 | 27.34 | 19,958 | 9,713,547 | |
| 2015-07-06 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 182 | 826,200 | 0.02 | 104.21 | 18,966 | 86,098,302 | |
| 2015-07-06 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 182 | 411,021 | 0.04 | 104.21 | 18,966 | 42,832,498 | |
| 2015-07-06 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 182 | 549,414 | 0.03 | 104.21 | 18,966 | 57,254,433 | |
| 2015-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5,260 | 64,858 | 8.83 | 3.66 | 19,252 | 237,380 | |
| 2015-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5,260 | 64,858 | 8.83 | 3.66 | 19,252 | 237,380 | |
| 2015-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5,260 | 64,858 | 8.83 | 3.66 | 19,252 | 237,380 | |
| 2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 6,103,033 | 6,103,033 | |||||
| 2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 506,166 | 506,166 | |||||
| 2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 94,412 | 94,412 | |||||
| 2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 66,154 | 66,154 | |||||
| 2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 65,811 | 65,811 | |||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,250 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,250 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,250 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,500 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,500 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,500 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -3,000 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -3,000 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -15,000 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7,500 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7,500 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7,500 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,250 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,750 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,750 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,750 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -9,184,771 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12,250 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12,250 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12,250 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12,250 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12,250 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -680,187 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -143,462 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -200,526 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7,500 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7,500 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7,500 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -15,000 | 0 | -100.00 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 21,196 | 100,523 | 26.72 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -211,614 | 12,250 | -94.53 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 497 | 79,327 | 0.63 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -100,490 | 12,250 | -89.13 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 40,449 | 78,830 | 105.39 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -1,068,128 | 680,187 | -61.09 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 5,543 | 38,381 | 16.88 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -55,479 | 12,250 | -81.91 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 12,500 | 32,838 | 61.46 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -165,213 | 12,250 | -93.10 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 19,318 | 20,338 | 1,893.92 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -206,800 | 12,250 | -94.41 | ||||
| 2015-06-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12,500 | 12,500 | |||||
| 2015-06-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20,000 | 20,000 | |||||
| 2015-06-10 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 70,000 | 70,000 | |||||
| 2015-05-27 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15,000 | 15,000 | |||||
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 198,802 | 27,005,386 | 0.74 | 43.27 | 8,602,242 | 1,168,533,854 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 57,202 | 26,816,266 | 0.21 | 43.29 | 2,476,343 | 1,160,908,335 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 16,300 | 26,759,064 | 0.06 | 43.67 | 711,775 | 1,168,493,400 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 90,155 | 26,742,764 | 0.34 | 43.62 | 3,932,723 | 1,166,567,503 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 150,000 | 26,652,609 | 0.57 | 42.93 | 6,439,500 | 1,144,196,504 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9,200 | 26,492,927 | 0.03 | 40.95 | 376,718 | 1,084,821,778 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 52,381 | 26,483,727 | 0.20 | 41.54 | 2,176,038 | 1,100,200,229 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 139,683 | 26,431,346 | 0.53 | 42.68 | 5,961,908 | 1,128,134,781 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 13,352 | 26,291,663 | 0.05 | 42.97 | 573,749 | 1,129,779,051 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 2,300 | 26,278,311 | 0.01 | 42.15 | 96,949 | 1,107,675,482 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7,382 | 26,276,011 | 0.03 | 41.24 | 304,410 | 1,083,538,610 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,500 | 26,268,629 | 0.02 | 41.07 | 184,815 | 1,078,852,593 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 89,100 | 26,264,129 | 0.34 | 40.57 | 3,614,475 | 1,065,443,789 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 120,529 | 26,175,029 | 0.46 | 41.09 | 4,951,958 | 1,075,406,301 | |
| 2015-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9,260 | 9,260 | |||||
| 2015-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9,260 | 9,260 | |||||
| 2015-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,700 | 26,054,500 | 0.01 | 39.94 | 147,778 | 1,040,616,730 | |
| 2015-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,700 | 26,054,500 | 0.01 | 39.94 | 147,778 | 1,040,616,730 | |
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 410,839 | 5.12 | 7.68 | 153,600 | 3,155,244 | |
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 410,839 | 5.12 | 7.68 | 153,600 | 3,155,244 | |
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 410,839 | 5.12 | 7.68 | 153,600 | 3,155,244 | |
| 2015-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2015-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2015-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 26,050,800 | 0.04 | 5.11 | 51,100 | 133,119,588 | |
| 2015-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 26,050,800 | 0.04 | 5.11 | 51,100 | 133,119,588 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,100 | 26,040,800 | 0.00 | 37.07 | 40,777 | 965,332,456 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 46,617 | 26,039,700 | 0.18 | 37.15 | 1,732,013 | 967,481,618 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8,334 | 25,993,083 | 0.03 | 35.85 | 298,745 | 931,761,050 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 129,118 | 25,984,749 | 0.50 | 36.40 | 4,700,515 | 945,969,590 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 137,800 | 25,855,631 | 0.54 | 36.25 | 4,995,250 | 937,266,624 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 155,731 | 25,717,831 | 0.61 | 36.67 | 5,710,048 | 942,972,563 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 23,012 | 25,562,100 | 0.09 | 35.91 | 826,437 | 918,019,366 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 354,300 | 25,539,088 | 1.41 | 34.76 | 12,315,078 | 887,710,606 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 59,973 | 25,184,788 | 0.24 | 34.61 | 2,075,833 | 871,716,030 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,330 | 25,124,815 | 0.02 | 33.99 | 147,177 | 853,992,462 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 90,397 | 25,120,485 | 0.36 | 34.56 | 3,123,949 | 868,116,233 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21,952 | 25,030,088 | 0.09 | 34.52 | 757,888 | 864,158,782 | |
| 2015-04-02 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5,470 | 59,598 | 10.11 | 3.52 | 19,254 | 209,785 | |
| 2015-04-02 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5,470 | 59,598 | 10.11 | 3.52 | 19,254 | 209,785 | |
| 2015-04-02 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5,470 | 59,598 | 10.11 | 3.52 | 19,254 | 209,785 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 306,609 | 0.21 | 30.43 | 19,962 | 9,330,112 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 1,349,991 | 0.05 | 30.43 | 19,962 | 41,080,226 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 1,349,991 | 0.05 | 30.43 | 19,962 | 41,080,226 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 1,349,991 | 0.05 | 30.43 | 19,962 | 41,080,226 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 1,349,991 | 0.05 | 30.43 | 19,962 | 41,080,226 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 306,609 | 0.21 | 30.43 | 19,962 | 9,330,112 | |
| 2015-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,880 | 25,008,136 | 0.01 | 34.72 | 99,986 | 868,217,461 | |
| 2015-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6,439 | 25,005,256 | 0.03 | 34.47 | 221,935 | 861,863,660 | |
| 2015-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 158,771 | 24,998,817 | 0.64 | 34.69 | 5,507,401 | 867,151,464 | |
| 2015-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 116,946 | 24,840,046 | 0.47 | 34.62 | 4,049,208 | 860,076,657 | |
| 2015-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19,600 | 24,723,100 | 0.08 | 34.82 | 682,537 | 860,939,928 | |
| 2015-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,021 | 24,703,500 | 0.02 | 34.79 | 139,882 | 859,380,417 | |
| 2015-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 213,820 | 24,699,479 | 0.87 | 34.76 | 7,432,169 | 858,529,191 | |
| 2015-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 211,400 | 24,485,659 | 0.87 | 34.92 | 7,382,532 | 855,090,632 | |
| 2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,000 | 24,274,259 | 0.00 | 35.60 | 35,595 | 864,042,249 | |
| 2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 62,650 | 24,273,259 | 0.26 | 34.46 | 2,159,163 | 836,551,171 | |
| 2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 163,054 | 24,210,609 | 0.68 | 33.80 | 5,510,818 | 818,258,058 | |
| 2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,995 | 24,047,555 | 0.02 | 33.60 | 167,830 | 807,985,824 | |
| 2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49,416 | 24,042,560 | 0.21 | 33.65 | 1,662,843 | 809,029,740 | |
| 2015-02-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,898,409 | 6,323,855 | 343.64 | 3.75 | 18,369,034 | 23,714,456 | |
| 2015-02-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 434,924 | 625,495 | 228.22 | 3.75 | 1,630,965 | 2,345,606 | |
| 2015-02-02 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 390,935 | 2,604,832 | 17.66 | 20.00 | 7,818,700 | 52,096,640 | |
| 2015-02-02 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 34,065 | 159,934 | 27.06 | 20.00 | 681,300 | 3,198,680 | |
| 2015-01-09 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 1,000,000 | 9,184,771 | 12.22 | 94.19 | 94,190,000 | 865,113,580 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -21,441 | 345,074 | -5.85 | 3.86 | -82,762 | 1,331,986 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -859,988 | 12,589,950 | -6.39 | 3.86 | -3,319,554 | 48,597,207 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -118,571 | 1,851,789 | -6.02 | 3.86 | -457,684 | 7,147,906 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -21,548 | 366,515 | -5.55 | 3.81 | -82,130 | 1,396,972 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -863,100 | 13,449,938 | -6.03 | 3.81 | -3,289,706 | 51,264,439 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -118,652 | 1,970,360 | -5.68 | 3.81 | -452,242 | 7,510,027 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -4,554 | 388,063 | -1.16 | 3.55 | -16,184 | 1,379,059 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -182,454 | 14,313,038 | -1.26 | 3.55 | -648,387 | 50,864,243 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -25,092 | 2,089,012 | -1.19 | 3.55 | -89,169 | 7,423,722 | |
| 2015-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3,927 | 54,128 | 7.82 | 4.90 | 19,242 | 265,227 | |
| 2015-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3,927 | 54,128 | 7.82 | 4.90 | 19,242 | 265,227 | |
| 2015-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3,927 | 1,425,446 | 0.28 | 4.90 | 19,242 | 6,984,685 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 305,953 | 0.20 | 31.97 | 19,949 | 9,781,317 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 1,349,335 | 0.05 | 31.97 | 19,949 | 43,138,240 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 11,420,289 | 0.01 | 31.97 | 19,949 | 365,106,639 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 1,909,412 | 0.03 | 31.97 | 19,949 | 61,043,902 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 193,242 | 0.32 | 31.97 | 19,949 | 6,177,947 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 353,901 | 0.18 | 31.97 | 19,949 | 11,314,215 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -8,415 | 392,617 | -2.10 | 3.65 | -30,711 | 1,432,856 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -337,123 | 14,495,492 | -2.27 | 3.65 | -1,230,330 | 52,901,298 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -46,362 | 2,114,104 | -2.15 | 3.65 | -169,198 | 7,715,423 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -4,746 | 401,032 | -1.17 | 3.68 | -17,447 | 1,474,274 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -190,117 | 14,832,615 | -1.27 | 3.68 | -698,908 | 54,527,659 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -26,137 | 2,160,466 | -1.20 | 3.68 | -96,085 | 7,942,305 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -2,825 | 405,778 | -0.69 | 3.71 | -10,482 | 1,505,680 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -112,855 | 15,022,732 | -0.75 | 3.71 | -418,760 | 55,743,349 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -15,420 | 2,186,603 | -0.70 | 3.71 | -57,217 | 8,113,609 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -16,182 | 408,603 | -3.81 | 4.21 | -68,102 | 1,719,606 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -647,781 | 15,135,587 | -4.10 | 4.21 | -2,726,186 | 63,698,118 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -88,937 | 2,202,023 | -3.88 | 4.21 | -374,291 | 9,267,214 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -3,558 | 424,785 | -0.83 | 4.29 | -15,260 | 1,821,903 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -142,543 | 15,783,368 | -0.90 | 4.29 | -611,367 | 67,694,865 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -19,599 | 2,290,960 | -0.85 | 4.29 | -84,060 | 9,825,927 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -14,753 | 428,343 | -3.33 | 4.31 | -63,571 | 1,845,730 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -590,638 | 15,925,911 | -3.58 | 4.31 | -2,545,059 | 68,624,750 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -81,109 | 2,310,559 | -3.39 | 4.31 | -349,499 | 9,956,199 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,900 | 23,993,144 | 0.02 | 31.97 | 124,679 | 767,036,821 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 500 | 23,989,244 | 0.00 | 30.80 | 15,400 | 738,868,715 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49,685 | 23,988,744 | 0.21 | 31.82 | 1,581,096 | 763,379,407 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,855,894 | 23,939,059 | 8.40 | 31.94 | 59,276,698 | 764,606,363 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 597,000 | 22,083,165 | 2.78 | 31.75 | 18,954,631 | 701,136,072 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 305,532 | 21,486,165 | 1.44 | 31.68 | 9,680,415 | 680,763,355 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 70,867 | 21,180,633 | 0.34 | 31.41 | 2,226,244 | 665,376,877 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -6,874 | 443,096 | -1.53 | 4.27 | -29,358 | 1,892,419 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -274,734 | 16,516,549 | -1.64 | 4.27 | -1,173,361 | 70,540,529 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -37,592 | 2,391,668 | -1.55 | 4.27 | -160,552 | 10,214,575 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -9,908 | 449,970 | -2.15 | 4.45 | -44,093 | 2,002,456 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -396,496 | 16,791,283 | -2.31 | 4.45 | -1,764,486 | 74,724,568 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -54,396 | 2,429,260 | -2.19 | 4.45 | -242,073 | 10,810,693 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -5,457 | 459,878 | -1.17 | 4.71 | -25,724 | 2,167,865 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -218,383 | 17,187,779 | -1.25 | 4.71 | -1,029,457 | 81,023,190 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -29,960 | 2,483,656 | -1.19 | 4.71 | -141,231 | 11,707,954 | |
| 2014-12-10 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -8,429 | 465,335 | -1.78 | 4.62 | -38,907 | 2,147,940 | |
| 2014-12-10 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -337,541 | 17,406,162 | -1.90 | 4.62 | -1,558,056 | 80,345,103 | |
| 2014-12-10 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -46,383 | 2,513,616 | -1.81 | 4.62 | -214,099 | 11,602,600 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 100,000 | 21,109,766 | 0.48 | 34.95 | 3,495,000 | 737,786,322 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 354,000 | 21,009,766 | 1.71 | 34.27 | 12,131,651 | 720,008,883 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 14,772 | 20,655,766 | 0.07 | 34.53 | 510,114 | 713,295,239 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 185,378 | 20,640,994 | 0.91 | 34.33 | 6,364,935 | 708,706,465 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 30,507 | 107,504 | 39.62 | ||||
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 30,507 | 3,993,087 | 0.77 | ||||
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | -399,208 | 0 | -100.00 | ||||
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,500 | 20,455,616 | 0.03 | 33.90 | 186,438 | 693,400,380 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 80,430 | 20,450,116 | 0.39 | 34.64 | 2,786,393 | 708,467,684 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 42,500 | 20,369,686 | 0.21 | 33.28 | 1,414,515 | 677,958,148 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 185,528 | 20,327,186 | 0.92 | 33.31 | 6,180,420 | 677,151,416 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 216,284 | 20,141,658 | 1.09 | 32.56 | 7,043,267 | 655,911,079 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 38,614 | 19,925,374 | 0.19 | 33.00 | 1,274,254 | 657,533,357 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 24,890 | 19,886,760 | 0.13 | 33.06 | 822,744 | 657,360,829 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -28,086 | 473,764 | -5.60 | 4.55 | -127,671 | 2,153,589 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -1,122,584 | 17,743,703 | -5.95 | 4.55 | -5,102,930 | 80,657,551 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -153,618 | 2,559,999 | -5.66 | 4.55 | -698,301 | 11,636,987 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -11,965 | 501,850 | -2.33 | 4.84 | -57,913 | 2,429,054 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -486,800 | 18,866,287 | -2.52 | 4.84 | -2,356,209 | 91,316,602 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -69,153 | 2,713,617 | -2.49 | 4.84 | -334,714 | 13,134,449 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -10,534 | 513,815 | -2.01 | 5.36 | -56,453 | 2,753,586 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -428,583 | 19,353,087 | -2.17 | 5.36 | -2,296,819 | 103,715,129 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -60,883 | 2,782,770 | -2.14 | 5.36 | -326,278 | 14,913,143 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 98,076 | 19,861,870 | 0.50 | 36.57 | 3,586,737 | 726,368,448 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10,639 | 19,763,794 | 0.05 | 36.75 | 390,999 | 726,349,075 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 69,397 | 19,753,155 | 0.35 | 35.88 | 2,490,291 | 708,836,041 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 63,137 | 19,683,758 | 0.32 | 36.74 | 2,319,502 | 723,134,028 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25,505 | 19,620,621 | 0.13 | 35.91 | 915,851 | 704,550,993 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 22,839 | 19,595,116 | 0.12 | 35.55 | 811,963 | 696,637,726 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13,116 | 19,572,277 | 0.07 | 35.56 | 466,413 | 696,001,913 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 17,098 | 19,559,161 | 0.09 | 34.91 | 596,816 | 682,724,250 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 104,140 | 19,542,063 | 0.54 | 35.98 | 3,746,947 | 703,121,473 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 29,006 | 19,437,923 | 0.15 | 35.28 | 1,023,471 | 685,863,225 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13,500 | 19,408,917 | 0.07 | 34.26 | 462,530 | 664,978,610 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25,769 | 19,395,417 | 0.13 | 34.58 | 890,989 | 670,615,938 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 866,669 | 19,369,648 | 4.68 | 33.79 | 29,287,172 | 654,554,641 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,394 | 18,502,979 | 0.02 | 33.71 | 148,139 | 623,807,584 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 38,166 | 18,498,585 | 0.21 | 34.83 | 1,329,390 | 644,339,013 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 252,474 | 18,460,419 | 1.39 | 34.41 | 8,686,949 | 635,173,175 | |
| 2014-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8,914 | 50,201 | 21.59 | 2.16 | 19,254 | 108,434 | |
| 2014-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8,914 | 50,201 | 21.59 | 2.16 | 19,254 | 108,434 | |
| 2014-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8,914 | 1,421,519 | 0.63 | 2.16 | 19,254 | 3,070,481 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 305,329 | 0.23 | 28.54 | 19,978 | 8,714,090 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 305,329 | 0.23 | 28.54 | 19,978 | 8,714,090 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 1,348,711 | 0.05 | 28.54 | 19,978 | 38,492,212 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 11,419,665 | 0.01 | 28.54 | 19,978 | 325,917,239 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 192,618 | 0.36 | 28.54 | 19,978 | 5,497,318 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 353,277 | 0.20 | 28.54 | 19,978 | 10,082,526 | |
| 2014-09-16 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 7,000 | 7,000 | |||||
| 2014-09-16 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 5,500 | 524,349 | 1.06 | ||||
| 2014-09-16 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 5,500 | 524,349 | 1.06 | ||||
| 2014-09-16 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 5,500 | 524,349 | 1.06 | ||||
| 2014-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6,182 | 41,287 | 17.61 | 2.83 | 17,495 | 116,842 | |
| 2014-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6,182 | 41,287 | 17.61 | 2.83 | 17,495 | 116,842 | |
| 2014-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6,182 | 1,412,605 | 0.44 | 2.83 | 17,495 | 3,997,672 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 304,629 | 0.24 | 27.86 | 19,948 | 8,486,964 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 1,348,011 | 0.05 | 27.86 | 19,948 | 37,555,586 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 11,418,965 | 0.01 | 27.86 | 19,948 | 318,132,365 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 1,908,088 | 0.04 | 27.86 | 19,948 | 53,159,332 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 191,918 | 0.37 | 27.86 | 19,948 | 5,346,835 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 352,577 | 0.20 | 27.86 | 19,948 | 9,822,795 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 670 | 416,208 | 0.16 | 39.80 | 26,668 | 16,566,494 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 27,046 | 18,207,945 | 0.15 | 39.80 | 1,076,523 | 724,738,118 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,471 | 415,538 | 0.36 | 39.93 | 58,731 | 16,590,770 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 59,400 | 18,180,899 | 0.33 | 39.93 | 2,371,604 | 725,890,573 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,938 | 414,067 | 0.47 | 39.99 | 77,503 | 16,559,036 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 78,262 | 18,121,499 | 0.43 | 39.99 | 3,129,791 | 724,700,491 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,155 | 412,129 | 0.28 | 39.84 | 46,021 | 16,421,239 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 46,653 | 18,043,237 | 0.26 | 39.84 | 1,858,884 | 718,930,974 | |
| 2014-06-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 70,000 | 70,000 | |||||
| 2014-06-10 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12,500 | 12,500 | |||||
| 2014-06-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20,000 | 20,000 | |||||
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,534 | 410,974 | 1.36 | 38.96 | 215,578 | 16,009,574 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 223,466 | 17,996,584 | 1.26 | 38.96 | 8,705,163 | 701,060,529 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 534 | 405,440 | 0.13 | 38.56 | 20,591 | 15,633,847 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21,559 | 17,773,118 | 0.12 | 38.56 | 831,319 | 685,334,985 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 477 | 404,906 | 0.12 | 37.52 | 17,895 | 15,190,413 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19,223 | 17,751,559 | 0.11 | 37.52 | 721,168 | 665,965,712 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,757 | 404,429 | 0.94 | 37.40 | 140,504 | 15,124,795 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 151,530 | 17,732,336 | 0.86 | 37.40 | 5,666,904 | 663,152,128 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,411 | 400,672 | 0.61 | 37.67 | 90,826 | 15,093,995 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 97,254 | 17,580,806 | 0.56 | 37.67 | 3,663,724 | 662,298,849 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 496 | 398,261 | 0.12 | 37.63 | 18,667 | 14,988,274 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 20,011 | 17,483,552 | 0.11 | 37.63 | 753,100 | 657,981,241 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,534 | 397,765 | 0.39 | 36.04 | 55,281 | 14,334,377 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 61,878 | 17,463,541 | 0.36 | 36.04 | 2,229,916 | 629,338,866 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 572 | 396,231 | 0.14 | 36.39 | 20,817 | 14,419,995 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 23,058 | 17,401,663 | 0.13 | 36.39 | 839,147 | 633,296,981 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19 | 395,659 | 0.00 | 35.27 | 670 | 13,956,001 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 781 | 17,378,605 | 0.00 | 35.27 | 27,548 | 612,992,058 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,137 | 395,640 | 0.54 | 34.38 | 73,479 | 13,603,725 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 86,201 | 17,377,824 | 0.50 | 34.38 | 2,963,944 | 597,520,838 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 270 | 393,503 | 0.07 | 35.11 | 9,481 | 13,817,386 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10,896 | 17,291,623 | 0.06 | 35.11 | 382,600 | 607,174,592 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,809 | 393,233 | 0.46 | 34.05 | 61,604 | 13,391,196 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 72,980 | 17,280,727 | 0.42 | 34.05 | 2,485,268 | 588,479,605 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 480 | 391,424 | 0.12 | 34.21 | 16,421 | 13,391,046 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19,348 | 17,207,747 | 0.11 | 34.21 | 661,916 | 588,695,953 | |
| 2014-05-29 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15,000 | 15,000 | |||||
| 2014-05-27 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 11,600 | 11,600 | |||||
| 2014-05-27 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8,400 | 518,849 | 1.65 | ||||
| 2014-05-27 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8,400 | 518,849 | 1.65 | ||||
| 2014-05-27 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8,400 | 518,849 | 1.65 | ||||
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10,000 | 390,839 | 2.63 | 7.02 | 70,200 | 2,743,690 | |
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10,000 | 390,839 | 2.63 | 7.02 | 70,200 | 2,743,690 | |
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10,000 | 390,839 | 2.63 | 7.02 | 70,200 | 2,743,690 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 8,750 | 8,750 | |||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 8,750 | 8,750 | |||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 8,750 | 8,750 | |||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,151 | 390,944 | 0.30 | 34.08 | 39,232 | 13,325,287 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 46,460 | 17,188,399 | 0.27 | 34.08 | 1,583,584 | 585,864,861 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,921 | 389,793 | 0.76 | 34.03 | 99,415 | 13,266,449 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 117,879 | 17,141,939 | 0.69 | 34.03 | 4,011,965 | 583,419,037 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,500 | 386,872 | 0.91 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,500 | 386,872 | 0.91 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,500 | 17,178,061 | 0.02 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 505 | 383,372 | 0.13 | 34.26 | 17,304 | 13,136,012 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 20,395 | 17,020,560 | 0.12 | 34.26 | 698,822 | 583,199,276 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7 | 382,867 | 0.00 | 34.10 | 239 | 13,055,765 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 293 | 17,000,165 | 0.00 | 34.10 | 9,991 | 579,705,626 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 382,860 | 2.68 | 7.26 | 72,600 | 2,779,564 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 382,860 | 2.68 | 7.26 | 72,600 | 2,779,564 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 382,860 | 2.68 | 7.26 | 72,600 | 2,779,564 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 746 | 372,860 | 0.20 | 34.60 | 25,815 | 12,902,522 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 30,122 | 16,989,872 | 0.18 | 34.60 | 1,042,348 | 587,920,929 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 740 | 372,114 | 0.20 | 33.73 | 24,964 | 12,553,191 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 29,865 | 16,959,750 | 0.18 | 33.73 | 1,007,490 | 572,133,774 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,069 | 371,374 | 0.29 | 34.31 | 36,673 | 12,740,319 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 43,131 | 16,929,885 | 0.26 | 34.31 | 1,479,648 | 580,794,942 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 783 | 370,305 | 0.21 | 33.92 | 26,559 | 12,560,486 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 31,617 | 16,886,754 | 0.19 | 33.92 | 1,072,427 | 572,786,875 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 329 | 369,522 | 0.09 | 34.74 | 11,430 | 12,837,564 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13,271 | 16,855,137 | 0.08 | 34.74 | 461,048 | 585,564,315 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,933 | 369,193 | 0.80 | 33.77 | 99,060 | 12,469,235 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 118,389 | 16,841,866 | 0.71 | 33.77 | 3,998,506 | 568,822,235 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 839 | 366,260 | 0.23 | 33.72 | 28,295 | 12,352,009 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33,868 | 16,723,477 | 0.20 | 34.72 | 1,176,056 | 580,717,722 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,534 | 365,421 | 0.42 | 33.98 | 52,118 | 12,415,252 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 61,892 | 16,689,609 | 0.37 | 33.98 | 2,102,793 | 567,032,804 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 623 | 363,887 | 0.17 | 34.01 | 21,190 | 12,376,779 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25,156 | 16,627,717 | 0.15 | 34.01 | 855,623 | 565,553,550 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,228 | 363,264 | 0.34 | 33.40 | 41,020 | 12,134,580 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49,553 | 16,602,561 | 0.30 | 33.40 | 1,655,283 | 554,596,928 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 984 | 362,036 | 0.27 | 33.54 | 33,007 | 12,143,991 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 39,710 | 16,553,008 | 0.24 | 33.54 | 1,332,016 | 555,247,479 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 746 | 372,860 | 0.20 | 34.60 | 25,815 | 12,902,522 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 30,122 | 16,989,872 | 0.18 | 34.60 | 1,042,348 | 587,920,929 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 740 | 372,114 | 0.20 | 33.73 | 24,964 | 12,553,191 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 29,865 | 16,959,750 | 0.18 | 33.73 | 1,007,490 | 572,133,774 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,069 | 371,374 | 0.29 | 34.31 | 36,673 | 12,740,319 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 43,131 | 16,929,885 | 0.26 | 34.31 | 1,479,648 | 580,794,942 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 783 | 370,305 | 0.21 | 33.92 | 26,559 | 12,560,486 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 31,617 | 16,886,754 | 0.19 | 33.92 | 1,072,427 | 572,786,875 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 329 | 369,522 | 0.09 | 34.74 | 11,430 | 12,837,564 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13,271 | 16,855,137 | 0.08 | 34.74 | 461,048 | 585,564,315 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,933 | 369,193 | 0.80 | 33.77 | 99,060 | 12,469,235 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 118,389 | 16,841,866 | 0.71 | 33.77 | 3,998,506 | 568,822,235 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 839 | 366,260 | 0.23 | 33.72 | 28,295 | 12,352,009 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33,868 | 16,723,477 | 0.20 | 34.72 | 1,176,056 | 580,717,722 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,534 | 365,421 | 0.42 | 33.98 | 52,118 | 12,415,252 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 61,892 | 16,689,609 | 0.37 | 33.98 | 2,102,793 | 567,032,804 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 623 | 363,887 | 0.17 | 34.01 | 21,190 | 12,376,779 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25,156 | 16,627,717 | 0.15 | 34.01 | 855,623 | 565,553,550 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,228 | 363,264 | 0.34 | 33.40 | 41,020 | 12,134,580 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49,553 | 16,602,561 | 0.30 | 33.40 | 1,655,283 | 554,596,928 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 984 | 362,036 | 0.27 | 33.54 | 33,007 | 12,143,991 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 39,710 | 16,553,008 | 0.24 | 33.54 | 1,332,016 | 555,247,479 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 303,913 | 0.25 | 26.57 | 19,981 | 8,074,968 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 303,913 | 0.25 | 26.57 | 19,981 | 8,074,968 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 1,347,295 | 0.06 | 26.57 | 19,981 | 35,797,628 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 11,418,249 | 0.01 | 26.57 | 19,981 | 303,382,876 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 1,907,372 | 0.04 | 26.57 | 19,981 | 50,678,874 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 191,202 | 0.39 | 26.57 | 19,981 | 5,080,237 | |
| 2014-03-19 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 80,000 | 80,000 | |||||
| 2014-03-12 |
|
4 | IDP |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 60,000 | 60,000 | |||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,784,624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3,019,499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,648,181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,784,624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3,019,499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,648,181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,784,624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3,019,499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,648,181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,784,624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3,019,499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,648,181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,784,624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3,019,499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,648,181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,784,624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3,019,499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,648,181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,784,624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3,019,499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,648,181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,784,624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3,019,499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,648,181 | ||||||||
| 2014-03-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 11,738 | 452,540 | 2.66 | 28.50 | 334,533 | 12,897,390 | |
| 2014-03-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 475,644 | 18,476,847 | 2.64 | 28.50 | 13,555,854 | 526,590,140 | |
| 2014-03-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 38,934 | 1,552,055 | 2.57 | 28.50 | 1,109,619 | 44,233,568 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 303,161 | 0.23 | 29.27 | 19,962 | 8,873,522 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 303,161 | 0.23 | 29.27 | 19,962 | 8,873,522 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 11,243,600 | 0.01 | 29.27 | 19,962 | 329,100,172 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 1,732,723 | 0.04 | 29.27 | 19,962 | 50,716,802 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 16,553 | 4.30 | 29.27 | 19,962 | 484,506 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 177,212 | 0.39 | 29.27 | 19,962 | 5,186,995 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 639 | 361,052 | 0.18 | 39.91 | 25,504 | 14,410,344 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25,596 | 16,513,298 | 0.16 | 39.91 | 1,021,590 | 659,080,401 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,280 | 360,413 | 0.36 | 39.92 | 51,100 | 14,388,372 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 51,244 | 16,487,702 | 0.31 | 39.92 | 2,045,758 | 658,220,390 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,063 | 359,133 | 0.30 | 39.65 | 42,153 | 14,241,383 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 42,646 | 16,436,458 | 0.26 | 39.65 | 1,691,123 | 651,786,098 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,486 | 358,070 | 0.70 | 39.70 | 98,694 | 14,215,379 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 99,775 | 16,393,812 | 0.61 | 39.70 | 3,961,068 | 650,834,336 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,377 | 355,584 | 0.39 | 39.54 | 54,442 | 14,058,725 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 55,256 | 16,294,037 | 0.34 | 39.54 | 2,184,656 | 644,217,341 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,056 | 354,207 | 0.87 | 39.53 | 120,798 | 14,001,201 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 122,660 | 16,238,781 | 0.76 | 39.53 | 4,848,541 | 641,891,407 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,492 | 351,151 | 1.59 | 43.98 | 241,512 | 15,441,935 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 219,958 | 16,116,121 | 1.38 | 43.98 | 9,672,697 | 708,709,644 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 553 | 345,659 | 0.16 | 44.00 | 24,332 | 15,208,823 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 22,147 | 15,896,163 | 0.14 | 44.00 | 974,457 | 699,423,224 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,863 | 345,106 | 0.84 | 44.05 | 126,102 | 15,200,366 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 114,663 | 15,874,016 | 0.73 | 44.05 | 5,050,389 | 699,178,972 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 170 | 342,243 | 0.05 | 43.42 | 7,382 | 14,861,800 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6,814 | 15,759,353 | 0.04 | 43.42 | 295,896 | 684,345,176 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,512 | 342,073 | 0.74 | 42.95 | 107,883 | 14,691,043 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 100,626 | 15,752,539 | 0.64 | 42.95 | 4,321,595 | 676,525,868 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 340 | 339,561 | 0.10 | 43.72 | 14,864 | 14,845,233 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13,632 | 15,651,913 | 0.09 | 43.72 | 595,976 | 684,284,419 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,011 | 339,221 | 0.30 | 43.01 | 43,479 | 14,588,403 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 40,471 | 15,638,281 | 0.26 | 43.01 | 1,740,480 | 672,533,657 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,818 | 338,210 | 0.54 | 43.20 | 78,547 | 14,612,329 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 72,807 | 15,597,810 | 0.47 | 43.20 | 3,145,619 | 673,901,821 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 455 | 336,392 | 0.14 | 43.64 | 19,858 | 14,681,829 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 18,232 | 15,525,003 | 0.12 | 43.64 | 795,736 | 677,588,756 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 290 | 335,937 | 0.09 | 42.65 | 12,369 | 14,328,721 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11,617 | 15,506,771 | 0.07 | 42.65 | 495,500 | 661,410,303 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,551 | 335,647 | 1.07 | 42.56 | 151,129 | 14,284,968 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 142,220 | 15,495,154 | 0.93 | 42.56 | 6,052,812 | 659,466,007 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,632 | 332,096 | 0.80 | 42.41 | 111,631 | 14,085,188 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 105,414 | 15,352,934 | 0.69 | 42.41 | 4,470,924 | 651,163,990 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,816 | 329,464 | 0.86 | 42.31 | 119,144 | 13,939,556 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 112,797 | 15,247,520 | 0.75 | 42.31 | 4,772,419 | 645,119,522 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -127,000 | 892,000 | -12.46 | 432.60 | -54,940,390 | 385,880,538 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -4,567,000 | 31,967,000 | -12.50 | 432.60 | -1,975,691,050 | 13,828,972,150 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -1,084,000 | 7,587,000 | -12.50 | 432.60 | -468,940,026 | 3,282,147,580 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -2,459,000 | 1,019,000 | -70.70 | 425.88 | -1,047,233,756 | 433,969,580 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -88,153,000 | 36,534,000 | -70.70 | 425.88 | -37,542,414,519 | 15,559,023,199 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -20,922,000 | 8,671,000 | -70.70 | 425.88 | -8,910,217,424 | 3,692,787,271 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 170,000 | 6,050,000 | 2.89 | 104.52 | 17,768,043 | 632,333,295 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 6,830,000 | 243,450,000 | 2.89 | 104.52 | 713,857,257 | 25,444,882,755 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 242,000 | 5,880,000 | 4.29 | 104.25 | 25,228,500 | 612,990,000 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 9,758,000 | 236,620,000 | 4.30 | 104.25 | 1,017,271,500 | 24,667,635,000 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 61,000 | 5,638,000 | 1.09 | 103.75 | 6,328,750 | 584,942,500 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 2,439,000 | 226,862,000 | 1.09 | 103.75 | 253,046,250 | 23,536,932,500 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 121,000 | 5,577,000 | 2.22 | 104.75 | 12,674,750 | 584,190,750 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 4,879,000 | 224,423,000 | 2.22 | 104.75 | 511,075,250 | 23,508,309,250 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 5,456,000 | 5,456,000 | 100.00 | 545,600,000 | 545,600,000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 5,456,000 | 5,456,000 | 100.00 | 545,600,000 | 545,600,000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 219,544,000 | 219,544,000 | 100.00 | 21,954,400,000 | 21,954,400,000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 219,544,000 | 219,544,000 | 100.00 | 21,954,400,000 | 21,954,400,000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 25,000,000 | 25,000,000 | 100.00 | 2,500,000,000 | 2,500,000,000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 25,000,000 | 25,000,000 | 100.00 | 2,500,000,000 | 2,500,000,000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 133,000 | 5,674,000 | 2.40 | 104.09 | 13,844,090 | 590,611,767 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 5,367,000 | 228,326,000 | 2.41 | 104.09 | 558,655,860 | 23,766,658,833 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 85,000 | 5,541,000 | 1.56 | 104.12 | 8,850,625 | 576,956,625 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 3,415,000 | 222,959,000 | 1.56 | 104.12 | 355,586,875 | 23,215,605,875 | |
| 2013-10-28 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 8,721 | 40,308 | 27.61 | 17.50 | 152,618 | 705,390 | |
| 2013-10-28 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 346,965 | 2,213,897 | 18.58 | 17.50 | 6,071,888 | 38,743,198 | |
| 2013-10-28 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 44,314 | 125,869 | 54.34 | 17.50 | 775,495 | 2,202,708 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 302,479 | 0.22 | 30.33 | 19,957 | 9,174,188 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 11,242,918 | 0.01 | 30.33 | 19,957 | 340,997,703 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 1,732,041 | 0.04 | 30.33 | 19,957 | 52,532,804 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 15,871 | 4.33 | 30.33 | 19,957 | 481,367 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 176,530 | 0.37 | 30.33 | 19,957 | 5,354,155 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 196,794 | 0.34 | 30.33 | 19,957 | 5,968,762 | |
| 2013-08-21 |
|
4 | XOMA |
XOMA Corp
Common Stock |
A - Award | 21,410 | 510,449 | 4.38 | 3.62 | 77,504 | 1,847,825 | |
| 2013-08-21 |
|
4 | XOMA |
XOMA Corp
Common Stock |
A - Award | 1,854,058 | 19,767,770 | 10.35 | 3.62 | 6,711,690 | 71,559,327 | |
| 2013-08-21 |
|
4 | XOMA |
XOMA Corp
Common Stock |
A - Award | 882,323 | 2,829,753 | 45.31 | 3.62 | 3,194,009 | 10,243,706 | |
| 2013-08-21 |
|
4/A | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 21,410 | 510,449 | 4.38 | 3.62 | 77,504 | 1,847,825 | |
| 2013-08-21 |
|
4/A | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 1,854,058 | 19,767,770 | 10.35 | 3.62 | 6,711,690 | 71,559,327 | |
| 2013-08-21 |
|
4/A | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 882,323 | 2,829,753 | 45.31 | 3.62 | 3,194,009 | 10,243,706 | |
| 2013-08-02 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24,705 | 145,533 | 20.45 | 4.40 | 108,702 | 640,345 | |
| 2013-08-02 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 991,161 | 4,832,285 | 25.80 | 4.40 | 4,361,108 | 21,262,054 | |
| 2013-08-02 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 120,498 | 1,642,513 | 7.92 | 4.40 | 530,191 | 7,227,057 | |
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3,030 | 3,030 | |||||
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3,030 | 3,030 | |||||
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3,030 | 3,030 | |||||
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3,030 | 3,030 | |||||
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3,030 | 3,030 | |||||
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3,030 | 3,030 | |||||
| 2013-07-11 | 3 | MYG |
Mirati Therapeutics, Inc.
Common Stock |
81,555 | ||||||||
| 2013-07-11 | 3 | MYG |
Mirati Therapeutics, Inc.
Common Stock |
1,866,932 | ||||||||
| 2013-07-11 | 3 | MYG |
Mirati Therapeutics, Inc.
Common Stock |
31,587 | ||||||||
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 301,821 | 0.20 | 32.85 | 19,907 | 9,914,820 | |
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 301,821 | 0.20 | 32.85 | 19,907 | 9,914,820 | |
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 301,821 | 0.20 | 32.85 | 19,907 | 9,914,820 | |
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 1,731,383 | 0.04 | 32.85 | 19,907 | 56,875,932 | |
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 15,213 | 4.15 | 32.85 | 19,907 | 499,747 | |
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 175,872 | 0.35 | 32.85 | 19,907 | 5,777,395 |
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)
